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ABSTRACT 
Fertilisation is a chance event dependent on, amongst other things, the number, 
motility, and physical characteristics of sperm. There is a strong link: between ATP 
production and sperm motility. The mitochondrially encoded OXPHOS ATP production 
pathway provides ATP for sperm motility. Thirteen polypeptides involved in OXPHOS 
are encoded in mtDNA. Therefore, the aim of this study was to assess the influence of 
point mutations and small deletions in mtDNA on human male fertilising potential. Two 
hundred and fifty two semen samples were screened for mutations in the ATPase 6 and 
8, and COlI genes using polymerase chain reaction (PCR), followed by single-strand 
conformation polymorphism (SSCP) analysis of restriction digests of two overlapping 
amplicons. ATPase 6 and 8 gene analysis of 210 semen samples identified three singly 
occuning known homoplasmic polymorphisms (G -t A 8860, G -t A 8856, and G -t A 
8839); one polymorphism found in 13 samples that created a known Haell RFLP; and a 
novel heteroplasmic point mutation (T -t C 8821) found in the immature sperm from 
two semen samples from an oligo-astheno-teratozoospermic individual. Based on amino 
acid homologies and protein structure this new heteroplasmic mutation is predicted to be 
potentially pathogenic. COlI gene analysis of 223 semen samples identified two 
previously described, singly occurring homoplasmic polymorphisms (C -t T 7476, and G 
-t A 7853); three novel singly occuning homoplasmic polymorphisms (T -t C 8077, G 
-t A 7789, and G -t A 7754); two known homoplasmic polymorphisms found in 
multiple samples (9 bp deletion, 7 samples; G -t A 8251, 11 samples) and one novel 
heteroplasmic homopolymeric tract insertion in the COIIltRNALys intergenic spacer. Of 
the multiply occurring variants found in these genes only a 9 bp deletion from the 
COIIltRNALys intergenic spacer of 7 semen samples could be associated with 
asthenozoospermia. This association was negated when disease and cultural factors were 
considered. 
In addition to the characterisation of true heteroplasmy, one case of pseudogene-
created heteroplasmy was characterised in the COlI amplicon from one semen sample. 
During the analysis of this known pseudogene-created heteroplasmy, two other novel 
pseudogenes paralogous to the mitochondrial ND4/ND5 genes and the HVI region of 
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the D-loop were isolated. All three pseudogenes were characterised and the times of 
pseudogene insertion were calculated. The COIl and ND4/ND5 pseudogenes are 
predicted to have inserted into nuclear DNA since the time of the last common ancestor 
of humans and chimpanzees, whilst the HVI pseudogene is predicted to have an ancient 
origin. These pseudogenes may act as useful markers for molecular evolution. 
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Chapter 1 
GENERAL INTRODUCTION 
Mitochondrial DNA 
The human mitochondrial DNA (mtDNA) genome is a covalently closed circular 
molecule normally consisting of 16,569 nucleotide pairs. It encodes 2 rRNAs, 22 tRNAs, and 
13 of the 67 subunits of the mitochondrial respiratory chain and oxidative phosphorylation 
(OXPHOS) system: 7 subunits of NADH CoQ reductase (complex I), Cytochrome b 
(complex III), subunits I, II, and III of Cytochrome c Oxidase (complex IV), and subunits 6 
and 8 of the FoPl ATP synthase (Fig. 1.1) (Anderson et al., 1981). First sequenced in its 
entirety in 1981 from a mixture of human placenta (European origin) and HeLa cells, the 
initial human mtDNA sequence has since been deemed a worldwide reference, called the 
Cambridge sequence (after the locality where the sequencing was performed). This sequence 
has since been revised (Marzuki et al., 1991). Within this thesis, reference to the Cambridge 
sequence, inplies the revised sequence. 
Mitochondrial DNA is predominantly maternally inherited. The reasons for this are 
still debated but could include dilution effects (oocytes have up to 200 fold more copies of 
mtDNA than sperm), destruction of the mitochondrion-containing sperm mid piece 
(Cummins, 1997) or preferential inactivation of sperm mtDNA in the oocyte cytoplasm 
(Kaneda et aI., 1995). However, paternal transmission has been demonstrated in a number of 
species (e.g. Gyllensten et al., 1991, Magoulas and Zouros, 1993) with mussels (Mytilus sp.) 
having almost uniform biparental inheritance (Zouros et al., 1992). In sea urchins, the spenn 
mitochondria actively participate in embryogenesis up to the 8-cell stage (Anderson and 
Perotti, 1975). In mammals this has never been demonstrated although there is a requirement 
in the developing embryo for extra-nuclear paternal input (e.g. Sathananthan et al., 1996). 
The lack of mixing of the paternal and maternal mtDNA at fertilisation (predominant 
uniparental inheritance) means that mtDNAs do not recombine, although the machinery for 
recombination is present (Lightowlers et al., 1997). Because of the lack of recombination 
almost all mtDNA variation is the product of random, sequential mutations along maternal 
lineages. 
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Figure 1.1. Diagrammatical representation of the human mtDNA molecule. The protein encoding genes are 7 
subunits ofNADH CoQ reductase (N01, 2,3,4, 4L, 5, 6), Cytocluome b (Cyt b), subunits I, IT, and TIl of 
Cytocluome c Oxidase (COl, IT, TIl), and subwllts 6 and 8 of the FoPl ATP synthase (ATPase 6,8). Transfer 
RNAs are refered to by their single letter codes. The iso-acceptors of serine and leucine are specified. 
Ribosomal RNAs are refered to by their size in Svedberg wlits. Origins of replication for the heavy (Ow and 
light (OL) strands are shown. No attempt has been made to specify the coding strand of each gene. Where 
relevant tills is mentioned in the text (adapted fTOm Wallace, 1993). 
Mitochondrial DNA is particularly prone to mutations! since the mtDNA is not 
packed with histone-like proteins (Torroni and Wallace, 1994). Mitochondria have a low 
efficiency DNA repair system and mtDNA are attached to the mitochondrial inner membrane 
in close proximity to OXPHOS, where many mutagenic oxygen free radicals are generated 
(Bandy and Davison, 1990). As a result of the proximity of the mtDNA to OXPHOS, the 
I The tenninology defining 'changes' can be ambiguous. Throughout this thesis events that cause variation are temled Illutational 
events, hence the variations they cause are Illutations. l1lis is not intended to imply all mutations have deleterious effects. Where 
mutations have been shown previously to be population variants, with no known deleterious effects they are refered to as polymorphisll1s. 
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mutation rate2 of mtDNA, whilst not uniform, is generally 10 to 17 times higher than nuclear 
DNA (including pseudogenes) (Shoifuer et ai., 1990). Paradoxically, mtDNA is not designed 
to accommodate a higher mutation rate. Whilst an altered genetic code including frequent use 
of a 'four-way pairing system' for codon assignment (A vise, 1991) may be an advantage in a 
high mutation system, the lack of intergenic spacers and introns to act as mutation 'sinks' is 
not. The mtDNA molecule has been streamlined and compacted through evolution by the loss 
of intergenic spacers and introns and the transfer of functional genes to the nuclear genome 
(Wallace, 1986). This may have provided selective advantage, as small sized mtDNA 
molecules will replicate faster and hence enhance fitness both at the intracellular and 
organismallevel (Avise, 1991). 
One intergenic non-coding region not lost over time is the displacement loop (D-
loop) (Fig. 1.1). The D-loop contains three relatively invariant conserved sequence blocks 
(CSB) and two hypervariable regions (HV1 and 2) and is thought to help regulate 
transcription and replication (Saccone et ai., 1991). The lack of coding and general functional 
constraints in HVI and 2 have allowed them to evolve at a very high rate to the extent that 
they have been investigated as an alternative to DNA fingerprinting for between-individual 
identification (piercy et ai., 1993). This high rate of mutation and the lack of recombination 
has allowed mtDNA to be used as a marker for population variation and species evolution 
(for recent review see Cavalli-Sforza, 1998). 
Mitochondrial biogenesis 
Mitochondrial DNA is a double stranded molecule. The two strands differ 
markedly in their base composition. The heavy, (H)-strand contains most of the guanine 
(G) residues whilst the light (L)-strand contains most of the cytosine (C) residues. The 
H-strand functions as the template for the two rRNAs, 12 of the polypeptides, and 14 of 
the tRNAs whilst the L-strand is the template for the ND6 polypeptide and 8 tRNAs 
(Ojala et ai., 1981). MtDNA uses two replication origins; OL and OH. Replication from 
OH is initiated first by prior RNA transcription from the light strand propmotor (LSP) 
using an mtRNA polymerase in association with a mitochondrial transcription factor 
(mtTF A). This RNA molecule binds strongly to two conserved sequence blocks (CSBI, 
2 Whilst it is acknowledged that the mutation rate and the mutation fixation rates are frequently different, the tenn mutation mte is used 
generally to cover both except where specified. 
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II) prior to OH. The non-bound RJ"fA is clipped by an MRP Rnase. The bound RJ"fA then 
acts as a primer for H-strand replication. With the progression of H-strand synthesis 
(clockwise on Figure 1.1), the parental H-strand is displaced. L-strand synthesis is 
initiated in an anti-clockwise direction, when OL is exposed (Wong and Clayton, 1986). 
L-strand synthesis proceeds back along the free H-strand, thus replication is bidirectional 
but asynchronous (for review see Shadel and Clayton, 1997) 
Transcription is also bidirectional with promoters for both the H and L-strands in 
the D-loop facing in opposite directions. The H-strand promoter (PH) reads 
anticlockwise whilst the L-strand promoter (PL) reads clockwise (Montoya et al., 1981). 
Both transcripts encompass the entire genome. As tRJ"fAs are formed they fold and are 
cleaved out (Ojala et al., 1981) releasing mRJ'\fAs and rRJ"fAs in the process. Messenger 
RJ"fA poly-A tails are added posttranscriptionally (Anderson et al., 1981). As mtDNA 
uses a different genetic code to nuclear DNA (Anderson et al., 1981) mitochondrial 
mRJ'\fA cannot be translated in the cytoplasm. 
Mitochondrial DNA as a marker for human population variation 
As a consequence of random mutations along defined lineages, human 
populations now harbour a wide variety of ethnic-specific changes. This has given rise to 
defined haplotypes which associate with specific populations or ethnic groups. However, 
mutations are random, continuous and reversible meaning that not all individuals with 
one change will belong to the same haplotype. Population variants fall into two 
categories. (1) Mutations can be neutral, silent changes that have no bearing on amino 
acid sequence or the functional properties of mtDNA These changes in populations are 
termed polymorphisms. (2) Deleterious mutations, however, can also become fixed in 
populations if they are expressed later in life and have no affect on the reproductive 
fitness of an individual. As more and more sequences are compared between and within 
popUlations, more discriminatory markers are found and sub-haplotypes are created 
within existing haplotypes. Haplotype creation, essentially the classification of 
discriminatory markers, has been made possible with the help of computer aided 
phylogenetic analysis based on the pairwise comparison of sequences or restriction 
fragment length polymorphism (RFLP) frequency tables (e.g. Cann et al., 1987). 
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Analysis of haplotype relatedness by phylogenetic methods can give startling 
insights into human evolution. Cann et al. (1987) demonstrated, by phylogenetic analysis 
of the mitochondrial genome, that all modern humans could be placed on one 
.'1 
phylogenetic tree rooted in Africa 200,000 years ago. An assumption in this analysis is, 
however, that the rates of mutation (and hence presumably mutation fixation) have 
remained constant in evolutionary history (Kocher et al., 1989). Analysis of more recent 
human radiations from the timing of human population expansions (e.g. Sherry et al., 
1994) to the determination of ethnicity progression (for review see Torroni and Wallace, 
1994) have all been possible with phylogenetic analysis using mtDNA. 
Mitochondrial DNA diseases 
As mtDNA has few intergenic spacers and mutations occur at random positions, the 
coding region accumulates many mutations. Whilst relaxed codon usage limits the damage 
these mutations may do, many are known to be deleterious. All 13 polypeptides encoded by 
mtDNA are integral to OXPHOS, therefore deleterious mutations invariably cause a decrease 
in ATP production. fu addition to the 13 polypeptides, the 22 tRNAs and 2 rRNAs can also 
contain deleterious mutations. As no nuclear encoded tRNAs are imported into mitochondria 
from the cytoplasm, mutations in the tRNA genes can have severe effects on mitochondrial 
protein synthesis. An increasing number of diseases have been attributed primarily to mtDNA 
mutations (for review see Brown and Wallace, 1994). Many of these diseases share similar 
characteristics of inheritance and penetrance. fu genu and somatic cells, there are many 
mitochondria, frequently interconnected, but all containing many copies of mtDNA All 
mtDNA mutations initially exist as a single copy of mtDNA in a cell of an individual. These 
mutations, providing they do not affect replication, are reproduced when the mtDNA 
replicates. During mitosis, the mutation containing mtDNA segregates either randomly or 
selectively to daughter cells. Cells, tissues, or individuals that have more than one type of 
mtDNA are said to be heteroplasmic. Cells can withstand a certain amount of deleteriously 
mutant mtDNA before they are phenotypically affected. The point at which the abnormal 
phenotype becomes detectable is called the threshold, and is dependent on the balance of 
ATP requirement and optimal ATP production. The threshold can vary between cells and 
tissues, and depends on the type of mutation and whether there are other changes that can act 
as secondary mutations. Deleterious mutations (with exceptions) are seldom passed on as 
homoplasmic changes as these have a negative effect on fitness. They can, however, be 
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inherited heteroplasmically for a number of generations. All mutations go through a state of 
heteroplasmy. Selectively advantageous or neutral mutations tend to become fixed to 
homoplasmy or get lost rapidly, with the rate often exceeding that expected by chance alone 
(Hauswirth and Laipis, 1982). In some instances heteroplasmic changes are fixed to 
homoplasmy in as little as one generation, but in others they are maintained in a heteroplasmic 
state, for many generations (Howell et al., 1996) (see Chapter 4). The mechanisms for 
maintenance of heteroplasmy are poorly understood, but may involve selective amplification 
of rare 'alleles' within developing oocytes, a so called 'bottleneck' effect (poulton, 1995). 
Given that all mtDNA mutations must go through a state of heteroplasmy, and that the 
mtDNA mutation rate is high, one would expect that heteroplasmy is common. However, 
until recently, little heteroplasmy has been found. 
Heteroplasmy (discussed in Chapter 4), and indeed mtDNA diseases, can be divided 
into two groups according to the nature of the mutations. Those caused by nucleotide 
substitutions and those caused by irisertions and deletions. Nucleotide substitutions can occur 
anywhere in the mtDNA, but when causing disease, the changes usually occur in the 
conserved nucleotides in the protein coding region or tRNA or rRNA coding regions. For 
example Leber's hereditary optic neuropathy (LHON), a maternally inherited form of adult 
acute-onset vision loss, can be caused by a number of nucleotide substitutions. Sixteen 
LHON mutations have been characterised to date, 11 of which occur in the mitochondrial 
ND genes (from OXPHOS complex 1). The most common of these changes is a G ~ A 
transition at nucleotide (nt) 11778 (Wallace et al., 1988) which is present in over 50% of 
LHON patients. It changes a conserved arginine to a histidine residue in ND4. In addition to 
primary mutations there are a number of characterised secondary mutations that are mildly 
deleterious, accumulate over time, and predispose an individual to LHON. Such mutations 
require additional factors to cause LHON, and therefore are generally associated with late 
onset of the disease (Howell et al., 1993). Primary LHON mutations are frequently 
homoplasmic. Between LHON lineages, incomplete penetrance and the presence or absence 
of secondary mutations creates a complex population picture of mitochondrial diseases. 
Like nucleotide substitutions in protein coding genes, those in tRNA and rRNA 
coding regions are also frequently heteroplasmic. An A ~ G transition in tRNALys at nt 8344 
gives rise to myoclonic epilepsy with ragged red fibres (MERFF) (Silvestri et al., 1993), This 
maternally inherited disease, which causes uncontrolled jerking (myoclonic epilepsy) and 
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myopathies is associated with a decrease in the synthesis of complex I and IV mitochondrial 
proteins. Likewise an A -+ G at nt 3243 within tRNALeu(UUR) causes mitochondrial 
encephalopathy, lactic acidosis, and stroke like episodes (MELAS) (penn et al., 1992). Both 
MERFF and MELAS are generally heteroplasmic, with the severity of the phenotype being 
directly dependent on the percentage of mutant DNA in cells, tissues, and individuals; and the 
age of the patient. The age of the patient is thought to be important because older people do 
not have as efficient OXPHOS as younger people, possibly because of a lifetimes' 
accumulation of secondary mutations in post-mitotic tissues. Therefore, a small proportion of 
mutant DNA may create a disease phenotype in an older person, while a larger proportion of 
the same mutant is needed to produce the disease phenotype in a younger person (Shoffuer et 
al., 1990). Mitochondrial DNA diseases caused by nucleotide substitutions typically require a 
tissue to have greater than 80% mutant DNA for a disease phenotype to manifest itself. As 
mentioned, this threshold is both age and tissue specific. The earliest affected tissues (those 
with the lowest threshold and highest ATP demand) have been characterised as brain, kidney, 
heart, and liver (in this order) (Brown and Wallace, 1994). In addition, type I muscle fibres 
are readily affected, and if present in the pancreatic islet cells, mutations that cause a 
reduction in OXPHOS inhibit insulin secretion leading to late onset diabetes (type IT). 
The second type of mtDNA mutation, insertions and deletions, can also cause disease 
phenotypes. Diseases caused by deletions range from the mild chronic progressive external 
opthalmoplegia (CPEO) to the severe Keams-Sayre syndrome (KSS). Patients with these 
disorders are clinically variable, although most have ophthalmoplegia (paralysis of the eye 
muscles), ptosis (droopy eye lids), and mitochondrial myopathy. Patients with KSS can also 
have retinitis pigmentosa, hearing loss, heat conduction defects, ataxia, and dementia 
(Wallace, 1992). Although over 100 deletions are associated with these and other conditions, 
the deletions share many common properties. Firstly, they are rarely maternally inherited, 
arising spontaneously within an individual. There are examples of autosomal dominant 
deletion inheritance, where the deletions are not inherited per se, but the propensity for 
deletion occurrence is (Suomalainen et al., 1995). Secondly, deletions commonly occur 
between direct repeats, the most common deletion occurring between the largest direct 
repeat, suggesting that a common mutagenic mechanism is slip-replication (eg. Johns et aI., 
1989; Shoffuer et al., 1989). Thirdly, most deletions remove at least one tRNA, thus affecting 
many OXPHOS complexes (Wallace, 1992). Fourthly, deletions tend to spare the heavy and 
light strand origins of replication, allowing replication to proceed on the shortened molecule. 
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Because of the decreased length of the molecule, replication is faster than for normal length 
molecules, and therefore the deleted molecule increases in proportion temporally in affected 
individuals. Conversely, mtDNA insertions causing Pearson's syndrome incorporate both 
replication origins. The doubling of replication origins in inserted molecules presumably leads 
to an increase in replication and could explain the selective enrichment of these larger 
molecules characteristic of this syndrome (Brown and Wallace, 1994). 
Neutral mtDNA mutations 
In addition to the above insertion and deletion events, all of which are heteroplasmic 
and deleterious, there are a number of presumably silent insertion and deletion events 
characterised. A 9 bp deletion within an intergenic spacer between COlI and tRNALys is 
commonly found in Afiican, Polynesian and some American Indian populations (eg. Sykes et 
al., 1995). In the same intergenic spacer, a simple 4 bp homopolymeric insertion has been 
seen presumably caused by replication slippage (discussed in Chapter 3). In the D-Ioop such 
homopolymeric insertions are frequently seen in heteroplasmy, with variable lengths of tracts 
being added. All of these insertions and deletions are, however, assumed to be neutral, given 
that they cause no phenotypic effects, even in homoplasmy. 
The assignment of nucleotide sequence changes as either polymorphisms or 
deleterious mutations is difficult. Riordan-Eva and Harding (1995) used a number of criteria 
to distinguish between the two. Firstly, deleterious mutations should be found specifically in 
individuals with the disease and not in normal individuals. Secondly, the mutations should 
change a highly conserved nucleotide or amino acid. Thirdly, the mutations should not be 
found with other disease causing mutations. Fourthly, the mutations should be heteroplasmic, 
with a large amount of mutant DNA being required before the mutant phenotype is displayed. 
In addition they defined a need for maternal inheritance. This and other points, are in dispute. 
Many mutations such as deletions arise spontaneously or may be inherited in an autosomal 
dominant fashion. Some LHON mutations are homoplasmic but fit all of the other criteria. 
Many secondary mutations can be found in normal individuals but only have phenotypic 
effects in the presence of other mutations. Thus the distinction between deleterious mutation 
and polymorphic sequence variant is often blurred. Recent evidence suggests that even 
seemingly silent, haplotype-defining, polymorphisms may be markers for mtDNA disease 
susceptibility (e.g. Hofmann et al., 1997). 
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Mitochondrial DNA mutations, selection, and fertility 
The predominantly uniparental maternal inheritance of mtDNA creates interesting 
selection issues. Any mutation affecting males is effectively neutral on a population level 
because: 
"Maternally transmitted mutations that enhance male fitness tend not to 
increase deterministically within populations, since their beneficial 
effects on males are not rewarded by increased representation among 
later generation progeny; and female-transmitted alleles with male-
limited deleterious effects may be retained simply because of relaxed 
direct selection against their loss" Avise (1991). 
In fact a germ-line mitochondrial mutation with severe effects on males, but only mild 
effects on females, could increa:se to relatively high population frequencies because 
natural selection of mitochondria occurs only in females. 
At least one maternally inherited mitochondrial disease affects males more 
severely than females. Between 75 and 85% of individuals affected by LHON are male 
(Brown and Wallace, 1994). As mentioned, 16 distinct base-pair substitutions in 
germline mtDNA have been directly associated with this disease. Linkage analysis 
initially suggested that a deleterious X-linked mutation in combination with defective 
mitochondria may be the cause of this sex bias (Vilkki et al., 1991). Juvonen et al. 
(1996) and others found no further evidence for this, and indeed an analysis of X-
inactivation by Oostra et al. (1996) further argues against an X-linked effect to this sex 
bias. Males may just be more susceptible to the mitochondrial defects. Wallace (1992) 
suggests that men may have a higher optic nerve metabolic rate than women, and 
therefore a lower threshold. Theoretically male-female dimorphism is possible in a 
number of tissues, including the heart (Frank and Hurst, 1996). 
Males germ cells (sperm) may be preferentially affected by deleterious mtDNA 
mutations. Sperm have around 50 copies of mtDNA held in 13 mitochondria, spirally-
arranged in the sperm midpiece (Folgef0 et al., 1993). There is tight coupling between 
mitochondrial energy production and sperm motility, with almost all energy produced by 
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the mitochondria being used to drive the flagellum and propel the sperm (e.g. Kao et al., 
1995). It must be noted, however, that much of the ATP used in flagellar action is 
derived from glycolysis, not OXPHOS (Ford and Harrison, 1981). Additionally, within 
fertile men, the level of seminal A TP is not predictive of fertilising potentiae (Cummins 
et al., 1994). Reduced power output translates directly into reduced motility and 
probably reduced fertilising potential. The effect that deleterious mtDNA mutations, have 
on sperm and ultimately fertilising potential through ATP reduction, however, has to be 
weighed against the fitness effects in females. If the same effects are seen in females in 
other tissues, then these changes will be rapidly selected against and lost, and the 
ultimate effect on population male fertility will be low. 
Human male fertilising potential 
Fifteen percent of couples have problems conceiving. Of these, 30% are due to a 
male cause, with another 20% being related to incompatibility of both partners. Infertility 
(or subfertility) is difficult to define as it is related to a couple's mutual potential to 
reproduce. The World Health Organisation (WHO, 1992) defines infertility as an inability 
to conceive after 12 months of regular intercourse. Lack of male fertilising potential can 
be attributed to a variety of factors. Based on WHO guidelines (WHO, 1992) a male is 
considered to have normal fertilising potential if his ejaculate sperm count is greater than 
20 x 106 spermfrnl of semen, at least 50% of which are motile, and at least 50% having 
normal morphology. Values below these yield the clinical conditions oligozoospermia, 
asthenozoospermia, and teratozoospermia respectively. 
Low male fertilising potential can be caused by a large number of factors that can 
be divided into five categories. Obstruction of excurrent testicular or ejaculatory ducts 
accounts for 7 to 15% of low male fertilising potential. Testicular lesions causing 
spermatogenic failure account for a further 30%. These lesions may include testicular 
trauma, varicocele, genital tract infection or Y -chromosome deletions. Erectile or 
ejaculatory problems, whilst rare, can also cause fertilising potential decrease; as can 
endocrine disorders, such as hypogonadotropic hypogonadism. The most frequent cause, 
however, is termed idiopathic sperm dysfunction (Le. dysfunction with no known 
3 No individual has inherent fertility, fertility is only proven after a child is conceived. Therefore the tenu 'fertilising potential' is used in 
this study to describe the potential to fertilise all egg. 
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aetiology) (Cummins et al., 1994). Causes for this may include antisperm antibodies, 
drug or alcohol use, smoking, environmental factors, and undetermined genetic factors. 
F ertiHsing an egg is a chance event. The ability to fertilise an egg in vivo is 
enhanced with larger numbers of highly motile sperm with normal morphology. 
Conversely, the chances are reduced with fewer active sperm. In this sense, an ejaculate 
of seminal fluid can be considered as a tissue. A 20% decrease in motility could decrease 
an individual's fertilising potential by an equal amount, possibly rendering the affected 
couple effectively infertile. The very tight coupling between mitochondrial energy 
production and motility, and between motility and fertilising potential suggests that if 
deleterious mtDNA mutations were present within sperm they could potentially cause a 
reduction in fertilising potential (Frank and Hurst, 1996). This has been demonstrated in 
a number of studies (e.g. Folgero et al., 1993; Kao et al., 1995). 
There are two types of deleterious mtDNA mutations that have been shown to 
possibly affect male fertilising potential. Firstly, mtDNA deletions within the testes have been 
correlated with spermatogenic failure, resulting in severe oligozoospermia. Cummins et al. 
(1993) first showed that spermatogenic failure in a 36 year-old man might be caused by . 
premature testicular aging as a result of a 4977 bp deletion in the mitochondrial genome, a 
deletion which was first described in normal heart muscle and brain of older people 
(Cortopassi et al., 1992). Kao et al. (1995) then showed that such mutations were relatively 
common in oligozoospermic men, but were also found in normal men. Significantly, they 
showed that the proportion of the mutation present in the semen correlated very well with the 
sperm motility (r -0.98, Kao et al., (1995); Fig. 3 therein), supporting the tight coupling 
between mitochondrial energy production and motility. Others, however, have not found such 
a good correlation (St John et aI., 1997). Lee et al. (1994) could not detect the mutation in 
the testes until the age of 60 years. The mechanisms causing these deletions are unknown. 
Cummins et al. (1994) speculates that the deletions are created in the testes by premature 
testicular aging due to an ischaemic injury. Recent evidence that mutations can be induced in 
rat testes by ischaemic iQjury supports this hypothesis (AM. Jequier, pers. comm.). The 
presence of the mtDNA mutation within testes could explain the lack of mature sperm being 
produced (oligozoospermia) whilst the mutation presence in sperm may explain a reduction in 
motility (asthenozoospermia). 
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Mitochondrial DNA point mutations have also been found in cells within semen. 
Folgef0 et al. (1993) demonstrated that a 50 year old male patient with MERRF with an A ~ 
G transition at nt 3243 in the mitochondrial tRNA Leu{UUR) gene also had reduced sperm 
motility. Although the proportion of mutant DNA within the testes was not stated, blood 
platelet DNA from other members of the proband's family had between 13 and 59% mutant 
DNA (Folgere et al., 1995). The effect on fertility was noted by seminal substrate therapy. 
Different energy substrates can enter the electron transport chain (ETC) at different positions. 
For example, glucose and lactate are both metabolised to pyruvate which enters the ETC in 
complex L Succinate, however, bypasses complex 1, and increases ATP production at 
complex III and possibly complex IV. In this way, if complex 1 is affected by mtDNA 
mutations, ATP production can be increased with the addition of succinate. Incubation of 
semen in succinate selectively increased the motility of sperm from the proband whilst having 
limited effect on semen of control samples (Folgef0 et al., 1993). Therefore, it was concluded 
that the motility of sperm was directly affected by this mtDNA mutation. Contrary to Folgef0 
et ai's report, Huang et al.(1994) failed to detect changes in the sperm motility of a patient 
with MELAS who had the same tRNA mutation. They estimated that 30% of amplified 
mtDNA from cells within semen contained the mutation, and found that sperm motility was 
not different from control samples. They did not, however, demonstrate that the mutation 
was present in sperm per se, only in seminal cells, and did not attempt to increase motility by 
substrate therapy. Semen is a mixture of different cell types, frequently containing leucocytes, 
immature spermatids, and epithelial cells from spermatogenic ducts. All of these will 
contribute mtDNA to a seminal preparation. These two conflicting reports, however, show 
that it is still unclear whether point mutations in sperm mtDNA can affect sperm function. 
All of the above sperm mtDNA mutations have known deleterious effects in 
other tissues. As suggested earlier, a decrease by 20% of sperm motility may cause a 
pathological reduction in fertilising potential. Given the coupling between energy 
production and motility, this could be caused by a 20% proportion of deleteriously 
mutant mtDNA with the sperm. No other tissue is likely to be affected by a proportion 
this low in males, and indeed no tissue in females will be affected at all. This then begs 
the question: 'Could the threshold of seminal fluid, to withstand the effects of mtDNA 
mutations, be very low?' Given that there is no selection against mtDNA mutations in 
males, these mutations may be relatively common, as long as the fitness effect when the 
mutations are in females is low (as would be the case if only a small amount of mutant 
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DNA were present). The incidence of mtDNA defects causing a decrease in male 
fertilising potential is presently unknown. 
This study was instigated to analyse some of the above phenomena. When 
examining the effect mtDNA mutations have on male fertilising potential, there are two 
possible approaches to the problem. The first method involves recruiting subjects with 
known mitochondrial disease and investigating their seminal parameters (akin to the 
work of Folgef0 et al., 1993). However, there are a number of problems with this 
approach. Firstly, the number of patients in New Zealand with defined mitochondrial 
disease is small. Secondly, patients with defined mitochondrial disease are often severely 
affected, frequently not living to reproductive age. And thirdly, an analysis of the 
fertilising potential in patients with mitochondrial disease is not predictive of the 
incidence of reduced fertilising potential being caused by mtDNA mutations in the 
general population. Because of these reasons a different approach was taken in this 
study. This involved recruiting patients in an infertility clinic and screening seminal 
samples for mtDNA variation. Like the earlier approach, this has shortcomings. The 
mitochondrial genome is large and point mutations are small. Because of this only three 
coding genes are screened for mutations in the present study. As the work ofFolgef0 et 
al. (1993) showed substrate therapy can ameliorate the effects of some mitochondrial 
defects. Given that these substrates (such as succinate) may be naturally present in 
semen, we hypothesised that mutations in complexes that cannot be by-passed by natural 
substrates may show greater phenotypic effects than mutations in complexes that can. 
Therefore in this study, the ATPase 6 and 8 genes from the FoP 1 A TP synthase 
(unofficially called complex V) and the COIl gene from complex IV were screened for 
mutations. Recent studies carried out in our laboratory on complex I genes found no 
heteroplasmy associated with fertilising potential (S.l O'Carrol, unpublished MSc thesis, 
University of Canterbury, 1996). The work reported here, therefore, is part of an on 
going project in our laboratory, with other genes such as Cyt b and com being studied. 
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The aims of the present study are: 
1. To instigate a (biased) population study of mtDNA variability in the semen samples 
from men presenting samples to an andrology clinic in Christchurch, New Zealand. 
2. To screen mtDNA protein coding genes ATPase 6, ATPase 8 and COlI for sequence 
variability. 
3. To investigate correlations between the presence or absence ofmtDNA mutations and 
seminal quality. 
4. To characterise new mtDNA heteroplasmy within human sperm for the analysis of: 
a. Fertilising potential 
b. Mitochondrial DNA variation 
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Chapter 2 
ATPASE 6 AND 8 GENE MUTATIONS 
Introduction 
The ATPase amplicon 
The mitochondrial FoFl ATP synthase utilises an electrochemical gradient, generated 
by the electron transport chain, to synthesise ATP from ADP + Pi. Called complex V, this 
ATP synthase (incorrectly but commonly called an ATPase) along with the electron transport 
chain complexes (I, II, ill, IV) and adenine nucleotide translocator constitute the 
mitochondrial energy generating pathway, OXPHOS. Intact ATP synthase was first isolated 
from bovine heart mitochondria in 1974 (Hatefi, 1993). Mammalian mitochondrial FoP! ATP 
synthase is composed of at least 13 polypeptides, two of which (ATPase 6 and ATPase 8) are 
encoded by the mitochondrial genome and syntllesised in the mitochondria. ATPase 8 is also 
commonly called A6L. The coding regions of ATPase 6 and 8 overlap by 46 nucleotides 
(8537 - 8572, numbering from the Cambridge sequence) at the 5' end of ATPase 6. ATPase 
6 and 8 have different reading frames (Anderson et al., 1981). Both ATPase 6 and ATPase 8 
are found within the Fo subunit of FoPl ATP synthase. This subunit acts as a membrane 
anchor and proton pore, facilitating proton movement through the inner mitochondrial 
membrane across an electrochemical gradient. Within the Fo pore, it is thought that ATPase 8 
is in a 1 : 1 molar ratio with the pore itself (Hekman et at., 1991), It is anticipated that 
ATPase 6 is in the same molar ratio, consistent with ATPase 6 and ATPase 8 both being 
transcribed on the same mRNA. In addition to the two mitochondrial subunits, five additional 
nuclear encoded subunits malce up the Fo pore (Hatefi, 1993). 
The structure of ATPase 8 is presently unknown. Hekman et at. (1991) demonstrated 
that parts of ATPase 8, including its C-terminus, were exposed on the matrix side of the inner 
mitochondrial membrane in bovines. Consistent with the lack of known stlUcture is the lack 
of known function, and the lack of pathogenic mutations affecting stlUcture and function. 
Structural models of the human ATPase 6 protein are based on models of the 
homologous Escherichia coli Fo A TP synthase subunit a protein. Multiple mutational studies 
have been performed on the E. coli protein to elucidate its secondary stlUcture and residues 
16 
important for its function in the FoP 1 ATP synthase. Cox et al. (1986) proposed a five 
transmembrane helix (a1 - as) secondary structure model for both the E. coli and human 
proteins (Fig. 2.1). Homology studies, site-directed mutagenesis studies and naturally 
occurring mutations have provided evidence that conserved residues in helix a4 are essential 
in allowing the Fo subunit of the FoPl ATP synthase to function as a proton pore (for review 
see Senior, 1990). 
COOH 
Inside 
a1 a2 a3 a4 as 
Outside 
Figure 2.1. Proposed structure oftbe human ATPase 6 protein (modified from Cox et al., 1986). Membrane 
spanning helicies are labelled al - a5. Inside and outside refer to the orientation within the inner mitochondrial 
membrane. 
Five deleterious mutations have been identified in the ATPase 6 gene. The most 
common of these is a T -+ G transversion at nt 8993. It changes a highly conserved leucine to 
an arginine at residue 156 in helix a4 of the ATPase 6 protein (Holt et al., 1990). A T -+ C 
transition at the same position has been seen, changing the Leu156 to a proline (de Vries et al., 
1993). These mutations cause diseases with varying severity ranging from neurogenic muscle 
weakness, ataxia and retinitis pigmentosa (NARP) (Holt et al., 1990) to subacute necrotizing 
encephalopathy (Leigh's disease) (Tatuch et al., 1992). They have been found both in 
homoplasmy and heteroplasmy but require high proportions of mutant DNA for phenotypic 
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symptoms. Leu156 is considered to be an integral residue for proton translocation across the 
inner mitochondrial membrane as demonstrated in E coli and yeast studies (de Vries et al., 
1993). A T --+ C transition at nt 8851 has been described in a patient with bilateral striatal 
necrosis (similar to Leigh's disease) (de Meirleir et al., 1994). This mutation changes 
tryptophan residue 109 to an arginine in helix a3. Similarly, aT --+ C transition at nt 9176 was 
found in two brothers, also with bilateral striatal necrosis (Thyagarajan et al., 1995). This 
alters the highly conserved leucine residue 217 to a proline. The mutation only manifested 
phenotypically when the proportion of mutant DNA was greater than 98%. Leu217 is in the C-
terminus of ATPase 6, a region which has been proposed to be involved in proton 
translocation (Hartzog and Cain, 1993). A T --+ C transition at nt 9101 has been associated 
with LHON (see Chapter 1) (Lamminen et al., 1995). However, the affected proband and 
three unaffected maternal relatives all had this change in homoplasmy. Additionally, the amino 
acid residue affected (Del92) within helix a5 is very weakly conserved even in vertebrates. 
Based on these last two points the T --+ C at nt 9101 may at best be a secondary mutation. 
The incidence of mtDNA defects causing a decrease in male fertilising potential is 
presently unknown. Since mutations in the ATPase 6 and 8 genes are known to affect the 
phenotypes of individuals carrying the mutations and the protein products of these genes 
are integral products of complex 5, the penultimate OXPHOS complex, and as such can 
not be bypassed by natural energy substrates (see Chapter 1), a mutation in these genes 
may affect sperm function. 
The aims of the present study were to assess the variability in the ATPase 6 and 8 
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genes and identify mutations in these genes in a Christchurch male population and to 
determine if these mutations can be related to the fertility status of the individuals 
carrying the mutations. 
In this study, mutation screening (described below) was facilitated by polymerase 
chain reaction (PCR) amplification of the ATPase 6 and 8 genes in an ATPase amplicon. This 
amplicon spans not only these genes but regions of COIl and corn and also tRNALys. COIl 
and tRNALys are covered in the following chapter. As shown in the results, no changes were 
found in com and so this will not be mentioned further. To detect'sequence variability in the 
ATPase amplicon single-strand conformation polymorphism (SSCP) analysis 
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was used (Orita et al., 1989). SSCP relies on the fact that when single stranded DNA is 
cooled quickly it folds up on itself forming a secondary structure. When separated through 
non-denaturing polyacrylamide gels, these secondary structures have a mobility dependent on 
both size and shape. A difference of one base pair between two otherwise identical DNA 
fragments frequently changes the shape of one and hence creates a mobility shift with respect 
to the other. 
Matetials and Methods 
Sample collection 
Subjects were recruited from couples who presented for semen analysis at 
Christchurch Women's Hospital between January 1994 and the January 1997. Included in this 
group are couples who have male factor infertility, female factor infertility, or infertility of 
unknown aetiology. Additionally, semen from some donors involved in the donor 
insemination program and samples produced prior to long term storage were included. 
Ethical approval was obtained from the Southern Regional Health Authority Ethics 
Committee (Canterbury). The donors gave consent for the residue of their semen samples 
(after routine semen analysis) to be used for research. Semen samples were produced by 
masturbation after 3 - 5 days of abstinence. The semen samples were analysed at the 
Atfdrology Laboratory, Christchurch Women's Hospital, according to standard criteria 
(WHO, 1992). Whole semen samples were transferred frozen to the Zoology Department, 
University of Canterbury, thawed on ice and re-aliquoted to 100 I-li aliquots. These aliquots 
were snap frozen to -80°C for long term storage. For confidentiality reasons, sample 
information used in this study was restricted to non-identifYing sample codes with sperm 
counts, sperm motility, seminal volume and year of birth of the donor. All screening in this 
study was non-biased. Samples were sequentially chosen from the pool irrespective of count 
or motility. Within the sample pool there are cases of repeated samples from donors. 
For ATPase amplicon screening, 210 semen samples were analysed with a mean 
count of 69 x 106 sperm/ml (± 78), a mean sperm motility of 48% (± 20) and a mean 
donor age (at time of donation) of 36. Full details of the samples used in this screening 
are included in Appendix 1. 
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Cell DNA isolation 
The preferential purification of mitochondrial DNA generally requires large volumes 
of starting tissue. Frequently, after routine semen analysis, the volume of semen obtained for 
this study was under 100 Ill. Therefore in seeking a DNA extraction protocol the following 
points were considered. (1) Sperm have relatively less mtDNA than other tissue types, (2) the 
volume of sample was a limiting factor, and (3) if possible all seminal mtDNA had to be 
available for PCR (see Chapter 4). For the above reasons a modified buccal cell alkaline lysis 
protocol (Lench et al., 1988) was used for the extraction of mtDNA from semen. This 
method requires little manipulation, can be performed in a single tube (ensuring no loss of 
DNA by repeated extractions), and is ideal for small volumes of starting material. 
Semen samples were thawed on ice. Cells were pelleted from 5 ~tl aliquots by 
centrifuging at 4,500 x g, 4°C for 10 min (Jouan MR 14.11 centrifuge). The cell pellet was 
washed with 400 ~ of 100 mM NaCI, 10 mM EDTA (pH 8.0), then re-centrifuged as before. 
The cell pellet was resuspended in 40 ~tl of 50 mM NaOH by vortexing, then boiled for 15 
min and neutralised with 10 ~tl of 1 M Tris-HCI (pH 8.0). Ten-microlitre aliquots were frozen 
at -20°C until further use. The impurity of this DNA preparation meant that no quantification 
of DNA could be made, suffice as to say that between 2.5 and 5 III of prepared DNA was 
sufficient for PCR amplification irrespective of the cell count of the original semen sample. 
In one instance mtDNA was isolated from whole blood by first lysing red cells in a 
50 ~ll aliquot of whole blood with 1 ml of 0.14 M NH4Cl. This was shaken gently for 10 
min before pelleting white cells in a bench top microfuge at 550 x g for 2 min. The cells 
were washed with 1 ml of 0.14 M NRtCI and pelleted again as before. The pellet was 
resuspended in 400 ~LI of 50 mM NaOH and boiled for 15 min as above then neutralised 
with 100 III of 1 M. Tris (pH 8.0). Five-microlitre aliquots provided sufficient template 
for PCR amplification. 
Polymerase chain reaction 
ATPase amplicon primers were chosen using the OSP computer program (Hillier 
and Green, 1991) in such a way that they did not fall on common mtDNA polymorphic 
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sites, did not anneal to themselves or each other with high affinity and had melting points 
above 50°C for high specificity binding. The primers chosen were HMTL817 (5' 
CAATGCTCTGAAATCTGTGG) and HMTH934 (5' tagtatgaggagcgttatgg). These 
primers amplifY a 1174 bp ATPase amplicon between nt 8186 and nt 9341 (numbering 
from the Cambridge sequence). The ATPase amplicon encompasses genes for ATPase 6, 
ATPase 8, tRNALys, 101 bp of COIl and 134 bp of COllI. PCR conditions for the ATPase 
amplicon were optimised for MgCh concentration and annealing temperature. 
For the analysis of the ATPase amplicon, a 5 ~Ll aliquot of total cell DNA was 
subjected to 30 cycles of touchdown PCR in a 25 ~LI reaction. The 25 ~Ll reaction mixtures 
contained 20 pmol of each primer, 5 nmol of each dNTP, 2.5 J..ll of 10 x reaction buffer (500 
mM KCI, 100 mM Tris-HCI (PH 9.0», 2 mM MgCb and 0.75 units of Taq polymerase 
(Promega or Boehringer Mannheim). The cycling parameters were an initial five cycles of 
94°C/30 sec, 60°C/30 sec; and nocll min 20 sec followed by a further five cycles of 
94°C/30 sec, 56°C/30 sec, and 72°CIl min 20 sec. This was followed by 20 cycles of 
94°C/30 sec, 54°C/30 sec, and 72°CIl min 20 sec. Prior to initiation of the PCR, reaction 
mixes were equilibrated at 80°C for between 2 and 5 min. This equilibration step was found 
to be essential for highly specific, and efficient product formation. Thennal cycling was 
performed in two different PCR cyclers (Perkin Elmer 480 and MJ Research PTC 100) with 
no product variability being seen between these machines. 
Mutation Detection 
The 1174 bp ATPase ampli~n PCR product from all 210 semen samples was 
cleaved to completion by Taq1 restriction endonuclease prior to SSCP analysis. Ten 
microlitres of PCR product (100 - 200 ng) was cleaved with 2 units Taql (Boelllinger 
Mannheim) at 65°C to yield fragments of 789 bp and 384 bp. No star or partial activity 
was observed with Taql digestion. For SSCP analysis, 3 J..lI of digested DNA (15 - 30 ng) 
was heat denatured with 8 J..lI offonnarnide gel loading buffer (95% formarnide (v/v), 20 mM 
EDTA, 0.05% Bromophenol blue (w/v), 0.05% xylene cyanol FF (w/v) (Po on et al., 1993» 
for 5 min at 95°C before being plunged onto ice and left for at least 5 min. Samples were 
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electrophoresed on 5% non-denaturing polyacrylamide gels (49010 acrylamide : 1% bis-
acrylamide) (Appendix 2) for 8 hours (4°C, 200 V). Gels were pre-run to equilibrate in 45 
ruM Tris-HCI, 45 ruM Orthoboric acid and 1 ruM EDTA (0.5 x TBE). Gels were fixed and 
silver stained using a modification of the protocol of Bassam et al. (1991) (Appendix 2). 
Band densities, where appropriate, were determined from dried gels using a hand held 
scanning densitometer and Biomed Image Analysis software (Advanced American 
Biotechnology, Fullerton, CA). 
Undenatured DNA, when electrophoresed on SSCP gels gave single bands that 
did not interfere with scoring of denatured bands. To assign fragment sizes to denatured 
bands, both of the ATPase amplicon Taql fragments were isolated from agarose gels 
individually by either a 'freeze and squeeze' protocol (Towner, 1993) or using a 
commercial gel extraction kit (BioRad or Boehringer Mannheim) and were 
electrophoresed as denatured and undenatured forms on SSCP gels. 
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Where changes in SSCP pattern were observed during screening, the samples 
were analysed again to confirm the change in pattern. The ATPase amplicons from 
samples with consistently different patterns were then cleaved with different restriction 
endonucleases and re-analysed bySSCP analysis. The DNA fragments carrying the 
nucleotide changes were identified by comparing the mobilities of the fragment bands 
with those of the controls. 
Each of the two single strands (ssDNA) of a fragment of double stranded DNA 
(dsDNA), when denatured and allowed to form a secondary structure, will fold 
differently. Because of this, each fragment, a single band when undenatured, will move as 
two bands in an SSCP geL On occasion, one of the single strands may form more than 
one stable secondary conformation; creating three or more bands representing the 
original dsDNA fragment. A homo plasmic or polymorphic change can be recognised by 
one or both of the ssDNA bands having altered gel mobility when compared with a 
control sample. While a heteroplasmic change can be identified when one or more new 
bands are seen in addition to the bands which are present in the control sample (Fig. 2.2). 
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Figure 2.2. Diagrammatical representation of SSCP analysis. Circles represent normal bases with 
triangles being the mutated counterparts at the same position. Filled and empty shapes represent bases 
on different strands of the sanle fragment. When resolved, homoplasmic normal samples give two bands 
per fragment as shown in lane 1. Heteroplasmic samples (lane 2) have both normal bands (as lane 1) 
and one or two additional bands representing the mutant strands. Lane 3 represents a homoplasmic 
mutant where one or both of the bands runs in a different position to the normal (lane 1). 
Single cell analysis and sequencing 
Heteroplasmy, as seen in SSCP gels, can be analysed in a number of ways. (1) If the 
mutant DNA is greater than 20% of the total DNA (Smith et al., 1992), direct sequencing of 
the mixture will often resolve the mutation. If the sequencing creates any other artefacts, 
however, this will not work as the sought after variation will also appear as an artefactual 
band or peak. (2) Mutant bands can be extracted directly from SSCP gels and amplified to 
enrich the mutant component for sequencing (Suzuki et al., 1991; Sherratt et al., 1996). This 
can be done only if the DNA is stained with ethidium bromide (which only weakly stains 
single stranded DNA) or is isotopically labelled. Silver stained DNA can not be re-amplified. 
(3) The heteroplasmic region of interest can be cloned into plasmids; the resulting clones will 
be either mutant or normal (see Chapters 3 and 4). (4) Finally, and potentially most 
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infonnatively, single cells can be isolated, and the DNA amplified and analysed. As different 
cells have different proportions of mutant mtDNA in heteroplasmy, mutant enriched cells can 
be analysed and the mutant mtDNA sequenced. This procedure was chosen for the analysis of 
an ATPase amplicon heteroplasmy in two samples from one individual ( see results). 
Single cells were aspirated from a 1,000 times diluted semen sample under oil using 
micromanipulation techniques. Briefly, 1 rom D.D. glass needles (Clark Electromedical 
Instruments) were pulled to a 2 [lm O.D tip using a Narishige microelectrode puller. Tips 
were ground to a 45° bevel with an inner hole diameter of 5 !lID using a Narishige EG-7 
microgrinder. Needles were sterilised by baking at 150°C for 4 hours and then exposing to 
UV. light for 20 min. Cells were resuspended in PBS (120 mM NaCI, 16 mM Na$IP04, 4 
mMNaHiP04 (PH 7.3» at 10,000 cells per ml and 20 [ll was transferred to the base ofaLux 
5221 tissue culture dish. This drop was covered in sterile mineral oil (Sigma) to prevent 
optical edge effects and cells were visualised under a Leitz Diavert inverted microscope. 
Single cells were aspirated into the bevelled tip of a needle held in an M3301 
Micromanipulator (World Precision Instruments). The fine control for cell pick-up was 
provided by holding pressure from a PV830 Pneumatic Picopump (World Precision 
Instruments) attached to a N2 gas supply. When cells other than single spenn were analysed, 
needle hole diameter was increased to between 10 and 20 [lm. Cells were transferred to a 
drop of mineral oil in the cap of 0.5 ml Eppendorf tubes for DNA extraction and subsequent 
PCR amplification. Two and a half microlitres of 200 mM KOH and 50 mM DTT was 
added to the cells and they were incubated for between 10 and 30 min at 65°C. This 
solution was neutralised with 2.5 ~LI neutralising buffer (300 mM KCI, 900 mM Tris 
(pH8.3), 200 mM HCI) (Cui et al., 1989). 
The 5 [ll solution containing the lysed cell was directly subjected to a PCR 
amplification of one cycle of 94°C/3 min, 40 cycles of 94°C115 sec, 50°C1l5 sec, and nocll 
min, and one cycle of nOC/5 mm usmg primers HMTL822 
(5' ATTCCCCTAAAAATCTTTGAAA) and HMTH897 (5'tgagtaggctgatg). This 25 [ll 
reaction contained 2.5 pmol of each primer, 2.5 nmol of each dNTP, 2.5 [ll of 10 x reaction 
r< 
buffer (500 mM KCl, 100 mM Tris-HCI (PH 9.0», 2 mM MgCh and 0.5 units of Taq 
polymerase (Boehringer Mannheim). A 5 [.tl aliquot of this primary 595 bp PCR product 
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was then re-amplified using a hemi-nested PCR protocol. Primer HMTH897 was joined by 
the internal primer HMTL854 (5'TCATTCATTGCCCC) to amplify a 430 bp fragment using 
the same cycling conditions as above. Primer quantities were increased to 5 pmol and the 
MgCh concentration for this internal PCR was 1 mM. Conditions for the above PCR 
reactions are based on Lien et al. (1993). A 1.5 J.lI aliquot ofthe second PCR product was 
directly analysed by SSCP analysis as before. In addition to single cells and cellular aggregates 
being analysed in this way, seminal fluid controls were taken. Five microlitres of seminal fluid 
suspended in PBS was centrifuged for 10 min at 12,000 x g to pellet all cells. That there were 
no cells in suspension was checked in a Makler counter (Makler, Israel). Aliquots of seminal 
fluid were then treated as before to prepare DNA and subjected to the same PCR reactions 
and SSCP analysis. 
Cycle sequencing of the 430 bp PCR product and other PCR products containing 
homoplasmic changes was carried Qut using a Gibco BRL dsDNA cycle sequencing system 
with primers HMTL817, HMTL854, HMTH897 and HMTH934. To obtain purified PCR 
product for sequencing, products from a number ofPCR reactions were pooled. An equal 
volume of 3 M ammonium acetate was added, followed by two volumes of isopropanol. 
DNA was precipitated for 10 min at room temperature before being pelleted by 
centrifugation at 12,000 x g for 10 min at room temperature. The DNA pellet was 
washed with 500 J.lI 70% ethanol, spun as before, air dried and resuspended in TE8. One 
picomole of the appropriate primer was isotopically end labelled with y32p or i 3p ATP 
(-3,000 Cilmmol) and included in the appropriate reaction with 50 fmol of template 
DNA. The PCR conditions used for sequencing were 20 cycles of 95°C/30 sec, 50°C/30 
sec and 70°CIl min followed by 10 cycles 95°C/30 sec and 70°C/l min. Sequencing gels 
were pre-run at 1500 V, 35 - 45 mA for 1 hour. Individual sequencing mixes were 
heated to 80°C for 2 min and rapidly cooled on ice. Two microlitres of denatured sample 
was used for sequencing. Gels were run at 1500 - 1700 V with a constant current of 35 
rnA per gel in a BRL S2 sequencer. After electrophoresis the gels were dried onto 
backing paper in a Biorad 583 gel drier and exposed to X-ray film (Kodak X-OMAT 
AR) for different lengths of time ~epending on their radioactive counts. Films were 
developed and the sequence was scored manually. 
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Results 
Six different SSCP patterns were seen from the screening of the Taql cleaved 
ATPase amplicon from 210 semen samples (Table 2.1). The most common pattern (not 
shown in Table 2.1) is assumed to represent the Cambridge sequence as this is a 
consensus sequence of European origin. For a full list of screened samples see Appendix 
1. 
Of the 210 samples screened, 31 % were oligozoospermic 48% of these being 
severely oligozoospermic « 5 x 106 sperm/ml) (excluding missing data), 49% of samples 
were asthenozoospermic. A strong correlation exists between reduced sperm count and 
motility in this sample group (S. Richards, unpublished Masters Thesis, University of 
Canterbury, 1996). A number of individuals have known seminal defects including Y 
chromosome micro-deletions (N, Kerr, unpublished Masters Thesis, University of 
Canterbury, 1997). Additionally, not all seminal samples contain the same cell types. A 
number of samples were from individuals who have undergone vasectomies reducing the 
cells in the semen to peripheral leucocytes and possible epididymal cells. There were a 
number of samples that were obtained from seminal swimup or gradient procedures. 
These procedures enrich the semen sample in motile sperm. 
Pattern 1 (Fig. 2.3a) within sample EV, a drop in the bottom 789 nt band, is 
indicative of a homoplasmic change. This pattern was reproducible from different PCRs 
from the same semen sample but was not found in any other semen sample. When the 
EV ATPase amplicon was cleaved with Apal the bands representing the 1016 bp 
fragment showed a mobility shift when compared with control semen samples (Fig. 
2.3b). Bands representing fragments 753 bp and 558 bp, generated by cleavage with 
Seal and Hinfl respectively, also showed mobility shifts when compared with control 
samples (Fig. 2.3b). The overlapping region between all of the fragments showing 
mobility shifts was between the Hinfl cleavage site at nt 8784 and the Taql cleavage site 
at nt 8958. Therefore, it was hypothesised that pattern 1 was caused by a homoplasmic 
change between nt 8784 and nt 8958. 
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Table 2.l. SSCP patterns that differed from the control pattern after Taql digestion of the ATPase 
amplicon of 210 semen samples. 
Pattern Sample Fragment Change 
1 EV 789 bottom 789 band dropped 
2 QD747V 789 both 789 bands move 
3 SF95-171 789 top 789 band drops 
4 94-149 384 bottom 384 band raised 
4 95-5 384 bottom 384 band raised 
4 95-17 384 bottom 384 band raised 
4 95-22 384 bottom 384 band raised 
4 95-34 384 bottom 384 band raised 
4 GB1 384 bottom 384 band raised 
4 MC 384 bottom 384 band raised 
4 QD720I 384 bottom 384 band raised 
4 QD8070 384 bottom 384 band raised 
4 QR511C 384 bottom 384 band raised 
4 SF362 384 bottom 384 band raised 
4 SF94-86 384 bottom 384 band raised 
4 TI 384 bottom 384 band raised 
5 QR568B 789 extra heteroplasmic band 
Full length EV ATPase amplicon was prepared in duplicate and the region of 
interest was sequenced using primers HMTL854 and HMTII897. A G -+ A transition at 
nt 8860 was the only change seen in both amplification and sequencing reactions and was 
. . 
seen in all sequenced strands (Fig. 2.3c). This transition changes a threonine codon 
(ACA) to an alanine codon (GCA) therefore changing the amino acid assignment at 
residue 112 of the ATPase 6 polypeptide. Given that the G -+ A transition at nt 8860 
was the only change seen it was concluded that this transition created pattern 1. 
Patterns 2 (Fig. 2Aa) and 3 (Fig. 2.5a) within semen samples QD747V and 
SF95-171 respectively, had mobility changes in the 789 nt Taq1 bands when compared 
with the control pattern. Patterns 2 and 3 were reproducible from PCRs from the DNA 
extractions from the same semen samples but were not found in any other samples. 
Cleavage of the QD74.7V and SF95-171 ATPase amplicons with Hinfl and Rsa1 and 
subsequent SSCP of the resultant fragments showed changes in band position 
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corresponding to fragments of 558 bp and 411 bp respectively (Fig. 2.4b). Therefore, the 
overlapping region between all of the fragments showing mobility shifts is between the 
Hinfl cleavage site at nt 8784 and the Taql cleavage site at nt 8958 for both patterns 2 
and 3. 
Full length QD747V and SF95-171 ATPase amplicons were prepared in 
duplicate PCRs and the region of interest was sequenced using primers HMTL854 and 
HMTH897. A G ---+ A transition at nt 8856 was the only change seen in duplicated 
amplification and sequencing reactions from QD788L and was seen in all sequenced 
strands (result not shown). This mutation changes an alanine codon (GCG) to another 
alanine codon (GCA) therefore not changing the amino acid assignment at residue 110 of 
the ATPase 6 polypeptide. Given that the G ---+ A transition at nt 8856 was the only 
change seen it was concluded that this created pattern 2. A G ---+ A transition at nt 8839 
was the only change seen in both amplification and sequencing reactions of SF95-171 
and was seen in all sequenced strands (Fig. 2.5b). This mutation changes an alanine 
I 
codon (GCC) to a threonine codon (ACC) thereby changing the amino acid assignment 
at residue 105 of the ATPase 6 polypeptide. Given that the G ---+ A transition at 8839 
was the only change seen it was concluded that this created pattern 3. This change also 
created a HaeIII RFLP with the loss of the HaeIII restriction site centred at nt 8840. 
Pattern 4 (Fig. 2.6), a change in the mobility of bands representing the 384 bp 
Taql fragment, was seen in 13 semen samples. This pattern was indicative of a 
homoplasmic change. When the screening of semen samples showing pattern 4 was 
repeated, this pattern was frequently not seen again indicating that the mobility shift with 
respect to controls was very condition specific. Because of the variability in band shifting 
it is likely that 13 semen samples with this pattern is an underestimate. When semen 
samples with pattern 4 and controls were cleaved with HaeII, those with pattern 4 had a 
Haell RFLP due to the loss of a restriction site at position nt 9056 (not shown). The loss 
of this site has been seen previously and defines European haplotype K. European 
haplotype K is found in 7.4% of Caucasians (Torroni et al., 1994) and has been seen in 
" t 
all cited Caucasian populations studied to date. No study has defined the common 
nucleotide change that leads to this haplotype, however. This study is no exception. 
Marzuki et al. (1991) and Noer et al. (1991) both describe a G ---+ A 
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male with primary infertility due to oligo-astheno-teratozoospermia. He had a normal blood 
follicle stimulating hormone level and the two semen samples analysed were: 4.3 mI with a 
count of 0.3 x 106 sperm/m1, 20% motility; and 4.6 mI with 0.9 x 106 sperm/m1, and 17% 
motility. Both samples had large numbers of immature forms (spermatids), and a reduced 
forward progression (I.L. Sin, pers. comm). Only the second sample (QD205F) had enough 
spelm for a morphology assessment, and it showed 100% abnormal heads, as assessed by 
WHO criteria (1992). Both samples tested negative for a peroxidase test indicating that there 
are fewer than 1 x 106 peripheral blood lymphocytes per mI of semen. Scanning densitometry 
of SSCP gel bands from 12 different PCR reactions from either of the two DNA samples 
indicates that 16% ofthe PCR amplified DNA contains the mutation (x = 16.3%, s = 2.5%). 
An analysis of the peripheral lymphocytes from this donor also revealed the presence of the 
same heteroplasmic mutation, with 18% mutant DNA (x = 17.8%, s = 6.36%). Silver staining 
is, however, only semi-quantitative so these estimates have errors of unknown magnitude 
associated with them. 
: l ~ 
The mutation causing pattern 5 was narrowed down by cleavage of the PCR product 
nt- , 
with Seal and subsequent SSCP. Theheteroplasmic mutation was in a 753 bp Seal fragment 
(Fig. 2.7b). Double digestion of thtt QR568B ATPase amplicon with Taq1 and Seal 
delineated the heteroplasmic mutation to a 369 bp fragment between nt 8589 and nt 8958 
with no heteroplasmy being seen in any of the other fragments (Fig. 2.7c). 
Oligonucleotide primers HMTL854 and HMTH897 were designed, flanking this 
region, with the resultant 430 bp PCR product containing the heteroplasmy when tested 
by SSCP analysis. In an effort to obtain an enriched sample of mutant DNA for 
sequencing, single cell analysis was initiated. Semen samples QR568B and QD205F 
contained a range of cells other than mature sperm. These included epithelial cells, red 
blood cells, white blood cells, and various forms of immature sperm (spermatogonia, 
spermatocytes and spermatids). Identification of these cells is very difficult but is often 
clinically important. Neutrophils (white blood cells) can be determined, when live, by the 
peroxidase staining test but this method is crude and inaccurate. Other than this, electron 
microscopy is the only reliable method of positively identifying these cell types (Glover et 
al., 1990). Additionally, in semen samples there are often high titres of antisperm 
antibodies. These can instigate clumping (head to head or tail to tail) of sperm and the 
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agglutination of sperm to other cell types as is seen in QR568B and QD205F. Because of 
the confusion over cell identity, cells were categorised into classes based on size. The 
classes and the most probable cell types that they represent are listed in Table 2.2. Cell 
counts of QD205F indicate that there are high numbers of large round cells (9.4 x 106 
Iml (n 4» and even higher numbers of small round cells (40.2 x 106 /ml (n = 4». 
Two hundred and fifty four single cells and aggregates were analysed by PCR. 
Ninety five of these gave positive PCR signals and were further analysed by SSCP. The 
results of these are summarised in Table 2.3 with the raw data appearing in Appendix 3. 
Two from 30 seminal fluid controls gave positive PCR results, both having a normal 
SSCP pattern. Tllis indicated that there was some extra cellular DNA in solution. 
Table 2.2. Classed cell types found in semen samples QR568B and QD205F. Classes were used in single 
cell analysis, when individual cells are unidentifiable. 
Class 
I 
II 
III 
IV 
V 
VI 
VII 
Description 
tiny, spherical transparent bodies 
single small round cells 
single large round cells 
single sperm 
single large irregular cells 
clmllped cells other than sperm 
clumped sperm 
Probable cell types 
possibly cytoplasmic droplets? 
spermatids 
Epithelial cells, spermatogonia, 
spermatocytes and leucocytes 
single sperm 
rnacrophages (?) 
clumped class II and/or III 
clumped sperm often with sperrnatids 
Table 2.3. Summarised single cell and aggregate data for cells that gave positive PCR signals. *; mutant 
patterns with negligible amounts of normal DNA that were used for sequencing. 
Class Number analysed SSCP nattern 
normal· mutant mixture 
I 
II 16 15 1 0 
III 14 14 0 0 
IV 32 31 0 1 
V 9 8 0 1 
VI 11 9 0 2 
VII 13 10 2* 1 
i~, ,) 
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As shown in Table 2.3 there are two examples of nearly completely mutant SSCP 
patterns from class VII aggregates (Fig. 2.8a). The PCR samples giving rise to these were 
sequenced by PCR cycle sequencing using primers HMTH897 and HMTL854. Both ofthese 
sequences identified a T -+ C transition at nt 8821 (Fig. 2.8b, c). This was the only change 
found in both PCR reactions and these PCR products showed mutant SSCP patterns. It was 
therefore hypothesised that the heteroplasmic pattern seen in samples QR568B and QD205F 
was caused by a T -+ C transition at nt 8821. The class IT cell with a wholly mutant pattern 
(Table 2.3) was sequenced and found to have a different change. Given that this was seen 
only once, and the SSCP pattern created was neither normal nor the traditional mutant 
(Appendix 3) it is assumed that this change was caused by PCR artefact. Sequence from the 
PCR product of three single sperm was the same as the Cambridge sequence. A T -+ C 
transition mutation is predicted to change a serine codon (TCT) to a proline codon (CCT) 
and hence change Se(J9 to a proline in the ATPase 6 polypeptide. 
Discussion 
Sensitivity ofPCR-SSCP fOI' mutation detection 
Three different homoplasmic SSCP patterns (1 - 3) were caused by changes in 
the 789 bp Taql bands. These changes all fall within 40 bp of each other. Rather than 
tIus being a hotspot for mutations in 'mtDNA it is likely that this represents extremely low 
sensitivity in the mutation detection system. The main problems are probably the extreme 
size of the 789 bp Taq 1 fragment ano the lack of different gel electrophoresis conditions. 
The effect of size of the DNA fragment on SSCP sensitivity is much debated. The optimum 
fragment size is predicted to be between 100 and 300 bp, with fragments of 400 - 500 bp 
having a detection sensitivity of between 70 and 80% (Beier, 1993). Fragments of 600 bp 
have been analysed by SSCP with a sensitivity of3% (Sheffield et al., 1993) with the authors 
conceding, however, that the sequence context plays a very large part in this (different 
sequences of 135 bp having sensitivities of between 90 and 59%). Additionally Sheffield et al. 
(1993) attempted to detect variation in large fragments using SSCP conditions optimised for 
small fragments. There are a number of ways around the problem of lack of sensitivity 
with increased fragment size. Firstly, the ATPase amplicon could have been divided up 
into smaller overlapping amplicons (200 - 300 bp in length) that could have been 
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analysed individually. Because these amplicons are required to be overlapping (for full 
gene coverage) adjacent amplicons could not be multiplexed. The requirement, therefore, 
for more than one amplification reaction does not make this a cost effective option. 
Additionally with more primers, amplif)ring short sequences, there is more chance of 
allele specific amplification because of a primer binding over a mutation site. Secondly, 
longer PCR products could be generated and cleaved with different enzymes to create 
smaller fragments for analysis. Whilst tins is good in theory it is not practical because 
large tracts of the ATPase amplicon have no restriction enzyme recognition sites. 
Additionally suitable restriction enzymes are often prohibitively expensive for routine 
screening. In the present situation Rsal cleaves the ATPase amplicon at two positions 
giving fragments of 342 bp, 411 bp and 421 bp. Unfortunately the SSCP bands of these 
fragments frequently could not be separated from one another because of their sizes. 
The sensitivity of SSCP is dependant on conditions such as the size of the DNA 
fragment to be analysed, the gel temperature, ionic strength of the electrophoresis buffer and 
the porosity and composition of the gel (Hayashi, 1992 and references therein). Whilst the 
detection of changes in different DNA fragments often depends on these factors it is 
impractical to screen all samples with a variety of different conditions. Therefore one set of 
optimised conditions is used, with the possibility of some loss of sensitivity. Ideally these 
conditions are tested with a set of known mutations, but where these are not available an 
empirical approach is adopted. 
Other mutation detection systems can and have been used to analyse mtDNA 
mutations. Broadly speaking there are two groups of methods used for mutation detection. 
Diagnostic methods are used to detect known mutations whilst scanning methods are 
designed to search for new mutations. For these methods direct sequencing is the most 
informative but is expensive. Thus sequencing is used only as the last step in mutation 
identification. Most diagnostic methods use the pdnciple of specific oligonucleotide binding, 
whether as isotopically labelled probes or allele specific plimers for PCR amplification (eg. 
Gibbs et al., 1989; Seibel et al., 1994). Additionally RFLP analysis is still commonly used 
where the mutation falls on a known restriction endonuclease recognition site. 
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Scanning methods have been used successfully to detect changes in mtDNA where all 
have their inherent strengths and weaknesses. Most of the known polymorphisms in human 
mtDNA have first been seen as RFLP changes. However, using a high intensity RFLP 
procedure of 12 restriction enzymes, only approximately 20% of mtDNA will be screened, 
although all large insertions and deletions will be found (Brown and Wallace, 1994). Whilst 
this technique has the ability to screen thousands of bases of DNA and accurately pin point 
changes, the lack of recognition sites and excessive cost remain prohibitive. Many of the other 
methods rely on the separation of hetero- or homoduplexes in polyacrylamide gels. 
Denaturing gradient gel electrophoresis (DGGE) relies on the differential separation 
of partially melted homo- and heteroduplexes when electrophoresed through a gradient of 
denaturants (such as formamide or urea) (Fischer and Lerman, 1983). Frequently this method 
requires a high Tm G-C clamp to be attached to one end of the sequence to prevent complete 
strand separation and allow detection of base changes throughout the whole sequence (and 
. I 
not just in the lowest Tm regions) (Myers et al., 1985). Additionally the need for high 
temperatures and denaturant gradients! makes this procedure both costly and time consuming 
(Lessa and Applebaum, 1993). Variations on this technique include temperature gradient gel 
electrophoresis (Wartell et al., 1990) and constant denaturant gel electrophoresis (Smith-
S0renson et al., 1992) both of which have similar limitations to DGGE. Methods based 
around DGGE can have sensitivities approaching 100% for DNA fragments up to 500 bp in 
length (Lessa and Applebaum, 1993). 
The Heteroduplex method (HET) simply relies on the differential mobilities of hetero 
and homoduplexes in polyacrylamide gels. RET has the ability to show heteroplasmy directly 
and, with doping of samples, to detect homoplasmy. Whilst no special equipment is required, 
and this method is very simple to perfonn, the sensitivity is often reduced and the ability to 
differentiate between two different changes is frequently absent (Lessa and Applebaum, 
1993). 
Enzymatic methods utilising the ability of SI nuclease and RNase A to cleave single 
stranded DNA and RNA respectively have been developed. S 1 nuclease can theoretically 
cleave single stranded DNA loops at sites of mis-matches within heteroduplexes but with 
single base mis-matches this ability is almost negligible (Silber and Loeb, 1981). RNAse A 
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can cleave at single base mis-matches with high affinity and has 60 - 70% sensitivity but is 
expensive and requires the production of an RNA probe (Dianzani et al., 1993). 
Modifications of this method include the chemical cleavage method (CCM) in which mis-
matched T and C bases can be reacted with osmium tetroxide and hydroxylamine respectively 
before being cleaved with piperidine (Cotton, 1989). The fact that the sensitivity of this 
method is unknown and toxic chemicals are involved does not make this a method of first 
choice. 
Mutation analysis 
Six different SSCP pattems were seen from the screening of 210 semen samples for 
changes in the ATPase amplicon. The most common of these is assumed to represent the 
Cambridge sequence. Only pattem 4, found in at least 13 semen samples, was tested for 
statistically significant linkage to s.eminal parameters. Seven of the 13 samples with this 
change were oligozoospermic while 9 were asthenozoospermic. Neither the sperm count 
nor percent sperm motile from pattem 4 semen samples were significantly different from 
the sampled population proportions (exact binomial probabilities, p > 0.025, two tailed 
test with confidence limits of 95%). 
The G ~ A transition at nt 8860 within semen sample EV has been characterised 
previously. The original Cambridge sequence (Anderson et al., 1981) has an A at tins 
position with subsequent studies showing that a G in this position is probably more common 
among Europeans. Thus nt 8860 is considered to be one of the "mistakes" in the Cambridge 
sequence (see Chapter 1). A number of other studies have noted that whilst nt 8860 is 
probably a G, there are individuals who have an A in this position (e.g. Shofther et al., 1993, 
individuals C8 and C12) .. FrequentIy this is noted by the loss of an Hha1 restriction site. The 
population frequency of an A at nt 8860 is not known. In the present study the population 
frequency of this change was 0.48%. The nucleotide change at this position changes a 
threonine codon (ACA) to an alanine codon (GCA) therefore changing the amino acid 
assignment at residue 112 of the ATPase 6 polypeptide. No function has been assigned 
to this amino acid position and its homology is not well conserved (threonine in human 
and Xenopus, alanine in Bovine and mouse (Roe et al., 1985)). 
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The G ~ A transition at nt 8856, in tlllS study seen in semen sample QD747V, 
has been characterised previously (Ozawa et al., 1991; Tanaka and Ozawa, 1994). 
Tanaka and Ozawa (1994) found tlllS change in two out of 43 Japanese and Australian 
individuals. In the present study the population frequency of this change was 0.48%. Given 
that tills change does not alter amino acid assignments it is assumed to be a neutral or 
nearly neutral population variant. No information is known about QD747V's donor 
ethnicity so it is not possible to say if this variant has occurred just once or more 
frequently within recent human illstory. 
The G ~ A at nt 8839, found within semen sample SF95-171, has not previously 
been characterised. A HaeIII RFLP centred around tills site has been seen before 
(Wallace et al., 1995) but the nucleotide causing this RFLP has never been delineated. It 
is probable that nucleotide changes in addition to the G ~ A transition at nt 8839 can 
cause this RFLP. Interestingly, Ala105 is reasonably well conserved having been seen in 
all vertebrates to date and Drosophila but not in honey bees or sea urchins. Given that a 
HaeIII RFLP covers tills site, and this RFLP has been seen in humans before, it is 
unlikely that this change willist altering a relatively highly conserved nucleotide, has any 
pathological significance. Being found in only one out of 210 semen samples the 
population fi'equency of this change was 0.48%. 
The uncharacterised Haell RFLP seen in 13 samples is a marker for European 
haplotype K. Torroni et al. (1994), who first specified this change as a marker based on 
phylogenetic analysis, claim that it is present in 7.4% of Caucasians. In certain populations 
such as the Ashkenazi Jews this frequency can be up to 30% (Ritte et al., 1993). The estimate 
of6.2% (13/210) in tills study is probably an under representation. Slight variability in SSCP 
" 
gel conditions may have contributed to the mobility shift in some gels but not in others. The 
value of 6.2% in this study is not significantly different from the population percentage 
(7.4%) calculated by Torroni et al. (1994) (x,2 = 0.410, df= I, P> 0.05). 
The heteroplasnllc T ~ C transition at nt 8821 has not been characterised previously. 
No restriction endonuclease recognition site encompasses this position in either its normal or 
mutated state. This change was shown to be heteroplasmic in two semen samples from one 
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individual donated 9 months apart. No other semen samples have this change. At the time of 
the second donation a blood sample also contained the heteroplasmy with approximately the 
same proportion of mutant DNA as semen (see results). No familial studies were possible, 
within the bounds of this study, to analyse the familial nature ofthis mutation. It is unknown, 
therefore, whether the mutation in this individual has been inherited by him or arose within his 
mothers egg or his early blastocyst. The detection of this mutation within small round cells 
(most probably immature spermatids) negates the suggestion that its source in the semen is 
from lymphocyte contamination. 
Determining the pathogenicity of a mtDNA mutation is difficult. One of the key 
criteria, as stated by Riordan-Eva and Harding, (1995) is that heteroplasmy be present, as 
heteroplasmy is rarely a feature of harmless polymorphisms. The proportion of mutant DNA 
in a tissue has been shown to cOlTelate with the severity of the phenotype associated with 
many heteroplasmic mtDNA mutations. For example a high level (>90%) of a T ~ C or T ~ 
I 
G at nt 8993 within the ATPase 6 gene causes Leigh's disease, whilst a lower level (between 
70% and 80%) may cause only peripheral retinopathy (Brown and Wallace, 1994). Where 
heteroplasmy is involved it is believed that seminal fluid can have similar propelties to somatic 
tissues. However, the pathogenicity of mtDNA mutations is dependant on the threshold, and 
the cell function. The more mature, active, healthy spermatozoa that are ejaculated, the 
greater the chance there is of a fertilisation event. If a heteroplasmic mutation were to affect 
the motility of a large proportion of spermatozoa or decrease the number of mature sperm in 
ejaculated seminal fluid then it could be considered to be pathogenic in the same way as that 
occurs in somatic tissues, where tissues have a threshold of mutations they can withstand 
before exhibiting phenotypic effects. Important here is the concept of inter-versus intra-
cellular heteroplasmy. Tissues may have a higher mutational threshold if mutations are spread 
over all cells, with each cell having both normal and mutant DNA (intra-cellular 
heteroplasmy) than if individual cells are either normal or mutant (inter-cellular 
heteroplasmy). Examples of both types ofheteroplasmy can be seen in the literature. Studies 
of cloned myoblasts from patients carrying a 1VlERRF mutation (mtDNA tRNALys A ~ G at 
nt 8344) show that the clones are homoplasmic for either wild-type or mutant mtDNA 
(Boulet et aI., 1992; Larsson et al., 1992). Contrary to this is the finding that patients with 
MELAS can have intra-cellular heteroplasmy in fibroblasts which is maintained with cloning 
(Matthews et al., 1995). Whilst it was Oliginally thought that there was a progression from 
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intra- to inter-cellular heteroplasmy with repeated random assortment of mtDNA, there are 
examples of heteroplasmy maintenance, far beyond what would be expected from random 
assortment. Where the mutation is deleterious it is advantageous to retain heteroplasmy 
because homoplasmic mutants are often lethal. This then begs the question of whether sperm 
are individually homo or heteroplasmic. To appreciate the consequences of this, consider a 
semen sample with a 50% mutational load. If this 50% is placed in all cells evenly, then the 
sperm will probably survive, perhaps with a reduced forward progression but still with normal 
motility. If the 50% mutant load is in 50% of the cells then the effect on fertilising potential 
could be quite marked as there is an effective drop in sperm motility of 50%. This study does 
not really address this issue for a number of reasons. Firstly, all examples of mutant DNA 
found in single cell or aggregate analysis had at least traces of normal mtDNA. It is tempting 
to say that this is due to extra cellular DNA contamination but intra-cellular sources can not 
be ruled out. Secondly, even if cells appeared to be individually homoplasmic, they may be so 
because of allele drop-out (ADO). ADO occurs when the amount of template DNA is very 
small and one allele is amplified preferentially to another leading to a false homozygous (in 
this case homoplasmic) state (Ray et al., 1995). By using aggregates of cells, the chance of 
ADO is reduced. 
The stability of the mutation in two semen samples donated 9 months apart suggests 
that the precursor germ cells may also carry the same mitochondrial mutation. One scenario is 
that the small number of fully mature spenn, possibly without the mutation, may be derived 
from unaffected germ cells, and the immature spermatozoa containing the mutation may be 
derived from the precursor cells carrying the mutation. A second scenario is that the 
precursor germ cells are individually heteroplasmic. If this is true, then it would suggest non-
random segregation of the mtDNA during spermatogenesis, that is, the segregating units of 
mtDNA during meiosis are homo plasmic. A number of studies are presently looking at the 
clonal nature of mtDNA in sperm (A. Jaquier, pers. comm.; 1. Poulton, pers. comm.). At 
present it is not possible to differentiate between the two scenarios. 
The T ---t C transition mutation is predicted to cause the replacement of Se~ with 
proline in the ATPase 6 polypeptide. The five transmembrane helix (a1 - a5) secondary 
structure model for human ATPase 6 (Cox et al., 1986) predicts that Se~ lies in the NH3-
terminal end of helix a3. Whether this part of helix a3 is in or outside the membrane is still 
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ambiguous (L. Hatch, pers. comm.). Changes in the loop region between helix a2 and helix a3 
in E. coli affect the positioning of helix a4 (which is the functionality). Additionally, 
substitution of endogenous prolines within E. coli protein a affects the orientation of residues 
on the helical faces (Howitt et al., 1993). If the same is true for human ATPase 6 (where 
prolines 89 and 94 are probably analogous to 122 and 144 in E. coli), an additional proline at 
residue 99 will interfere with this orientation. Proline residues, when in the core of alpha 
helices, produce kinks in the helix structure (von Heijne, 1991). Whilst lipid bilayer 
membranes are uniquely suited to accommodate such kinks, the introduction of proline into a 
non-kinked helix will disrupt the structure of the protein, giving rise to the notion that prolines 
are helix-breakers (Chou and Fasman, 1978). Therefore the introduction of a proline at 
residue 99 is predicted to affect the ATPase 6 secondary and tertiary structure. 
For a mutation to be pathogenic the affected amino acid is likely to be in a highly 
conserved region of the encoded prptein (Riordan-Eva and Harding, 1995). Se~ is part of 
the hexamer pro94, Thr, Thr, Gin, Leu, Se~ with 100% conservation in vertebrates (Fig. 
2.9). Sea urchins have conserved Se~although other parts of the domain are less conserved. 
Invertebrates such as Drosophila and honey bees have other residues in this position (see Fig. 
2.9 for references). Therefore Se?9 could be considered to have medium conservation 
between species. No species analysed thus far has a proline in this position. 
Heteroplasmic mutant PTTQLPMNL 
Normal human PTTQLSMNL 
Bovine PTTQLSMNL 
Armadillo PTTQLSMML 
Rat PTTQLSMDL 
Whale PTTQLSMNV 
Chicken PTTQLSLNM 
Ostrich PTTQLSMNM 
Xenopus laevis PTTQLSMNM 
Salmon PTTQLSLNM 
Sea urchin ATSLISLTY 
Honeybee LTSHLLNMI 
Drosophila melanogaster STSHLTLTL 
Figure 2.9. Between species amino acid homology over the nanapeptide pro94 tIuough Leu102• Sequences were 
obtained from tile following references: Bibb et 01., 1981; Anderson et 01., 1982; Roe et 01., 1985; Cantore et 
01., 1989; Gadeleta et al., 1989; Thomas and Beckenbach, 1989; Desjardins and Morais, 1990; Arnson et al., 
1993; AnlSon et 01., 1997; Harlid et al., 1997. AliglIDlent is based on homology of tile ATPase 6 active site and 
other highly collSelVed domaitlS. Residue 99 in humans and homologous residues in otIler animals are holded. 
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Human spenn require ATP for motility. Ejaculated spenn are very flexible in their 
capacity to obtain energy from other substrates and much ATP is obtained from glycolysis 
rather than OXPHOS (Ford and Harrison, 1981). However, the addition of rotenone, an 
OXPHOS inhibitor, to samples of ejaculated semen causes ATP depletion and spenn 
immobilisation (de Lamirande and Gagnon, 1992). Folgem et al. (1993) have demonstrated 
this requirement for OXPHOS derived ATP clinically in a patient with a tRNK"u mutation, 
where the mutation causes a decrease in motility that could be partially increased by substrate 
therapy. It is not known whether the mutation found in the present study affects spenn 
motility, since no mature spenn were found with the mutation in homoplasmy, but the 
mutation may affect the ability ofthe spenn to mature fully. The stable nature of this mutation 
suggests that the mutation must be present in the type A spennatogonia, the earliest precursor 
genn cells. The role of OXPHOS in spennatogenesis is not known. However, the extra 
prominent cristae present in spelID mitochondria, and congregation of the mitochondria at the 
caudal end of the nucleus near the developing flagellum during spennatogenesis, may imply a 
functional role for the mitochondria in spermatogenesis (Glover et al., 1990). 
It is not known if the heteroplasmic mutation at nt 8821 is the cause of the subnonnal 
seminal characteristics seen in semen samples QR568B and QD205F. QF205F has 100% 
abnonnal head morphology in mature spenn that do not have detectable levels of the 
mutation. The proportion of mutant DNA in PCR products from bulk: DNA preparations was 
16 to 18%. This is probably too low to be seen as the causal genetic lesion. Unfortunately, the 
only other study suggesting point mutations having an effect on seminal characteristics 
(Folgem et al., 1993) does not quantify the level of heteroplasmy in the individual seminal 
samples although it is assumed that the point mutation is heteroplasmic (Folgem et al., 1995). 
The five other pathogenic mutations seen in the ATPase 6 gene (Introduction, this Chapter) 
all require above 90% mutant DNA for phenotypic effects within somatic tissues. 
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Chapter 3 
COIl GENE MUTATIONS 
Introduction 
con structure and function 
Cytochrome c oxidase subunit II (COIl) is one of three mitochondrially encoded 
subunits of the 13 subunit Cytochrome c Oxidase (COX), the terminal electron acceptor 
in the electron transport chain. COX catalyses the reduction of oxygen to water; a 
reaction that is coupled to the translocation of protons across the hiller mitochondrial 
membrane. In addition to 13 polypeptides, COX also contains two haem centres and 
three copper atoms at the active sites (for a review see Capaldi, 1990). The three 
mitochondrially. encoded subunits (CO I, II, and ill) make up the catalytic core of COx. 
COIl has two transmembrane a. helicies (as predicted by hydropathy plots) and a large 
hydrophilic domain which contains the ligands for CUA binding in addition to residues 
that interact with Cytochrome c (Tsukihara et al., 1996). COl and COIl interact to 
provide a catalytic core, whilst COllI may have a role in assembly, stapility or activity 
modulation (Capaldi, 1990). The structures and active sites of all three mitochondrially 
encoded subunits have been ascertained from bovine heart. Many residues assigned 
important roles in bovine heart are, however, conserved throughout evolution suggesting 
that the structures and active sites are similarly conserved (Fig. 3.1). 
The amino acid residues in COIl thought to be important catalytically include 
His161, Cys196, Cys200, and His204 which are ligands for CUA binding, Aspll2, GIU1l4, 
Asp158, and GIU198 which interact with Cytochrome c and Tyr105, Trp l06, Tyr108 and TyrllO 
which may provide a conduit for electron transfer to haem 1 in COL Glu198 may have an 
additional role in forming the CUA binding site and be a ligand for a regulatory 
magnesium atom (Capaldi, 1990). All of the above residues fall in the hydrophilic C~ 
terminal arm of COIl (Fig. 3.2). In addition to the ligands in the catalytic sites there are a 
number of amino acid residues that may be important structurally. For example, Asp57 
and HiS52 are bonded by a hydrogen atom to a phosphotidyl ethanolamine via the imide 
groups of the main chain on the matrix side of the hiller mitochondrial membrane 
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Figure 3.1. COIl polypeptide amino acid alignment between bovines and humans. Numbering denotes 
amino acid residue. (:) denotes synonymous residues between bovines and humans. * Indicates 
important functional sites that are not conserved. Underlining indicates important functional sites 
(Capaldi, 1990) that are conserved. Letters under sequence are human polymorphic amino acids as per 
(Wallace et al., 1995). '1 Indicates site that Capaldi (1990) assigned the residue TrplOl and hence is 
obviously ambiguous. 
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between helices al and a2 (Fig. 3.2). Additionally, GIl, on the cytosolic side, is bonded 
by a hydrogen atom via a main chain imide, to a phosphotidyl glycerol which also 
interacts with residues in COl and a nuclear encoded subunit COVlc (Tsukihara et at., 
1995). Lys49 does essentially the same thing but on the matrix side. This leads to a 
complex picture that has the membrane spanning a helicies of COIl in a structural role 
aligning the functional hydrophilic tail for its catalytic role. These functional sites have 
been ascertained both by high resolution X-ray spectroscopy and mutational studies in 
yeast and bacteria. Few studies have been performed in humans showing changes that 
reduce COX activity. No primary pathological mutations have been definitively assigned 
to the COIl gene. A number of popUlation variants have been characterised that change 
amino acid residues within the COIl protein. None of these variants change important 
ligands, and, in fact, many occur at sites that vary between species (Fig. 3.1). 
Inside 
01 02 
Outside 
COOH 
Figure 3.2. Proposed structure of the human COil polypeptide (derived from Tsukihara et al., 1996). 
Membrane spanning helicies are labelled a1 and a2. Inside and outside, refer to the orientation within the inner 
mitochondrial membrane. For reference to 0 57 see results. 
Population studies based on COlI gene variability 
Probably 90% of the known COlI gene variants are derived from RFLP studies 
with the highest intensity RFLP studies only screening about 20% of the COIl gene. 
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Additionally, where RFLPs are found, frequently the change causing the loss or gain of 
the restriction site is not characterised. This allows many different mutations to account 
for the same RFLP pattern. The mtDNA variation database (MITOMAP) lists 26 out of 
676 (3.8%) COIl nucleotide positions that are polymorphic (Wallace et al., 1995). Given 
that most of these changes have been found by RFLP analysis, this is probably a very 
conservative estimate. Few studies have sequenced the COIl genes to the extent that 
within human variation rates can be assigned. Ruvolo et aZ. (1993) specifically sequenced 
the COIl gene from six individuals (Northern European (Cambridge), Asian and 4 
Mrican) and found 7 polymorphic sites within 3 of the individuals when compared to the 
Cambridge sequence. Horai et a1. (1992) and Kondo et aZ. (1993) analysed nucleotide 
and protein sequences (respectively) between primates (with just one human sequence) 
for 6 mtDNA protein coding genes and found that COIl was second only to COl for 
having the lowest between primate rate of substitution per base. Recently, Davis et aZ. 
(1997) sequenced the COl, COIl and COllI genes from 506 individuals with Alzheimers 
and 95 controls. In addition to a common 'heteroplasmy', (falsely assigned; see Wallace 
et al. (1997), Hirano et aZ. (1997), and Chapter 4) they presumably also found a large 
number of polymorphisms. This polymorphic data is yet to be published. This would be 
the most defmitive study yet of COIl gene variability between humans. 
In the present study the COIl amplicon includes three tRNA genes and a 25 bp 
intergenic region. Both tRNALy. and tRNASer(UCN) can harbour primary pathogenic 
mutations that cause diseases (e.g. Reid et aZ., 1994; Nakamura et aZ., 1995). Pathogenic 
mutations in these genes can be heteroplasmic or homoplasmic; heteroplasmic being the 
more common as homoplasmic changes in tRNA genes are often lethal. Where these 
changes are relevant to the present study they are discussed. The 25 bp intergenic spacer 
between COIl and tRNA Ly. has no known function. That it is conserved, at least in part, 
in all species studied so far suggests that it may have an undescribed role. Analysis of 
", 
post-transcriptionally modified mRNA suggests that the COIl mRNA (transcribed off the 
mtDNA heavy strand) ends with a polyA tail 3' of the intergenic spacer suggesting that 
nucleotides within this spacer serve as a polyadenylation signal (Ojala et aZ., 1981). 
Within this spacer there is a 9 bp direct repeat, one copy of which is often missing in 
Asian, Polynesian and Mrican populations. This and other changes, where relevant, are 
discussed below. 
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In line with the previous chapter, the aims of the present study were to assess the 
variability in the can gene and identify mutations in this gene in a Christchurch male 
population and to determine if these mutations can be related to the fertility status of the 
individuals carrying the mutations. 
The can gene was chosen for this analysis because it has one of the lowest levels of 
intraspecific variation in humans (Marzuki et al., 1991) probably due to its structural and 
functional constraints. Additionally, the can polypeptide, like the ATPase 6 polypeptide is 
well characterised, allowing predictions about the effect gene mutations have on protein 
structure and function. 
Materials and Methods 
The rational and method of screening seminal samples for changes in the can 
gene are essentially the same as for the ATPase genes (Chapter 2). 
Sample statistics 
Two hundred and twenty three semen samples were screened for changes in the 
can amplicon with an average count of 72 x 106 sperrnlrnl (± 78), a motility of 48% (± 
20) with the average age of donor of 36 years (to year of sample donation). Many of 
these semen samples were used for ATPase gene screening as described in the previous 
chapter (see Appendix 1). 
Polymerase chain reaction 
can primers were chosen using the asp computer programme in such a way 
that they did not fall on common polymorphic sites, did not anneal to themselves or each 
other with high affinity, and had melting points above 50°C for high specificity binding. 
The primers chosen were HMTL712 (5' CCTACGCCAAAATCCATTTC) and 
HMTH844 (5' agttgggtgatgaggaatag). The can amplicon, consisting of 1316 bp, 
encompasses 319 bp of Cal, tRNASer(UCN), tRNAAsp, can, a 25 bp intergenic spacer, 
tRN~yg and 76 bp of ATPase 8. PCR conditions for the can amplicon were 
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optimised for MgCb concentration and annealing temperature. Optimal cycling 
conditions were an initial five cycles of 94°C/30 sec, 60°C/30 sec, and 72°C/l min 20 sec 
followed by a further five cycles of 94°C/30 sec, 56°C/30 sec, and 72°C/l min 20 sec. This 
was followed by 25 cycles of 94°C/30 sec, 54°C/30 sec, and 72°C/l min 20 sec. The 25 J.lI 
PCR reaction mixtures contained 5 III total cell DNA prepared as in the previous chapter, 20 
pmol of each primer,S nmol of each dNTP, 2.5 J.lI of lOx reaction buffer (500 mM KCI, 100 
mM Tris-HCI (PH 9.0», 1.4 mM MgCh and I unit of Taq polymerase (promega or 
Boehringer Mannheim). 
Mutation detection 
A 10 ~tl aliquot of the PCR product was digested to completion with two units of 
BstNl (New England Biolabs) in the appropriate buffer in a final volume of 20 III at 60°C. 
BstNl cleaves the COlI amplicon twice to give fragments of 597 bp, 467 bp and 252 bp. 
SSCP screening was carried out on the BstNI cleaved COlI amplicon as described in the 
, 
preceding chapter. BstNl occasionally gives additional bands as a result of nonspecific 
activity; however, these are larger than 597 bp (the largest BstNl fragment), and so did 
, t 
not hinder mutation detection. Undenatured DNA when electrophoresed on SSCP gels, 
gave single bands that did not interfere with scoring of denatured bands. When changes 
in the SSCP pattern were observed, the screening was repeated for confirmation. Once 
different patterns were confirmed, the COlI PCR product was cleaved with both RaeIlI 
and Accl restriction enzymes and then re-analysed by SSCP analysis. The DNA 
fragments carrying the nucleotide changes were identified by comparing the mobilities of 
the fragment bands with those of the controls. The digested fragments containing the 
mutations were cloned and sequenced. 
Cloning and colony selection for mutation cltamcterisation 
, 
Competent E. coli DH5a were prepared from an existing laboratory E. coli 
DH5a glycerol preparation. A single colony was selected from a streaked E. coli DH5a 
LB plate and grown overnight at 37°C, shaking at 250 rpm in 10 m1 ofLB broth. Two 
and a half millilitres of this culture was added to 100 m1 LB broth and grown, shaking as 
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before, at 37°C for 2 hours and 40 min (A5so between 0.6 and 0.7). Cells were collected 
by centrifugation at 3,000 x g for 5 min at 4°C in a Sorvall centrifuge. The cell pellet was 
resuspended in 15 ml of ice cold 50 ruM CaCh, 5 ruM Tris (pH 8.0) using a sterile 
siliconized pasteur pipette before being left to sit on ice for 20 min. Cells were again 
pelleted as before, and then re-suspended in 2 ml of ice-cold 50 ruM CaCh, 5 ruM Tris 
(PH 8.0), 15% (v/v) glycerol. Two-hundred microlitre aliquots were transferred to 
prechilled tubes and kept at 4°C for 19 hours. Cells were then snap frozen in liquid N2 
before being stored long term at -80°C. 
The cloning vector used in this study is the phagmid pBluescribe M13+ 
(pBSM13+) (Stratagene). pBSM13+ is a multicopy phagmid (500 - 700 copies) derived 
from pUC with an M13 origin of replication and binding sites for both T7 and T3 
promoter primers (T7 pIp and T3 pIp). Additionally, pBSM13+ contains the selectible 
Ampicilin (Amp) resistance gene. conferring Amp resistance to host bacteria and the 
LacZ gene, in which the mUltiple cloning site (MCS; pUC 19 polylinker) is found, 
allowing colour selection of recombinant colonies. Native pBSM13+ is 3204bp long. 
pBSM13+ was prepared from pBSM13+ transformed E. coli DH5a. Single colonies 
were selected from an LB + Amp (50 Ilg/ml) plate streaked with E. coli DH5a :: 
pBSM13+ and grown overnight in 10 ml ofLB + Amp (SO Ilg/ml) broth at 37°C shaking 
at 250 rpm. pBSM13+ was purified from these overnight cultures using a modified 
alkaline lysis and PEG precipitation protocol (Applied Biosystems Inc.). DNA 
concentrations and purity were assessed by spectrophotometric readings at A260 and A280 
in an LKB ultraspec II spectrophotometer. Purified phagmid was cleaved with Smal 
(Boehringer Mannheim) at 25°C overnight. A small sample ofthe digest was checked for 
complete digestion by agarose gel electrophoresis. Linearized phagmid DNA was 
precipitated with 0.1 volume of 3 M sodium acetate (pH 7.0) and 2 volumes of 100% 
ethanol at -20°C for 15 min before being pelleted by centrifuging at 12,000 x g at 4°C 
for 10 min. The pellet was washed with 70% ethanol, spun as before and dried for 3 min 
under vacuum to remove traces of~thanoL Purified DNA was re-suspended in 90 III of 
10 ruM Tris-HCI (PH 8.3) and 10 III 10 x calf intestinal alkaline phosphatase (ClAP) 
buffer (Sambrook et al., 1989). Three units of CIAP were added and the mix was 
incubated at 37°C for 20 min before the addition of another 3 units of ClAP with 
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subsequent incubation at 55°C for a further 40 min. TIns was then heat inactivated at 
75°C for 10 min. The de-phosphorylated phagmid DNA was then cleaned using standard 
phenol/chloroform extraction procedures. The purified DNA was dissolved in TE8 prior 
to ligation. 
Fragments to be cloned were amplified in a 100 f.!l PCR mix (the same as a 
standard 25f.!1 mix but scaled up 4 times). Fifty microlitres of the PCR products was 
digested with the appropriate restriction enzyme(s) overnight. As none of the restriction 
sites within the COlI amplicon were compatible with those of the multiple cloning site in 
pBSM13+, all the fragments had to be blunt end ligated. Between one and two units of 
Klenow polymerase (Boehringer Mannheim) was used to blunt end the PCR product 
digests at 37°C for 30 min. The reaction was inactivated at 75°C for 10 min. Digests 
were electrophoresed in a 3% agarose gel and the bands of interest were extracted by 
either a 'freeze and squeeze' protocol (Towner, 1993) or using a commercial gel 
extraction kit (BioRad or Boehringer Mannheim). The DNA obtained by the extraction 
kits was sufficiently clean for cloning, whereas the DNA obtained by the 'freeze and 
squeeze' extraction method required purification. One volume of 4 M ammonium acetate 
and two volumes of isopropanol were added to the DNA fragments recovered from 
agarose gels and kept at room temperature for 15 min and then the DNA was pelleted by 
centrifugation at 12,000 x g for 10 min at room temperature. The DNA was then washed 
in 70% ethanol, vacuum dried and re-suspended in TE8. 
Ligations were carried out essentially as per Sambrook et al. (1989) with a few 
modifications. The highest efficiency of blunt-end ligation was found to be with an insert 
to vector molar ratio of between 6:1 and 12:1. In most instances between 50 and 75 ng 
oflinear and de-phosphorylated vector DNA was ligated. Seven microlitres of vector and 
insert mix (in a 1:6 molar ratio) were heated to 65°C for 2 min then cooled on ice. One 
microlitre of 10 x DNA ligation buffer (200 roM Tris-HCI (pH 7.6), 50 roM MgCh, 50 
mM DTT, 500 f.!glml BSA Fraction V), one microlitre 10 roM ATP and one unit (1 f.!l) 
T4 DNA ligase (Gibco BRL) was then added to the DNA mix. Ligations were carried 
out at 16°C for between 13 and 16 hours. 
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Either 5 or 10 J-ll of the ligation mix was used to transform 200 J-ll of competent 
cells. The DNA was added, briefly mixed and then left on ice for a further 40 min. Cells 
were heat shocked for 2 min at 42°C, then place on ice for 2 min before the addition of 
400 J-ll SOC media (Appendix 2). Tubes were gently inverted and incubated at 37°C for 
1 hour. One hundred, 200 and 300 J-ll aliquots of transformed cells were plated on 
prewarmed SOC + Amp + Xgal + IPTG plates, dried and allowed to grow discrete 
colonies by incubating for 24 hours inverted at 37°C. For transformant colour selection, 
plates were placed at 4°C for at least 48 hours before being scored against a white 
background. Appropriate control transformations were performed to check for 
spontaneous Amp reversion. If subsequent colonies were still to small for accurate 
colour assessment, but plates were becoming over grown, 100 colonies were randomly 
selected and spotted in a regular array on SOC + Amp + Xgal + IPTG plates, and then 
grown as above. 
Separation of true and false positive recombinants was done using an alkaline 
lysis preparation. Colonies were transferred by toothpick into 3 ml LB + Amp (50 Ilglml) 
in sterile McCartney bottles. Cultures were grown, shaking at 250 rpm, with lids loosely 
capped, for 12 hours at 37°C. In addition to inoculating a culture, the colony was also 
streaked on an LB plate with the same toothpick and grown at 37°C overnight to provide 
a culture backup. One and a half millilitres of culture was centrifuged at 12,000 x g at 
4°C for 30 sec to obtain a cell pellet and the supernatant was aspirated off. The cell pellet 
was re-suspended in 350 III of 0.1 M NaCl, 10 mM Tris-HCl (pH8.0), 1 mM EDTA, 5% 
(v/v) Triton X-100 (STET), and 25 III of 10 mglmllysozyme (Boehringer Mannheim) in 
10 mM Tris (pH 8.0) by vortexing for 3 sec. Suspensions were boiled for 40 sec before 
pelleting the bacterial debris by centrifugation at 12,000 x g for between 5 and 10 min. 
Debris were removed with a sterile toothpick before adding 40 JlI of 3 M sodium acetate 
(pH 5.2) and 420 III of isopropanol. To aid precipitation this was vortexed and left to 
stand at room temperature for 5 min. Pelleting, washing and drying were performed as 
above with the recombinant phagmid pellet being re-suspended in TE8 + RNase A (20 
Ilglml) (Boehringer Mannheim). The small insert size meant that resolving recombinant 
and non-recombinant uncut phagmids on an agarose gel was difficult. Therefore 
phagmids were cleaved with Pvull (Boehringer Mannheim) which cuts on either side of 
54 
the MCS at nt 766 and nt 1148 (and not in the COlI amplicon) and then these cleavage 
products were resolved on 2% agarose gels. Pvull digestion of non-recombinant 
phagmids yields a 382 bp fragment with recombinants having larger fragments. 
When large numbers of clones were being analysed fi'om many concurrent 
cloning reactions alkaline lysis preparations as a means of differentiating recombinants 
from non-recombinants was inefficient. In these instances colonies were lysed on the 
plate, transferred to nylon membranes and probed with an a,32p dCTP labelled COlI PCR 
product to select for positive colonies as described below. Replica LB + Amp plates 
were prepared of white colonies and grown for 24 hours at 37°C. Included in each of 
these plates were blue colonies as a negative control, and known recombinants as a 
positive control. Hybond N nylon membrane was placed on colonies and left for 1 min to 
transfer the colony on to the membrane. Membranes were then placed colony side up on 
a stack of three filter papers soaked in denaturing solution (1.5 M NaCl, 0.5 M NaOH) 
and left for 7 min. The membranes were transferred to a stack of three filter papers 
soaked in neutralising solution (1.5 M NaCl, 0.5 M Tris (pH7.2), 1 mM EDTA) for 3 
min. After repeating the neutralising step the membranes were washed in 2 x SSC then 
transferred to filter paper to air dry. Membranes were wrapped in Saran wrap and V.v. 
fixed for 3 min before prehybridising for 1 hour at 65°C in prehybridisation solution 
(Appendix 2). The DNA probe was prepared by boiling 100 ng of COlI PCR product for 
10 min then quenching in an ice slurry (this DNA had been prepared by ammonium 
1, 
acetate / isopropanol precipitation).'A random prime reaction containing 2 J.lI (100 ng) 
DNA, 3 J.lI dATP, dGTP, dTTP, 2 J.lI reaction mix (Boehringer Mannheim), 4 J.lI 50 J.lCi 
a,
32p dCTP, 8 J.ll ddH20 and 1 unit (1 J.lI) Klenow polymerase was prepared and 
incubated at 3rC for 30 min. This reaction was stopped by heat inactivating at 65°C for 
10 min. The probe was boiled for 8 min, diluted with pre-heated prehybridisation 
solution and then added to membranes. Hybridisation was carried out overnight at 65°C, 
in a shaking waterbath. After hybridisation, membranes were washed twice with pre-
heated 0.3 M NaCI, 0.3 M sodium citrate (2 x SSC) for 15 min at 65°C with shaking, 
once with pre-heated 2 x SSC, 0.1% (v/v) sodium dodecyl sulphate (SDS) for 15 min at 
65°C with shaking and once with pre-heated 0.1 x SSC, 0.1% (v/v) SDS for 15 min at 
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65°C with shaking. Membranes were air dried, wrapped in Saran wrap and exposed to 
X-ray film (Amersham Hyperfilm MP) for between 5 and 24 hours. 
con heteroplasmy analysis 
When heteroplasmic SSCP patterns were identified and confirmed, the locations 
of the mutation(s) were identified to short sequences by digestion with restriction 
enzymes. COIl heteroplasmies were analysed by cloning using pBSM13+. COIl 
digestion fragments with heteroplasmic S SCP patterns were blunt end ligated into blunt 
ended Smal cut pBSM13+. pBSM13+ contains a high copy number pMBl replicon 
(Sambrook et al., 1989). To obtain only one clone type (normal or mutant) per colony, 
low efficiency transformation was petformed by using small amounts of ligated DNA and 
large numbers of competent cells. Because inserts were blunt end ligated, each of the 
mutant or normal clones containeq inserts in one of two orientations. SSCP was used in 
clone analysis. Pvull digests of recombinant colony boiling preparations were 
electrophoresed on 5% SSCP gels using the same conditions as outlined. A minimum of 
four patterns were seen on these SSCP gels (normal and reverse orientations had 
different patterns because the Pvull digests contained invariant phagmid DNA in addition 
to the insert). The orientation of each insert was ascertained by cutting the positive 
phagmids with enzymes that cleaved both in the insert and vector (different orientations 
giving different sized cleavage fragments). In this way, the SSCP patterns were explained 
by only the presence of normal and mutant DNA. Assuming that both normal and mutant 
fragments were cloned with equal efficiency, the proportion of clones with a mutant 
pattern was used to ascribe the proportion of mutant fragments in the PCR mixture. 
",I 
Representatives of both normal and mutant SSCP patterns were sequenced from 
duplicate cloning reactions using the T7 sequencing reaction. 
Sequencing for mutation characterisation 
DNA obtained by alkaline lysis preparations of recombinant phagmids was 
sequenced using a T7 sequencing kit (pharmacia Biotech). Sequencing gels were 
prepared and run as per Chapter 2. 
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Results 
Eleven different SSCP patterns were seen from the screerung of the BstN1 
cleaved COIl amplicon from 223 semen samples (Table 3.1.). The most common pattern 
(not shown in Table 3.1) was assumed to represent the Cambridge sequence as this has a 
European origin. Of the 223 samples screened, 28% are oligozoospermic 62% of these 
being severely oligozoospermic (excluding missing data). 46% of samples are 
asthenozoospermic. 
Table 3.1 Confirmed different SSCP patterns after BstN1 screening of con amplicon from 223 semen 
samples. As in Table 2.1, the most common pattern, assumed to represent the Cambridge sequence, has 
been ,omitted. Patterns have been ascribed retrospectively to aid reader understanding. * = nat and denat 
refer to native and denatured DNA respectively. 
Pattern Sample Fragment Change* 
1 IN 467 bands converge 
2 95-37 467 nat and denat dropped 
2 95-79 467 nat and denat dropped 
2 AM436E 467 nat and denat dropped 
2 AT665C 467 nat and denat dropped 
2 BT 467 nat and denat dropped 
2 QN182W 467 nat and denat dropped 
2 SF95-160 467 nat and denat dropped 
3 95-13 467 top band raised 
3 95-24 467 top band raised 
3 95-27 467 top band raised 
3 AM470K 467 top band raised 
3 QD747V 467 top band raised 
3 QR509H 467 top band raised 
3 QU380K 467 top band raised 
3 SF94-299 467 top band raised 
3 SF94-409 467 top band raised 
3 SF95-122 467 top band raised 
3 SF95/612 467 top band raised 
4 QD788L 597 top band lowered 
5 SF96-279 597 top band lowered 
6 CCR 597 top band lowered 
7 AM470K 597 top band lowered 
8 AM433B 597 heteroplasmy 
9 94-107 597 heteroplasmy 
10 TM 467 467 top band raised 
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Seven of the con SSCP patterns were due to homoplasmic point mutations 
(Table 3.2). Two of these patterns were found in 7 and 11 out of 223 semen samples. 
Twenty eight percent (62/223) of the sampled population were oligozoospermic, while 
two of the six (33%) semen samples with pattern 2 were oligozoospermic (excluding 
missing data). These proportions are not significantly different (exact binomial 
probabilities, p 0.3172, two tailed test with confidence limits of 95%). However, all of 
the five samples with pattern 2, for which motility was available, were 
asthenozoospermic. This is significantly different to the 46% of asthenozoosperrnic 
samples in the sampled population (exact binomial probabilities, p = 0.02119 *, two 
tailed test with confidence limits of 95%). Out of 10 samples showing pattern 3 for 
which data was available, two were oligozoospermic and two were asthenozoosperrnic. 
These proportions were not significantly different to the proportions of oligozoosperrnic 
and asthenozoospermic semen samples in the sampled population (oligozoosperrnic; 
exact binomial probabilities, p 0.2523, two tailed test with confidence limits of 95%, 
asthenozoospermic; exact binomial probabilities, p = 0.0669, two tailed test with 
confidence limits of95%). 
The seven homoplasmic con SSCP patterns are shown in Figures 3.3 to 3.9. 
These patterns were analysed as described in their respective figure legends. 
Table 3.2. Summary of the homoplasmic changes sequenced within the COIl amplicon. (nd) refers to 
digests not performed. For further infonnation about how these patterns ,,,ere analysed, refer to the 
respective pattern figure legends (Fig.). 
BstN1 HaeIII Accl 
Pattern Sample fragment fragment fragment Change Position AA change Fig. 
1 IN 467 364 548 T~C 8077 Ala~Ala 3.3 
2 7 samples 467 141 nd 9bp del 8272-8280? 3.4 
3 11 samples 467 364/141 nd G~A 8251 Gly~Gly 3.5 . 
4 QD788L 597 300 180 C~T 7476 tRNASerCUCN) 3.6 
389 548 G~A 7789 Leu~Leu 
5 SF96-279 597 389 548 C~A 7819 Leu~Leu 3.7 
6 CCR 597 389 548 G~A 7853 Va1~Ile 3.8 
7 AM470K 597 389 548 G~A 7754 Asp~Asn 3.9 
467 3641141 nd G~A 8251 Gly~Gly 
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The change within the 548 bp Acc 1 fragment was assumed to be between the 
Acel site at nt 7610 and the BstNl site at nt 7975. The second was in the 180 bp Acel 
fragment between nt 7430 and nt 7610 (Fig. 3.6 b) A BstNIIAcel double digest of 
AM433B COIl PCR product was cloned in duplicate. Clones containing the 365 bp 
fragment between nt 7610 and nt 7975 were differentiated from other positive clones by 
their size (when excised from the vector with PvuIl) and by cutting possible positives 
with Aspl (insert) and BamHI (vector). The inserts were excised, using Pvull digestion, 
from 15 clones with the correct insert and all with the same orientation and were 
analysed by SSCP to obtain clones for sequencing. Two SSCP patterns were obtained. 
Sequencing of the clones with these two patterns revealed that one SSCP pattern was 
caused by a G ~ A transition at nt 7789 represented by clones 147~3-11, 39 and 147-4-
1 (from two different cloning reactions). Clones with the other SSCP pattern (149-3-45 
and 149-4-66) had no changes with respect to the Cambridge sequence. Clone 147-3-8 
had an artefactual T ~ C transition,at nt 7943 even though it had the same SSCP pattern 
as clones 149-3-45 and 149-4-66. 
The inserts from clones containing the 180 bp fragment between nt 7430 and nt 
7610 were excised, using Pvull digestion. Ten clones with the correct insert were 
analysed by SSCP to obtain clones for sequencing. When sequenced, clones 147-3-1 and 
147-4-16 had a C ~ T transition at nt 7476 whilst clones 147-3-6 and 147-4-13 had a 
sequence identical to the Cambridge sequence. Therefore the changes causing pattern 8 
are at a minimum, a C ~ T transition at nt 7476 and a G ~ A transition at nt 7789. 
Pattern 9 was characterised by the appearance of an extra band associated with 
the 597 nt BstNl fragment doublet of sample 94-107 (Fig. 3.12). This band was 
reproduced fl:om six different PCRs from four different DNA preparations from this 
semen sample. To further characterise this pattern COli PCR product from 94-107 and 
controls was cleaved with Acel and the fragments were analysed on SSCP gels. The 
extra heteroplasmic band was now associated with the 548 nt Acc 1 fragment bands (Fig. 
3.11) and so the change was in a 365 bp fragment between nt 7610 and nt 7975. This 
fragment was cloned in duplicate. The inserts were excised, using Pvull digestion, from 
65 recombinant clones and analysed by SSCP to identifY clones for sequencing (Fig. 
3.13). Positive clones were cleaved with an Aspl/BamHI double digest to delineate 
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A number of these clones, representing different SSCP patterns, were sequenced. 
The mutant sequence was represented by five clones from two PCRs showing seven 
changes with respect to the Cambridge sequence, with the normal being the same as the 
Cambridge sequence (Table 3.3). 
Table 3.3 Consensus changes found in the COlI mutant clones of 94-107. SYll means synonymous, or no 
change. 
Nucleotide Change Amino Acid 
7650 C~T Thr~Ile 
7705 T~C syn 
7757 G~A Ala~Thr 
7810 C~T syn 
7868 C~T Leu~Phe 
7891 C~T syn 
7912 G~A 
! 
A number of clones had addi~ional changes that were seen only once and so were 
assumed to be PCR artefact (Appendix 4). Clone 3-1-4 did not have a G ~ A at nt 7757 
but did have other changes (although not sequenced in its entirety). Therefore, within the 
COli amplicon of sample 94-107 there are two populations of DNA differing by at least 7 
point mutations. 
Pattern 10 was initially thought to be the same as pattern 3. Sample TM showed 
an identical shift in the top BstNI 467 bp fragment band to pattern 3, but when cleaved 
with HaelII, the pattern 3 HaeIII RFLP was not present, and in fact no mobility 
differences were seen at all. When cleaved with Acel, however, the 284 bp fragment 
bands were condensed when compared to controls. 
Due to the proximity of primers HMTL817 and HMTH844, the COlI amplicon 
of semen sample TM was sequenced directly using cycle sequencing. Note that whilst 
primer HMTL817 falls within the region of interest, the sequence upstream of this primer 
was read from the other primer. The sequence obtained from TM PCR product was 
ambiguous, even when repeated. The sequence between HMTH844 and nt 8277 
appeared 'fuzzy' whilst sequence between HMTL817 and nt 8277 was clear (Fig. 3.14 
a). This implied a length heteroplasmy centred around nt 8277 which would then make 
sequence down stream from this site ambiguous. Given that there are C tracts in this non 
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coding area a homopolymeric C tract heteroplasmy was suspected. As stated by 
Marchington et al. (1997) in reference to mtDNA control region heteroplasmy, 
"Heteroplasmy of this length variation in homopolymeric tracts has not been recognised 
because of blurring of bands on a sequencing gel after the tract. That tins was not a 
sequencing artefact was demonstrated by cloning and sequencing of individual clones, at 
which point the sequence becomes readable". Because the changes were seen between 
primers HMTL817 and HMTH844 these were used to amplifY a short PCR product for 
cloning. This PCR product was cloned in duplicate as above. The inclusion of primers in 
the cloned sequence allowed clone inserts to be PCR amplified out of the phagmid to 
yield orientation independent products. Twenty nanograms of alkaline-lysis prepared 
phagmid DNA was used as the template for these amplifications with the PCR conditions 
being the same as for the initial amplification. Products were visualised on SSCP gels 
using standard conditions. Ten recombinant clones were sequenced (Fig. 3.15). 
CAMBRIDGE 
153-1-01 
153-1-10 
153-2-02 
153-2-07 
153-2-08 
153-1-14 
153-1-21 
153-2-12 
153-2-13 
TTTACCCTATAGCACCCCCTC------TACCCCCTCTAGAGCCC 
TTTACCCTATAGCACCCCCTC------TACCCCCACTAGAGCCC 
TTTACCCTATAGCACCCCCCCCCCCCCTACCCCCTGTAGAGCCC 
TTTACCCTATAGCACCCCCCTCCC---TACCCCCTCTAGAGCCC 
TTTACCCTATAACACCCCCTC------TACCCCCTCTAGAGCCC 
TTTACCCTATAACACCCCCTC------TACCCCCTCTAGAGCCC 
TTTACCCTATAGCACCCCCCCCCC---TACCCCCTCTAGAGCCC 
- --TTTACCCTATAGCACCCCCCCCC----TACCCCCTCTAGAGCCC 
TTTACCCTATAGCACCCCCCCCCC---TACCCCCTCTAGAGCCC 
- --TTTACCCTATAGCACCCCCCCCC----TACCCCCTCTAGAGCCC 
Figure 3.15. TM clone sequences between nt 8258 and nt 8294 showing point mutation and length 
beteroplasmy. Dashes are present for alignment purposes only. Underlining indicates mutations relevant 
to pattern 10. 
This sequencing revealed that two different heteroplasmic mutations were present 
in semen sample TM. The first was a T -+ C transition at nt 8277. This created a C7 
homopolymeric tract. The second mutation, which is probably wholly dependant on the 
presence of the first, was the non-templated addition of between C2 and C(; (Fig. 3 . 14b). 
The presence of variable C tracts all together created the blurring of sequence on the 
cycle sequencing autoradiogram after this point (Fig. 3.14a). Seven out of 20 TM clones 
(35%) showed a normal SSCP pattern with the other 65% having varying sizes of 
insertion. 
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Discussion 
Sensitivity of PCR-SSCP for mutation detection 
As mentioned earlier, SSCP when optimised, may resolve 70 to 80% of 
differences between fragments. As with the ATPase amplicon screening, two of the three 
BstN1 cut COlI fragments were outside the reported optimal size for SSCP mutation 
detection (Beier, 1993). The position of the changes found on the fragments (Fig. 3.16) 
are spread widely throughout the COlI amplicon but generally are not close to the 
fragment termini (with the exception of changes close to the HaelII site at nt 7888). The 
general lack of detection of mutations at fragment termini could be because either they 
are not present, or that that ends of the single stranded DNA are loose, (not bound in a 
secondary structure) and do not significantly contribute to the overall folding. Therefore, 
if a large amplicon is cleaved into many smaller fragments, the ability of SSCP to detect 
mutations may be reduced because of the increased proportions of ends. The larger the 
fragment the less effect a single change has on the overall conformation leading to less 
chance of a change in band mobility. There is, therefore, a trade off between small 
optimal fragment size and the inability of SSCP to detect changes in fragment ends. 
Mutation analysis 
In all, seven different single base changes, a 9 bp deletion, a heteroplasmic 
insertion and two apparently complex base substitution heteroplasmies were 
characterised within the COlI amplicon. Only those changes that were found in more 
than one sample were tested for statistically significant association to seminal parameters. 
The prop011ion of samples with pattern 2 with asthenozoospermia was found to be 
statistically significantly different to the sampled population proportion with 
asthenozoospermia. 
The T --). C transition at nt 8077 detected in semen sample IN has not been 
reported previously although the loss of an ATu! restriction site across tIus position has 
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Figure 3.16. BstNl, HaeIII and Ace! COll digest fragments and the position of the changes within 
them. Twenty bp primers are indicated in black at the ends of the COll amplicon. All genes are labelled 
in addition to 25 bp intergenic sequence (IS). The changes found in semen sample 94-107 have been 
excluded from this figure because the relative contribution of each of the changes to the overall SSCP 
pattern was unknown. 
(individual 68; Cann et al., 1987). Given that the new codon does not change amino acid 
assignment this is thought to be a sequence polymorphism with no pathological 
significance. This nucleotide position is not highly conserved, (Pongo pygmaeus, C 
(Horai et al., 1992); Bovine, T (Anderson et al., 1982); Xenopus, T (Roe et al., 1985)). 
In the present study the frequency of this polymorphism is 0.45%. 
QD788L has two changes evident within the COlI amplicon. The first, a C ~ T 
transition at nt 7476 within tRNASer{UCN), has been described previously (Houshmand et 
al., 1994; Howell et al., 1995). It is unlikely that this change has pathological 
significance as most tRNA changes that are a primary genetic defect are heteroplasmic, 
whereas in QD788L this change was homoplasrnic. The changed base falls in the 
anticodon stem of the tRNA and may actually strengthen this stem, by creating a 
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stronger U - A bond, theoretically creating a more stable tRNA (Fig. 3.17). Conversely, 
a study by Nakamura et al. (1995) found a pedigree with a heteroplasmic T ~ C 
transition at nt 7512 (Fig. 3.17) that weakens a strong bond in the acceptor stem. This is 
thought to manifest in MERFFIMELAS overlap syndrome. Whilst nt 7512 is not highly 
conserved,a strong bond (A - U or G - C) at this position is. The base at 7476 is neither 
highly conserved (Y okogawa et al., 1991) nor part of a highly conserved stable bond as 
shown in Figure 3.17. Therefore the change at nt 7476 is thought to be a neutral 
population polymorphism. 
DHU loop 
Acceptor 
stem 
o-B 
~B TWC 
DHU A ..... U stem 
stem A-U 
G-C UU 
. U CUDCC A 
AGGUAC IIIII G TljJCloop 
G I I I I GGGGGU C GCCAUG G U 
Go-UUU 
Anticodon 8=5 --+ A 
stem H=~ 
G-C 
C A 
U A 
UGA 
Anticodon loop 
Figure 3.17. tRNASer(UCN) secondary structure (modified from Yokogawa et ai., 1991) showing the 
position of the mutation at nt 7476. (-) indicates binding affinity (the thicker the band, the stronger the 
bond), Note that the T --7 C change appears as a G --7 A as this is an RNA structure and tRNASer{UCN) is 
transcribed off the mtDNA light strand. The circled base is changed in the study of Nakamura et al. 
(1995), 
QD788L has an additional G ~ A transition at nt 7789 that has not been 
reported previously. Given that the new codon does not change amino acid assignment 
this was thought to be a population variant with no pathological significance. Gorilla 
gorilla and Pan troglodytes (Ruvolo et a!., 1993) are both polymorphic at this position 
suggesting the residue is not highly conserved. 
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The C -t A transversion at nt 7819 in semen sample SF96-279 has not been 
reported previously. Given that the new codon does not change amino acid assignment 
this was thought to be a population variant with no pathological significance. This 
residue is an adenine inP. troglodytes and a thymine in P. paniscus (Ruvolo et al., 1993) 
indicating that both transitions and transversions have occurred at this site during primate 
evolution. In the present study the frequency of this polymorphism is 0.45%. 
The G -t A transition at nt 7853, seen here in semen sample CCR, has been 
reported previously (Chen et al., 1995) in five African individuals from two different 
racial groups. Sample CCR has not been tested for other African haplotype markers. A G 
-t A transition at this position will change COlI amino acid Val90 to an isoleucine 
residue. Both of these amino acids have aliphatic side chains giving them a hydrophobic 
tendency. Adenines at this nucleotide position can be seen in G. gorilla and P. pygmaeus 
. (Ruvolo et al., 1993). Semen sample CCR remained coagulated and viscous throughout 
this study, whereas normal seminal samples liquety within 20 - 30 minutes of ejaculation 
(Glover et al., 1990). It is unlikely, however, that the G -t A transition at nt 7853 in 
CCR had any bearing on this viscosity. As with other singly occurring mutations, in the 
present study the frequency of this polymorphism is 0.45%. 
AM470K had two defined nucleotide changes within the COlI amplicon. The G 
-t A transition at nt 7754 has not been previously reported although a Dde1 site (which 
this position is part of) centred at nt 7750 is polymorphic (Wallace et al., 1995). A G-t 
A transition at this position will change COli amino acid 57 from aspartic acid to 
asparagine. Asparagine is the amide derivative of aspartic acid. Interestingly, both the 
guanine at nt 7754 and ASp57 are moderately conserved (primates, G, Asp (Ruvolo et al., 
1993); Bovine, G, Asp (Anderson et al., 1982); Xenopus, G, Asp (Roe et al., 1985); sea 
urchin, G, Glu (Cantatore et al., 1989)) suggesting that these residues may be important. 
In beef heart COli, ASp57 is thought to be bonded by a hydrogen atom to the phosphate 
of a phosphotidyl ethanolamine just on the matrix side of the inner mitochondrial 
membrane (Fig. 3.2). This hydrogen bonding, however, is through the main chain imide 
group rather than through a side chain (Tsukihara et al., 1996), thereby, theoretically 
allowing any amino acid to take this position. No other role has been assigned to this 
residue. There are examples of both pathological mutations and population 
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polymorphisms being caused by moderately to highly conserved aspartic acid to 
asparagine amino acid changes (eg. Howell et al., 1993; Ozawa et al., 1991). It is 
unlikely that this change has any phenotypic effects on semen sample AM470K's donor 
given the average sperm count and motility of AM470K (Appendix 1), the moderate 
residue conservation, the homoplasmic nature of the change and the possibility that it 
may have been seen as a variant before as a Dde 1 RFLP. In the present study the 
frequency ofthis polymorphism is 0.45%. 
The other AM470K change found in the COIl amplicon is a G --)- A transition at 
nt 8251 which has been described and characterised in both a Japanese sample (Tanaka 
and Ozawa, 1994) and within a South African IKung individual (Hsa6; Ruvolo et al., 
1993). Contrary to this, however, is the finding of Torroni et al. (1994) that the HaeIII 
RFLP centred around this site (not sequenced by them) is specific to European haplotype 
I. The loss of the HaeIlI restriction site could be due to a mutation at any of the four 
nucleotides (GGCC) that make up the Haem recognition site, thus leaving doubt that 
the G --)- A at nt 8251 is the primary cause of the European haplotype I HaeIII RFLP. It 
has additionally been shown, however, that as well as losing a HaeIII site, individuals 
with the European I haplotype gain an AvaIl site (Torroni et al., 1994) with a cleavage 
site at nt 8249. For this to occur the mutation must be either a G --)- A or G --)- T at nt 
8251. Given that transitions are many times more frequent than transversions (Brown et 
al., 1982), the former of the two is more likely. If this is the case then the Haem RFLP 
is not specific for European haplotype I, but has occurred multiple times in human 
evolution in many ethnic groups. Supporting this idea is the study of Shoffuer et al. 
(1993) that places Caucasian individuals with haplotype I on three different branches ofa 
phylogenetic tree, suggesting three independent origins for this mutation (Shoffuer et al., 
1993; Fig. 4 therein), None the less, this change appears to be relatively common among 
Europeans with reported frequencies of 7.4% (Torroni et al., 1994) and 7.5% (Shoffner 
et al., 1993). Given that this change occurs at the third position of a glycine codon within 
con no amino acid change will occur. The G --)- A transition at nt 8251 is assumed to be 
a neutral population polymorphism. In the present study, 4.9% of the samples contained 
this change (11/223). This is not significantly different to the population percentage of 
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between 7.4 and 7.5% (:x2 "" 2.04, df 1, P> 0.05). No significant association was found 
between sperm count and motility and the presence or absence of this change (see 
results). AM470K was the only sample to have additional changes to the G -» A at nt 
8251. However, because it is assumed that the G -» A at nt 8251 has occurred on more 
than one occasion in evolution it is not possible to say which mutation occurred first. 
The 9 bp deletion in the COWtRNALys intergenic spacer, originally thought to be 
an Asian specific marker, has now been found widely in Polynesian and Central and 
Southern African populations (Sykes et al., 1995; SoodyaU et al., 1996 and references 
therein) and once in a Caucasian population (Barrientos et al., 1995). This well 
characterised deletion results from the removal of one of two copies of a 9 bp direct 
repeat (CCCCCTCTA) found in this intergenic sequence (either nt 8272 to nt 8280 or nt 
8281 to nt 8289). Haplotype analysis confirms that this mutation has re-occurred at least 
. twice in African populations and that the Asian deletion arose independently from these 
events (Soodyall et al., 1996). Up to 94% of Polynesian individuals in New Zealand 
carry this deletion (Sykes et al., 1995) with no Caucasians in this country being reported 
to harbour the change. Seven semen samples in this study had this change. Samples BT 
and 95-37 were donated by the same individual. The individual who donated samples BT 
and 95-37 has Kallmann's syndrome. This is an X-linked (Xp22.3) disorder characterised 
by a gonadotropin releasing hormone deficiency with hypogonadotropic hypogonadism 
and delayed puberty. Whilst there are also other autosomal recessive and dominant forms 
it is unlikely that the 9 bp deletion has any bearing on tlns disease. It is likely, however, 
that the low sperm counts and motilities of semen samples BT and 95-37 are caused at 
least in part by Kallmann's syndrome. The proportion of samples with pattern 12, with 
asthenozoospermia was found to be significantly different to the population proportion at 
the 95% confidence limits. If the two samples whose low counts can be explained by 
Kallmann's syndrome are removed from this analysis, leaving an effective sample size of 
three (excluding missing data) this becomes non-significant (exact binomial probabilities, 
p 0.0526, two tailed test with confidence limits of 95%). It is likely that the six 
individuals donating these samples have Polynesian maternal origins although this has not 
been tested fiuther. No evidence has ever been found that this deletion has deleterious 
effects. 
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Three examples of COlI amplicon heteroplasmy were seen during this screening. 
Sample TM has a homopolymeric C tract length heteroplasmy within the COIIItRNALys 
intergenic spacer. Homopolymeric tract heteroplasmies have previously been found in the 
human D-Ioop between nt 16184 and nt 16193 (Bendall and Sykes, 1995; Marchington 
et al., 1996; Marchington et al., 1997). No homopolymeric tract heteroplasrnies have 
been found in the COIIItRNALys intergenic spacer, however, analogous length changes 
have been seen in homoplasmy (Wrischnik et al., 1987; Ballinger et al., 1992). Oilly a 
length change, first seen by Cann and Wilson (1983), has been fully characterised 
(Wrischnik et al., 1987). This change (a Cll tract) and the ones presented here are 
probably caused by the same double hit mutational event. Firstly a T ~ C transition 
occurs at nt 8277. This is heteroplasrnic in semen sample TM but homoplasrnic in the Cll 
tract (Wrischnik et al., 1987). Secondly this transition creates a C7 tract that allows 
replication slippage to add C4 (Wrischnik et al., 1987) or Cn (present study). Without the 
transition at nt 8277 the replication -slippage does not occur (Fig. 3.19) 
CAMBRIDGE TTTACCCTATAGCACCCCCTC-TACCCCCTCTAGAGCCC 
FIRST CHANGE TTTACCCTATAGCACCCCCCC-TACCCCCTGTAGAGCCC 
SECOND CHANGE TTTACCCTATAGCACCCCC~CCnTACCCCCTGTAGAGCCC 
Figure 3.19. Schematic representation of mutational progression in COII/tRNALys of TM. Sequence 
shown is 11t 8258 to nt 8295. Dashes are used for aligllllent purposes only. Underlining indicates T -+ C 
transition at nt 8277. 
Interestingly, Cann and Wilson (1983) had difficulty sequencing this region 
(Gomer et al., 1985) possibly suggesting that their Cll tract is actually also 
heteroplasmic, but that not enough clones were analysed by Wrischnik et al. (1987) to 
recognise this. Other groups have recognised additions in his region that may well be 
caused by the same mechanism but these have not been cloned or sequenced (Ballinger et 
al., 1992). The changes appear to have occurred more than once in evolutionary history 
(Ballinger et al., 1992) and can be fixed to homoplasmy rapidly (Wrischnik et al., 1987). 
All three previously identified individuals with an addition in this region have an Asian 
mtDNA haplotype (the haplotype of TM's donor has not been identified). This 
homopolymeric tract heteroplasmy is not thought to have any phenotypic effect on TM's 
donor given that the heteroplasmy is within an intergenic spacer with no known function. 
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This change is probably under slight negative selection pressure as it would create a 
longer (slower replicating) mtDNA molecule. 
The TM SSCP pattern for the COIl amplicon (pattern 10) was almost identical to 
pattern 3. Both of these patterns were indicative of homo plasmic mutations. Sequencing 
revealed, however, that 35% of the TM DNA is normal (see results) and yet no normal 
pattern was seen. When TM COIl PCR product was electrophoresed on a denaturing 
polyacrylamide gel, there was no indication of variable length heteroplasmy (results not 
shown). Post cloning, however, the variable lengths were visible on SSCP gels. Given 
that the PCR and cloning reactions were replicated with the same results, the 
heteroplasmic T -7> C transition at nt 8277 is thought to be a real change. Subsequent 
length variants could be an artefact of the cloning. Whilst this satisfies the lack of length 
variation on PAGE gels prior to cloning it does not satisfy the lack of a heteroplasmic 
pattern in the original COIl screening. This point is still unresolved and requires further 
work to clarify. TM's donor additionally has cryptorchidism (retention of one or both 
testes within the abdomen) which may account for the reduced sperm count of this 
semen sample (Appendix 1). 
Changes seen in heteroplasmy in sample AM433B (C -7> T at nt 7476 and G -7> A 
at nt 7789) are the same changes seen in homoplasmy in sample QD788L. The sample's 
donors are not obviously related (IL Sin, pers. comm.) and it is considered highly 
unlikely, that the changes in AM433B arose independently of QD788L, and presumably 
each other, in equal proportions to each other and on the same strands of DNA It is 
assumed that AM433B is a mixture of QD788L and a normal sample and that the 
heteroplasmy in sample AM433B is artificiaL The only other viable source of semen 
sample AM433B heteroplasmy is through limited paternal inheritance but as the two 
individuals appear unrelated this is unlikely. Sample AM433B had a sperm count of 49 x 
106 sperm/mI, a motility of 36% and a donors age at donation of 38 years. Sample 
AM433B was obtained from a Percoll gradient, so contained only the most 
morphologically normal sperm from the original semen sample. 
The apparent extreme heteroplasmy in sample 94-107 was initially an enigma. 
Sample 94-107 has a sperm count of 349 x 106 sperm/ml, a motility of 66% and a donors 
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age at donation of 39 years. Davis et ai. (1997), reported multiple heteroplasmy in human 
COL and COIl genes in a group of patients with late onset Alzheimers. Of note, two of the 
changes found by Davis et al. (1997) were a C ~ T transition at nt 7650 and a C ~ T 
transition at nt 7868 also found in the present study. The other 94-107 COIl changes were 
not found in the study of Davis et ai. (1997). Whilst screening of the BstNl 94-107 COIl 
amplicon showed heteroplasmy in the 597 nt bands only, Davis et ai. (1997) found 
heteroplasmy spread within both the COL and COIl genes raising the possibility that the same 
could be true for sample 94-107. This was analysed further, the results of which are reported 
in Chapter 4. 
Of the seven homoplasrnic point mutations found in the COIl screening study, 
three have been characterised before with another two falling in known polymorphic 
restriction sites. With high resolution RFLP analysis it is unlikely the other two sites (at 
nt 7789 and nt 7819) would have been detected as they do not fall within the recognition 
sequences of the commonly used restriction enzymes (Alul, AvaIl, Dele 1 , FlluDll, 
Haelll, Hhal, Hillfl, Hpal, Hpall, Mbol, Rsal and Taql). The nt 7819 change can be 
detected by the loss of an Mnll restriction site (normally cleaving at nt 7827) but the nt 
7789 change does not alter or create a known restriction site and so cannot be detected 
by RFLP analysis. 
82 
Chapter 4 
ANALYSIS OF SAMPLE 94-107 APPARENT HETEROPLASMY 
Introduction 
Heteroplasmy prevalence and maintenance 
In 1985 Monnat and Loeb isolated, cloned and sequenced numerous copies of the 
human mtDNA COIn gene from five normal humans. Over 49 kilobases from 248 clones 
were sequenced to find a single base difference within one individuaL Later Laipis et al. 
(1988) and Koehler et al. (1991) demonstrated that in Holstein cows, mother-daughter 
pairs can be homoplasmic for different bases at the same position suggesting a 
segregation of heteroplasmy to homoplasmy within one generation. These studies 
suggest that heteroplasmy is rare and rapidly segregated. Also, as heteroplasmy is most 
often found when screening for disease causing mutations, it has predominantly been 
associated with mtDNA diseases. As mentioned previously, there are two types of 
heteroplasmy associated with mtDNA. Base substitution heteroplasmies have 
traditionally been single nucleotide substitutions, where maternally inherited, caused by 
replication mismatch or reactive oxygen species damage during oogenesis, or by nuclear 
factors where inheritance is Mendelian. 
Length heteroplasmy, as seen in the D-Ioop (Bendall and Sykes, 1995) and now 
in the con - tRNALys intergenic spacer (Chapter 3), is not normally disease associated. 
This heteroplasmy is presumably created by replication slippage of homopolymeric 
tracts, and whilst in non-coding regions is probably selectively only slightly negative due 
to the molecule's increased size. Replicative segregation of length heteroplasmies has 
been the main tool in ascribing a bottleneck mechanism to heteroplasmy inheritance. The 
bottleneck (purifying selection), theoretically acting on primary oogonia, is proposed to 
allow for the selective amplification of different types of mtDNA (reviewed by Poulton, 
1995). This could account for phenomena such as the rapid segregation of mtDNA in 
Holstein cattle. Conversely, others have demonstrated, using model fusion systems in 
mice, that all segregation phenomena can be explained by random genetic drift (eg. 
Jenuth et al., 1996). However, as Lightowlers et al. (1997) state "Whether segregation 
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really does occur by random genetic drift or through a complex 'sampling' process not 
yet understood, all models predict rapid segregation". 
Whilst rapid segregation may be the norm, not all heteroplasmies follow tins 
course. Howell et al. (1992) found slow mitochondrial DNA segregation in a silent 
heteroplasmic change in ND6 (G -j> A at nt 14560) that was found by chance when 
looking at a LHON pedigree. Interestingly, thls site is polymorphlc in humans suggesting 
there is no real selective advantage to maintain heteroplasmy at this silent site. In 1996, 
Howell et al. described another silent heteroplasmic polymorphlsm, seen within a large 
maternal lineage, at nt 14470. Thls was fixed to homoplasmy in one branch of the family, 
whllst withln another branch it remained heteroplasmic or was lost (Howell et al., 1996; 
Fig. 2 therein). ViIkki et al. (1990), like Howell and coworkers (1996), showed that a 
change within a large maternal lineage could be fixed rapidly, or remain heteroplasmic. 
Whilst the mutation described by Howell and coworkers (1996) is presumably silent, the 
mutation described by Vilkki and coworkers (1990) at nt 11778 is a primary LHON 
mutation. The same phenomenon can be seen in artificially created heteroplasmic mice 
strains, where heteroplasmy can be maintained for a number of generations (Meirelles 
and Smith, 1997). Thus silent and deleterious mutations can both be fixed rapidly, or 
retained in heteroplasmy. Thls observation suggests either an inefficient bottleneck or 
that the segregating unit is a heteroplasmic mitochondrion as opposed to a singleton 
mtDNA. This phenomenon can also be explained by the continued creation of 
heteroplasmy due to the presence of a nuclear propensity factor (e.g. Suomalainen et al., 
1995). 
Multiple site heteroplasmy 
Multiple site heteroplasmy can be divided into three classes, all of whlch are 
inter-related. The first of these, where mutations fall on different strands leading to 
triplasmy (multi-plasmy), has been demonstrated previously. Comas et al. (1995) found 
two heteroplasmies in the human D-Ioop withln one individual, but these appeared to be 
in different proportions and were never shown to be on the same strand of DNA. Howell 
et al. (1996) demonstrated an inherited form of triplasmy in a large maternal lineage, 
showing that the mutations never fell on the same strand. 
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The second class, and probably the most common, is likely an extension of the 
ftrst. Where further mutations occur in triplasmic individuals or lineages, some will fall 
on DNA strands already containing mutations. This leads to a state of multi-plasmy with 
mutational progression as has been observed in bat sequence variation (petri et al., 
1996). Jazin et al. (1996) showed that heteroplasmy was a natural state in human brains 
(non-dividing with a high energy metabolism) and that the level increased with age with 
multi-plasmy and mutational progression common. 
Probably the rarest, and most unconventional, class of multiple site heteroplasmy 
is when all of the mutations fall on the same DNA strands. This effectively gives two 
increasingly different populations of mtDNA within an individual, with or without 
intermediates. Bendall et al. (1996), whilst studying mono and di-zygotic twins, found 
one individual who was slightly heteroplasmic for two different bases and because, within 
clones, they were never found apart, it was assumed that they were on the same strands. 
No intermediates were found, although the number of clones analysed was small. Semen 
sample TM (Chapter 3) is an example of this type of multiple change heteroplasmy 
although the presence of one change is directly dependent on the other. Magoulas and 
Kouros (1993) showed that a proportion of Mediterranean anchovies (Engaulis 
encrasicolus) had two distinct populations of mtDNA differing by at least 7 restriction 
sites. The authors validly attributed the difference to bi-parental inheritance as they found 
individuals in the population of Mediterranean anchovies that were homoplasmic for one 
mtDNA type or the other (and in fact the two types of homoplasmy were common). 
Very recently Davis et al. (1997) demonstrated a seemingly common six base 
heteroplasmy within human COl and COlI genes that they associated with late onset 
Alzheimers. All six mutations were frequently on the same DNA strands, with the only 
variation being occasional intermediates, with DNA strands (represented by clones) 
missing one or more of the changes. In a note added in proof they suggest there are 
similarities between the mutant strands they found and the wild type mtDNA sequences 
of the great apes Pan troglodytes, Gorilla gorilla and Pongo pygmaeus and state that 
"this human mutant DNA molecule, therefore, may represent a transitional mtDNA of 
ancient origin". Hirano et al. (1997) and Wallace et al. (1997), when analysing the data 
of Davis et al. (1997), found the sequence divergence and the fact that the so called 
'mutant' molecules have phenotypic effects even though they are found in closely related 
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species, disconcerting. Both groups analysed mitochondrial free cells and found that a 
'mutant' sequence containing the changes described by Davis et al. (1997) could be 
amplified, suggesting that this 'mutant' sequence is a nuclear pseudogene. Both groups 
demonstrated that within the bounds of the COl and COIl genes, this pseudogene 
contains a large number of sequence variants, including all but one of the changes found 
within the 94-107 COlI 'heteroplasmy' in the present study (Chapter 3; pattern 9). That 
Davis et al. (1997) found only 6 of the 38 changes within the COl and con 
pseudogenes reported by Wallace et al. (1997) suggests that either Davis and coworkers 
observed different pseudogenes or that they overlooked the additional changes. Neither 
Davis et al. (1997), Hirano et al. (1997) nor Wallace et al. (1997) extended their studies 
to find the extent of the nuclear insertion beyond the COl and COIl gene boundaries. 
The aim of the present study was to extend the analysis of the 'heteroplasmy' 
seen within the con amplicon from semen sample 94-107 with the aim of confirming the 
pseudogene status of this mutant DNA. Conventional means of confirming pseudogene 
status including genomic DNA Southern hybridisation (Zischler et aI., 1995) and 
mitochondrial-free cell DNA amplification (Hirano et al., 1997; Wallace et al., 1997) 
were not possible because of a shortage of semen sample. Other less robust means were 
therefore used in this analysis. 
Materials and Methods 
To confirm pseudogene status for the mutant changes seen in COlI amplicon of 
sample 94-107 two different approaches were taken. The first involved differential cell 
extraction, and the second, further genomic amplification. 
Sperm nuclei are surrounded by highly thiolated (ramified) proteins, meaning that 
chromosomal DNA can generally only be purified if the extraction mixture contains 
DTT. In this way differential extraction can be carried out on sperm by prior extraction 
with non-DTT containing buffers, pelleting the sperm nuclei and then extracting the 
chromosomal DNA from sperm nuclei with DTT containing buffers (Gill et al., 1985). In 
normal seminal samples this method is not expected to give an additional fraction of 
purified mtDNA as the contaminating seminal white blood cells will give up their 
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chromosomal DNA in the non-DTT extraction. Twenty microlitres of seminal fluid was 
centrifuged at 4°C for 10 min at 4,500 x g. The pellet was resuspended in 250 fl.1 of 
extraction buffer (10 mM Tris-HCI (pH 8.0), 10 mM EDTA, 100 mM NaCi, 2% (w/v) 
SDS, 20 fl.glml proteinase K (Boehringer Mannheim)) and incubated at 37°C for 30 min. 
Sperm nuclei were pelleted by centrifuging for 5 min at 15,000 x g at room temperature. 
The nuclear pellet was washed once with extraction buffer and re-centrifuged as before. 
Nuclei were lysed in the extraction buffer with the addition of 3.9 mM DTT at 37°C 
overnight. DNA was purified from both the before and after DTT extraction fractions by 
a single phenol/chloroform extraction before being precipitated with 0.1 vol 3 M sodium 
acetate and 2.5 vol absolute ethanol at -20°C overnight. The DNA was centrifuged to 
pellet, washed with 70% ethanol, air dried and re-suspended in 20 fl.1 of ddH20. The 
COIl amplicon from semen sample 94-107 and controls was then amplified using primers 
HMTL712 and HMTH844 as described in Chapter 3. PCR products were cleaved with 
BstNl and electrophoresed on 5%BSCP gels using standard conditions. 
In addition to differential extraction, other regions of mtDNA were analysed to 
see if the differences between the normal and 'mutant' sequence were confined to the 
COIl amplicon (Table 4.1). PCR products from semen sample 94-107 and control 
samples were cleaved to completion by restriction enzymes that gave products suitable 
for SSCP analysis. SSCP analysis was performed using standard conditions. 
Based on the SSCP analysis of amplicons presented in Table 4.1, cloning of two 
other amplicons was carried out for replicate PCR products from semen sample 94-107. 
Alul cut HMTLI161-HMTH1357 94-107 PCR product was blunt ended (Klenow end 
filling) and the bands of interest were gel extracted using a BioRad prep-a-gene kit. 
These bands were then cloned into Smal cut pBSM13+. Positive colonies were selected 
and sequenced as described in Chapter 3. The possibility of heteroplasmy in the HVI 
PCR product created by primers HMTL1598 and HMTH1642 lead to the cloning ofthis 
amplicon. 94-107 HVI PCR product was blunt ended (Klenow end filling) and cloned 
into Smal cut pBSM13+ as previously described. To select clones for sequencing, 20 ng 
of boiling preparation from positive clones was PCR amplified with the same conditions 
and primers used to create the HVI insert for cloning (Appendix 5). This gave 
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Table 4.1. Amplicons used in the analysis of multiple difference 'heteroplasmy' with a diagrammatical 
representation of the amplicon coverage of mtDNA. Note that PCR conditions optimised for these 
amplicons are listed in Appendix 4. 
Primers Nucleotides Size Genes included 
1 HMTL321 3216-4557 618bp 16s rRNA, tRNALeu(UUR>, NDl, 
HMfH455 tRNAu., tRNAGln, tRNAC.Met, 87 bp ND2 
2 HMTL604 6040-7356 1316 bp 1316 bpCOI 
HMfH735 
3 HMTL712 7126-8442 1316 bp 319 bp COl, tRNASelWCN), tRNAA!p, 
HMfH844 COIl, 25 bp intergenic spacer, tRNALyo, 
76 bp ATPase 8 
4 HMTL817 8186-9341 1155bp 101 bp con, tRNAL)., ATPase 8, 
HMfH934 ATPase 6, 134 bp corn 
5 HMTL 10 12 10123-12461 2338 bp kg His 281 bp ND3, tRNA ,ND4L, ND4, tRNA , 
HMfH1246 tRNASet{AGY), tRNALeu(CUN), 125 bp ND5 
6 HMTL1161 11616-13574 1958 bp 520 bp ND4, tRNAHis, tRNASer(AOY), 
HMfH1357 tRNALeu(CUN), 1214 bp ND5 
7 HMTL1445 14459-15858 1399 bp 214 bp ND6, tRNAG1u, 1111 bp Cyt b 
HMfH1585 
8 HMTL1598 15981-16420 439bp 43 bp tRNAPro, 397 bp D-loop (HVl) 
HMfH1642 
8 __ 
6 
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To determine if the heteroplasmy was confined to COIl, 9931 bp of non-
continuous mtDNA was screened by amplifYing and cleaving specific amplicons (Table 
4.1), and analysing by SSCP as before. In addition to the variations seen in the COIl 
amplicon, only amplicons created by primers HMTLl161 - HMTH1357 (ND41ND5) and 
HMTL1598 - HMTH1642 (HVl) showed heteroplasmic variation when compared to 
control samples. 
ND4IND5 heteroplasmy 
Primers HMTLl161 and HMTH1357, spanning the ND41ND5 amp licon, give a 
1958 bp PCR product. When 94-107 ND4fI\.ID5 product was cut with Alul and 
electrophoresed on a 3% agarose gel, a large number of extra fragments were visible 
when compared with controls. In addition to the normal Alu 1 fragments (Fig. 4.2) of 
1000 bp, 388 bp, and 278 bp, semen sample 94-107 had fragments of 890 bp, 601 bp, 
531 bp, 359 bp, and 200 bp (Fig. 4.3). Control samples had an additional 143 bp Alu 1 
fragment that was missing from semen sample 94-107. 
The extra Alu 1 bands were associated with all of the ND41ND5 amplifications 
from semen sample 94-107. Additionally, there was no undigested PCR product which 
might suggest that the extra fragments were not a result of partial digestion. Nonspecific 
enzyme activity was unlikely because the same banding pattern was reproducible and was 
not seen with any of the other semen samples tested. When the same region was digested 
with HaeIII (Fig. 4.3) the expected fragments of 686 bp, 679 bp and 521 bp were still 
present with two additional fragments slightly larger than 686 bp and a fragment 
approximately 350 bp respectively. 
Two rounds of cloning and sequencing were performed to identifY changes to the 
ND4IND5 amplicon and to obtain a genetic map of the Alul digest fragments (Fig. 4.4). 
In the first round the 890 bp, 601 bp and 531 bp mutant fragments were cloned and 
sequenced. Later cloning of the mutant 359 bp fragment and the normal 388 bp fragment 
confirmed changes from the above sequencing and showed that at least for some of the 
ND41ND5 amplicon the normal sequence is the same as the Cambridge sequence (see 
Appendix 6 for clone sequences and Table 4.2 for a list of the most conserved changes). 
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Figure 4.3 Schematic representation of restriction endonuclease cleavage sites within the ND41ND5 
amplicon for enzymes A/u 1 (A) and HaeIII (H). Actual cutting sites are marked. 
Note that the normal 143 bp Allil fragment is not present on the agarose gel in 
Figure 4.2. This indicates that whilst the mutant DNA always cuts at nt 11683, the 
normal does not cut at nt 11683 (given that the normal cuts at nt 11826 to yield the 388 
bp fragment). Thus the normal is also different from the Cambridge sequence and has a 
change that the mutant does not have. No polymorphisms have been reported within this 
Alul site previously. 
~ ~ ~ ~ (;, ",'" 
,'0 ~ .& ~ t'\~{J A A A A' A); 
Clone 
178-1-531-4 531 bp 178-4-531-7 
178-1-531-10 
178-1-601-3 601 bp 
178-2-890-6 890bp 178-2-890-13 
178-4-359-3 359 bp 178-4-359-9 
178-4-388-11 388 bp 178-4-388-10 
Figure 4.4. Position of sequenced clones on a fragment map of A/u1 cut 94-107 ND41ND5 amplicon. 
Actual cutting sites of A/u 1 sites (A) are indicated. Restriction sites at nt 12214 and nt 12284 are cut 
only some of the time, indicating that these sites have within heteroplasmy variation. Nucleotide 11826 
and nt 12562 are never cut within mutant clones indicating that these sites always have this 
heteroplasmic change. 
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Of additional interest is the number of clones that appear to contain 
recombinations of mutant and normal DNA. Such recombinations are probably artificially 
created by Taq polymerase strand jumping (Bradley and Hillis, 1997). Often in these 
recombinations there are Alll1 restriction sites within the normal portion of the clone that 
are not cut. The reason for this is not known. 
Ten clones were sequenced so that, over the 890 bp between nt 11683 and nt 
12573, a consensus 'mutant' sequence was obtained. In addition to a new NDS 
premature termination codon created by a T -+ A change at nt 12441 there were 47 
other consensus point mutations (Table 4.2). In addition to the most conserved changes 
listed in Table 4.2, there were a number of changes that were only found in one or two. 
clones. These changes are probably artefacts of the peR and as such have not been used 
in any further analysis. 
Table 4.2 Consensus changes found, in the ND4/ND5 'mutant' clones of 94-107. Syn means 
synonymous, or no change. Dashes indicate no amino acids coded because the nucleotide change falls 
within a tRNA gene. Ter refers to a newly created termination codon. 
Nucleotide Change Amino acid Nucleotide Change Amino acid 
11708 A-+G Ile -+ Val 12285 T-+C 
11719 G-+A syn 12290 A-+G 
11767 C-+T syn 12346 C-+T His -+ Tyr 
11770 T-+C syn 12349 A-+G Thr -+ Ala 
11788 C-+T syn 12358 A-+C Thr -+ Pro 
11809 T-+C syn 12367 A-+G Thr -+ Ala 
11827 T-+C syn 12372 G-+A syn 
11852 G-+A Ala -+ Thr 12379 C-+T syn 
11857 C-+T syn 12390 C-+T syn 
11887 G-+A syn 12406 G-+A Val-+ He 
11914 G-+A syn 12417 C-+T syn 
11963 G-+A Val-+ He 12432 C-+T syn 
12007 G-+A syn 12441 T-+A Tyr -+ ter 
12013 A-+G syn 12454 G-+A Val-+ Thr 
12018 C-+G Thr -+ Ser 12466 T-+C Phe -+Leu 
12064 C-+T syn 12469 A-+G Ile -+ Val 
12088 C-+T syn 12474 C-+T syn 
12091 T-+C syn 12501 G-+A syn 
12115 C-+T syn 12503 G-+A Cys -+ Tyr 
12136 T-+C syn 12519 T-+C syn 
12189 T-+C 12528 G-+A syn 
12218 C-+T 12540 A-+G syn 
12236 G-+A 12543 C-+A syn 
12237 C-+T 12561 G-+A syn 
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Table 4.3. Individuals sharing tbe same sequence variant as the normal sequence of 94-107. Data were 
derived from The Concordance of Nucleotide Substitutions in Human mtDNA Control Region. 
Department of Anthropology, University of California at Santa Barbara (http://sscf.ucsb.edul~kmiller) 
on 10.8.97 at 12pm PST. Note that whilst one of these individuals is Mongolian, this race is presumed to 
have much sequence variation because of its historically wide ranging population assimilation. 
Individual Population Reference 
17 Bulgar Calafell et al., 1996 
38 Bulgar Calafell et al., 1996 
F193 Finnish Sajantila et al., 1995 
aukar5 Karelian Sajantila et al., 1995 
aukar10 Karelian Sajantila et al., 1995 
aukarll Karelian Sajantila et al., 1995 
17.31 Mongolian Kolman et al., 1996 
SW27 Swiss Pult et al., 1994 
Clones with the other SSCP pattern have a very different sequence to normal as 
shown in Figure 4.6. This mutant sequence has 106 transition/transversion mutations, 3 
single base deletions, 1 double base deletion and 6 single base insertions compared to 
both the Cambridge sequence and the 94-107 normal HVI sequence when aligned by the 
EMBL Homology Alignment Program in DNASIS. Thus, over the 376 bp HVI region 
(Fig. 4.6) the mutant sequence shows 72% sequence identity to the normal (not including 
insertions or deletions). See Appendix 7 for more details. 
Discussion 
Differential extraction 
The differential extraction technique was devised by Gill et al. (1985) for the 
separation of sperm nuclei from other cell types and debris in vaginal swabs. In this study 
differential extraction has been successfully used to isolate enriched fractions of nuclear 
and mitochondrial DNA. Subsequent PCR and SSCP analysis showed that the 'mutant' 
COIl band was restricted to the nuclear fraction consistent with the findings of Hirano et 
al. (1997) and Wallace et al. (1997). 
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Figure 4.6. Maximum homology alignment of the HVI region of mtDNA from a number of sources. 
Cambridge sequence (nt 16023 to nt 16399) is from Anderson et al. (1981), 94·107 normal and mutant 
are from this study. The mutant sequence is a consensus from 6 clones with individual clone sequences 
shown in Appendix 7. Maximum homology alignment was performed using the EMBL Homology 
Alignment Program in DNASIS. The neanderthal sequence is from Krings et al. (1997). The Nu 
(nuclear) insertion is from ZiscWer et al. (1995) and aligns with the Cambridge sequence between nt 
16089 and nt 16399, The Fan troglodytes, p, paniscus, Gorilla gorilla, Fongo pygmaeus ahelii and H. 
lar sequences are from EMBL and Genbank (accession nos. D38113, G643684, X93347, X97707 and 
X99256). k:=: g or t. Dots(,) indicate synonymous nucleotides to the Cambridge sequence. Dashes (.) are 
present for alignment purposes only, but may indicate possible sites of insertions and deletions. Note that 
the large deletion in the middle of the G. gorilla sequence actually contains the following non-alignable 
sequence (based on Foran et al., 1988):5' acaaccccccccttcccccccccctcctcca 3' 
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Analysis of further sample 94-107 amplicons 
Presently, all of the mutant DNA is contained in non-contiguous amplicons. To 
test whether all of the consensus mutations are on the same strand of DNA one can, for 
example, amplify long stretches of DNA between the facing primers of the BV1 and 
ND4/ND5 amplicons, clone the PCR product, and then analyse by SSCP and 
sequencing to see if the ends of the fragments in individual clones are mutant or normal. 
Unfortunately, as with Southern analysis for testing the pseudogene hypothesis, 'long' 
PCR requires relatively high concentrations of highly purified template DNA and this 
was unobtainable because of a lack of semen sample. An analysis of the changes found 
in the COlI, ND4/ND5 and BV1 amplicons (Table 4.4) can also help to show if all 
pseudogenes are contiguous. GC content, transition/transversion ratios, and homology 
with other species were all taken into consideration. 
Table 4.4. Comparison of GC content, transition/transversion ratios and species homology for sequenced 
regions of 94-107. For the siIriilarityanalysis, the ftrst number refers to the mutant, the second to the 
Cambridge sequence. O. gorilla HVI sequence only includes the alignable region. For the % changes 
explained in the HVI column the brackets enclose the absolute number of transitions and transversions 
explained. Note that the percent of changes explained by human sequence uses MITOMAP (Wallace et 
al., 1995) and so includes a large amount of human RFLP and sequence data from which to draw 
polymorphisms. P. troglodytes, P. paniscus and O. gorilla comparisons are made with just one sequence 
from each of these species (ref. Fig. 4.6) even though these species are assumed to have as much between 
individual variation as humans (eg. Goldberg and Ruvolo, 1997). 
COlI ND4!ND5 BV1 
% 94-107 mutant GC content 45 43 40 
% Cambridge GC content 46 44 46 
% AG/GA transitions 29 46 13 
% TC/CT transitions 71 46 34 
% transversions 0 8 53 
% similarity to Cambridge 98 95 72 
% similarity to P. troglodytes 92/90 90/91 67/83 
% similarity to P. paniscus 93/91 93/92 67/81 
% similarity to G. gorilla 88/87 90/90 60/83 
% changes explained by Human 0 21 33(31/4) 
% changes explained by P. troglodytes 86 58 19(17/3) 
% changes explained by P. paniscus 86 58 18(17/2) 
% changes explained by G. gorilla 57 52 21(1211 ) 
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94-107 con amplicon amplification 
There is a consensus of seven differences between the mutant and normal strands 
of the sequenced region (nt 7610 to nt 7975) of the COIl amplicon (see Chapter 3 for 
details). A number of mutant clones had additional changes that were seen only once. 
One clone, although not sequenced in its entirety, did not have a G ---,» A at nt 7757 but 
did have flanking mutations. Given that it is highly likely that the changes seen are a 
result of amplification of a nuclear pseudogene, it is also likely that this missing base is 
the result of allelic forms of this pseudogene. Neither Davis et al. (1997), Hirano et al. 
(1997) nor Wallace et al. (1997) found a G ---,» A at nt 7757 within the COIl pseudogene. 
Mosaics could additionally be explained by Taq polymerase strand switching (see 
previously) but in this instance this would require two switching events on the same 
molecule. The SSCP screening showed just one clear extra band associated with the 
mutation, indicating that, if intermediates are present, that they are in very low 
proportions. SSCP analysis of 65 clones shows that the clone ratio between normal and 
mutant is 1 : 0.5. In the present study no apparent heteroplasmy was evident in other regions 
of the COIl amplicon although changes were found throughout con in other studies (Hirano 
et aI., 1997; Wallace et al., 1997). No heteroplasmy was detected from the COl region in 
this study. Possible reasons for this are discussed below. 
From Table 4.4 it is seen that the 'mutant' COIl sequence does not have a 
markedly altered GC ratio (although six of the seven changes result in the loss of a C or 
G) probably because of the relatively small number of mutations. The i/v ratio is skewed 
towards transitions (with no transversions) which is normal for mtDNA (Brown et al., 
1982). Whilst the mutant sequence has more homology with humans than any other 
species, primate sequences have marginally more homology with the mutant sequence 
than with humans, with most of the changes being explained by single primate sequences. 
94-107 ND41ND5 amplicon amplification 
The ND41ND5 heteroplasmy was initially detected as Alu 1 RFLPs. Forty eight 
consensus changes were observed out ofa sequenced region of890 bp. Of additional interest, 
are instances where not all of the changes were present in all clones. Of the 10 clones 
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analysed, four had a mixture of mutant and normal DNA Three of these were normal at one 
end and mutant at the other, and the fourth (178-1-531-10) was only missing the T -» C 
transition at nt 11770 (Appendix 6). Bradley and Hillis (1997) experimentally demonstrated 
that Taq polymerase produced recombinant sequences three out of seven times in a 1128 bp 
amplicon. Theoretically, the rate of strand switching is dependent on amplicon length, 
polymerase processivity and fidelity, and PCR extension time but these factors have not been 
experimentally confirmed. 
Alu1 digests ofND41ND5 amplicon from 94-107 show that a number of Alul cut 
sites are themselves variably heteroplasmic. Sites at nt 12214 and nt 12284 were cut to 
produce 531 bp and 601 bp mutant fragments, but occasionally failed to be cut, producing 
890 bp mutant fragments. Variable mutations at nt 12218 and nt 12285 could account for 
these results. The lack of any normal Alu 1 143 bp fragment suggests, as mentioned above, 
that the normal sequence is. polymorphic at the Alu 1 site at nt 11683. The mutant strands 
were cut here suggesting that they were not polymorphic for this site. 
As for COlI, the mutant ND4!ND5 sequence does not have a markedly altered 
GC ratio (Table 4.4). The ilv ratio is skewed towards transitions (92% transitions) which 
is normal for mtDNA (Brown et al., 1982). The mutant sequence has more homology to 
humans than any other species, but with more than 50% of the changes being explained 
by single primate sequences. As with the COlI sequence, it is practically impossible to 
predict the effect that these mutations would have on protein structure and function 
given the large number of changes. The obvious exception to this is the new premature 
termination signal caused by a change at nt 12441. This would create a severely 
truncated ND5 polypeptide (34mer vs. 603mer), obviously altering protein structure and 
function. None of the tRNA changes affect the anticodon or amino acid acceptors, but 
beyond this it is difficult to predict the effects of the changes on tRNA Given that a 
severely truncated ND5 protein would alter mitochondrial complex 1 activity and the 
'mutant' ND41ND5 sequence has homology with primates, it is predicted that this 
sequence is also a nuclear pseudogene. Whether this pseudogene is related physically and 
temporally to the COlI pseudogene is unknown. 
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94-107 BY! amplicon amplification 
At least two different types ofHV1 DNA is present in semen sample 94-107. The 
normal type has just one change (C -j. T at nt 16354) with respect to the Cambridge 
sequence, and probably defines the donors maternal lineage as North Eastern European in 
origin. A consensus sequence of the 'mutant' type has 106 transition/transversion 
mutations, 3 single base deletions, 1 double base deletion and 6 single base insertions 
compared to both the Cambridge sequence and the other 94-107 HV1 type. Within the 
'mutant' type there is within-sequence variation at two positions. Nucleotide 16090 
alternates between being a normal T and a mutant G; whilst at nt 16328, one clone (180-
9-25) is missing the consensus C ~ G transversion. Other than these instances, all the 
clones analysed have all of the changes suggesting that other more divergent intermediate 
forms are rare or non-existent. Whilst the HV1 region is non-coding, Sbisa et al. (1997) 
recognised a relatively conserved putative hairpin domain (ETAS1) that may be a 
recognition site for the arrest of heavy strand synthesis. A number of changes in the 
'mutant' HV1 sequence are in conserved nucleotides in this putative hairpin. The large 
sequence divergence and possibility of ETAS 1 hair pin disruption suggest that this 
'mutant' HV1 sequence is also a nuclear pseudogene. An analysis of sequence 
characteristics shows that those for HV1 are very different from con and ND4/ND5 
(Table 4.4). The large number of changes and transversion bias has decreased the GC 
content by 6 percent. Primate sequences are more related to the normal human sequence 
than to the mutant, with less homology, the longer ago the primate diverged. Individual 
primate sequences can explain very few of the changes, and when broken down into 
transitions and transversions it can be seen that transitions can be explained much more 
frequently than transversions. 
Time of insertion for sample 94-107 pseudo genes 
The insertion of mtDNA into the nucleus is a frequent phenomenon that occurs in 
all plants and animals (for a review see Zhang and Hewitt, 1996). The ancient transfer of 
functional genes to the nucleus has allowed mitochondrial energy production to be under 
dual control (Wallace, 1986). The different codon usages between nuclear and mtDNA 
mean that more recent transfers result in pseudogene formation. Mitochondrial DNA 
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fragments can insert into functional nuclear genes with pathological consequences (Shay 
and Werbin, 1992). Nuclear insertions may involve non-continuous mtDNA regions 
combining to form a continuous nuclear pseudogene (Kamimura et al., 1989), or just a 
single mtDNA region inserting into the nuclear DNA (Zischler et al., 1995). 
Both nuclear genes and mtDNA accumulate mutations over time. Coding regions 
in both the nuclear and mtDNA have similar mutational constraints with respect to the 
need to retain structure and function of the encoded protein product. Pseudogenes, 
however, having no known function, have no such constraints. The rate of mutation 
fixation in pseudogenes is therefore assumed to be higher than that of coding nuclear 
DNA. Both coding and noncoding regions of mtDNA, however, generally have a higher 
rate of mutation fixation than nuclear pseudogenes (see Chaper 1). Estimates of this rate 
difference vary from ten-fold to forty-fold (Zischler et al., 1995). Arctander (1995) has 
traced one pseudogene insertion and its paralogous mitochondrial gene (Cyt b) through 
multiple species of South American birds. He found an overall thirty nine-fold difference 
in the rate of mutation fixation between the nuclear and mitochondrial genes. Collura and 
Stewart (1995) found a P. pygmaeus Cyt b pseudogene, also present in Hylobates lar 
and H. sapiens, that evolves at 0.15% per base per year, about 10 times slower than 
mitochondrial Cyt b. Because of the generally lower rate of change of nuclear 
pseudogenes compared to the paralogous mitochondrial genes many people believe that 
these pseudogenes can be used as molecular fossils (Arctander, 1995; Zischler et al., 
1995; Blanchard and Schmidt, 1996; Zhang and Hewitt, 1996; Wallace et al., 1997). 
That is, pseudogenes closely resemble the ancestral sequence at the time of pseudogene 
insertion. Assuming that all genetic transfer is vertical, pseudogenes can therefore be 
used to ascribe phylogenetic relationships. However, not all pseudogenes evolve more 
slowly than their paralogous mtDNA genes (Lopez et al., 1997). The faster rate of 
domestic cat 12s rRNA pseudogene evolution than mitochondrial 12s rRNA evolution is 
probably due to the constraints on the mitochondrial gene. Because of this, the use of 
pseudogenes· as molecular fossils must be treated with some caution (Zhang and Hewitt, 
1997). 
Calculating the time of pseudogene insertion is a complex matter. For recently 
inserted pseudogenes, it can be assumed that the pseudogene divergence between 
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individuals is minimal and hence the rate of change since insertion is effectively zero. 
This was shown experimentally by Zischler et al. (1995) with the analysis of a human D-
loop pseudogene. As not all humans sampled had this D-Ioop pseudogene it was 
assumed that the time of insertion was after the earliest radiation of modern humans. The 
pseudogene sequence from different races was identical, whilst the paralogous D-Ioop 
sequences from different races showed the normal level of variation suggesting that the 
rate of pseudogene mutation since insertion was effectively zero (Zischler et al., 1995). 
For ancient pseudogenes, an assumption of a zero rate of change since insertion will 
introduce greater errors with increasing time of divergence. To calculate the divergence 
(insertion) time of ancient pseudogenes, an assumption (or calculation) of the rate of 
pseudogene evolution is required. With the rate of pseudogene evolution and the rate of 
mtDNA evolution, one can estimate the coalescence time of the mtDNA and nuclear 
sequences and hence the time of insertion (Li et al., 1981; Collura and Stewart, 1995; 
Sorenson and Fleischer, 1996). 
Prior to calculating times of insertion of pseudogenes it is helpful to have a ball 
park idea of when the insertion took place (so that the appropriate model can be used for 
the analysis). Relationships between the inserted sequence and paralogous sequences are 
used to construct a phylogenetic (or cladistic) tree. Given that the data used in tree 
construction and divergence times is the same these methods are not independent of one 
another. To do this analysis, the PAUP (3.0s+9) computer program (Swofford, 1991) 
was used. In tree analysis, relationships between sequences are seen as branches. 
Minimum relative branch lengths are seen as a conservative estimate of evolutionary 
distance. Trees were created using a branch and bound algorithm with bootstrap analysis 
(Swofford, 1991). Bootstrap analysis quantifies the confidence that a particular branch 
falls in a particular position within a tree. Only the most parsimonious ND4/ND5 (Fig. 
4.7) and HVl (Fig. 4.8) trees are presented as trees for con and for ND4/ND5 were 
very similar. Trees are unrooted as suitable sequences were not available as outgroups 
(in the case of HVI it is uncertain if any of the primate sequences would predate the 
mutant sequence and non-primate HV 1 sequences have little alignable sequence) and no 
ancestral states were available. Additionally, within this analysis, character states are 
unweighted as the estimates of i/v bias vary between nuclear and mtDNA. Notes on the 
sequences used are included in the figure legends. An HVI tree including a G. gorilla 
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82% 
13 
51 
Orangutan 
100% 100% 
19 22 
57 Gibbon 
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Figure 4.7. Most parsimonious ND4/ND5 sequence phylogenetic tree. Tree was constructed by branch 
and bound algorithm of P AUF 3. Os+9. Only branches where the bootstrap value was greater than 50% 
are resolved. Tree length 580, Consistency index 0.788, Homoplasy index = 0.212. Branch lengths 
(below branches) are minimum possible lengths given by PAUF, while bootstrap values (above 
branches) are calculated from 200 replications. Accession numbers for sequences from EMBL and 
Genebank are as follows Human I , X62996 (Cambridge sequence); Human2, X93334; H;uman3, 
D381l2, Chimp2, D38113. Other sequences \-vere derived as follows: Chimpl, Gorilla, Orangutan and 
Gibbon are from Brown et al. (1982); Nuclear insertion (Nu-ins) is clone Lm-P6 from Fukuda et al. 
(1985), whilst mutant is the consensus 'mutant' sequence of sample 94-107 from this study. Sequences 
were compared over 890 characters (as shown in Appendix 8). Alignment followed Brown et al. (1982). 
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Figure 4.8. Most parsimonious HVI sequence phylogenetic tree. Tree was constructed by branch and 
bound algorithm ofPAUP 3.0s+9. Only branches where the bootstrap value was greater than 50% are 
resolved. Tree length = 389, Consistency index '= 0.774, Homoplasy index = 0.226. Branch lengths 
(below branches) are minimum possible lengths given by PAUP, while bootstrap values (above 
branches) are calculated from 200 replications. Accession numbers for sequences from EMBL and 
Genebank are as follows Human1, X62996 (Cambridge sequence); Human2, X93334; Human3, 
038112; Chimp2, 038113; Pygmy (pygmy chimpanzee P. panisclIs), 038116, Suorang (Sumatran 
orangutan, Pongo pygmaeus abelii) X97707, Gibbon (Hylobates Jar) X99256. Other sequences were 
derived as follows: Normal and mutant are representatives of sample 94-107 from this study, Neander is 
the consensus neanderthal sequence of Krings et al. (1997) and the Nu-ins (nuclear insertion) is derived 
from Zischler et al. (1995). Sequences were compared over 327 characters between nt 16088 and nt 
16414 (numbering includes missing values (gaps) included for alignment). Alignment of most sequences 
was based on the conserved ETAS domains presented at http://www.ba.cnr.itldloop.html prepared by 
Sbisa et al. (1997). Alignment of the HVI pseudogene (this study) and P. pygmaeus abelii were based 
on conserved domains at the 3 and 5' ends of HVI sequence. 
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sequence used only 175 alignable bases with no branches being resolved with a bootstrap 
level of50% or greater. Therefore G. gorilla sequences were left off this analysis. 
The ND41ND5 (and COlI) trees suggest that the 94-107 ND41ND5 pseudogene 
falls between modem human sequences and P. troglodytes. The lack of alignable primate 
sequence and the high sequence diversity of older primates in the HV1 region makes this 
analysis tenuous. The addition of a large number of further human and P. troglodytes 
sequences to this analysis does not enhance this analysis and so these have been left out 
of these trees. The small number of differences between (Human 1, Human2) in 
ND41ND5 and (Human1, Normal) in HV1 makes these branches impossible to resolve at 
a bootstrap confidence level of 50%. It is anticipated that the saturated sequence 
divergence of H. lar, P. pygmaeus abelii and the present study HV1 pseudogene make 
this trichotomy impossible to resolve above the bootstrap confidence limit of 50%. 
From Table 4.4 and the above phylogenetic relationships, it was assumed that the 
COlI and ND41ND5 pseudogenes were the result of recent insertions but that the HV1 
pseudogene was inserted much longer ago. Current theories of hominid evolution (and 
indeed the above trees) indicate that humans are most closely related to P. troglodytes, 
with G. gorilla and other primates being less closely related but more closely related than 
other mammals. African apes diverged from P. pygmaeus 13 million years ago (pillbeam, 
1984). Horai and others (1992) have used this time of divergence to estimate that the 
time of the last common ancestor of modern humans and P. troglodytes was between 
four and five million years ago. By computing the number of mtDNA nucleotide 
differences between humans and P. troglodytes and correcting for reversion mutations it 
is possible to estimate a rate of change per million years. By assuming that this molecular 
clock (evolutionary rate of mutation fixation) is constant across the board one can 
directly calculate the time of the last common ancestor between two species without 
there having to be a fossil record. Whilst this is most predictive using coding DNA, due 
to the constraints on mutation fixation and therefore the relative lack of reversion 
mutations, this method has been performed on D-Ioop mtDNA sequences (Vigilant et 
al., 1991 and refs therein). 
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Using a three-substitution-site (3ST) fonnula from Kimura (1981) the 
probabilities of transitions and transversions per nucleotide between sequences were 
calculated. Between-sequence transition (TC and AG substitutions) frequencies per site 
were tenned P. Per site, between sequence transversion frequencies were divided into 
TA and CO substitutions (Q) and TG and CA substitutions (R). These frequencies were 
then corrected for multiple substitutions at a site using equation (1) (Kimura, 1981; eq. 
6) to give the overall corrected substitution rate (K) (rate of fixation at a nucleotide 
position) as shown in Table 4.5. 
K -0.25 x In[(1-2P-2Q)(1-2P-2R)(1-2Q-2R)] (1) 
If the divergence time (T) is known, then the base substitution rate per unit time (knuc) is 
given by equation (2) (derived from Kimura, 1981; eq. 7; see Appendix 9) 
knuc = KJ(T) (2) 
Table 4.5. Corrected nucleotide substitution rates between different sequences. Sequences compared are 
the Cambridge (H), 94-107 'mutant' (M), P. troglodytes (C) and G. gorilla (G). Chimpanzee and gorilla 
sequences can be seen in the appropriate appendices. con n 365, ND4fND5 n = 890, HV1 n = 238 
where (n) is the number of nuc1eotides used in the analysis. Note that for HV1-K values, the sequence 
used is only that over which G. gorilla has alignment. 
COIl-K ND4/5-K HVI-K 
M-H 0.01955 0.05681 0.31990 
M-C 0.08953 0.08755 0.34935 
M-G 0.13988 0.10500 0.37314 
H-C 0.10615 0.09590 0.14763 
H-O 0.14348 0.11485 0.19787 
C-G 0.16140 0.11740 0.26527 
Assuming a time of last common ancestor (T) of humans and P. troglodytes (H-
C) of between four and five million years, the rate of nucleotide substitution per site per 
million years (knuc) (calculated for COIl) is between 0.0212 and 0.0265. Then assuming 
that the rate of change since insertion of the COIl pseudogene was zero, the theoretical 
time of insertion of the con pseudogene (calculated from M-H) is K for M-H divided 
by the constant rate of substitution per million years calculated above. This gives M-H 
divergence (insertion) times of between 0.74 - 0.92 million years before present. When 
the same analysis was done for the ND4/ND5 pseudogene the times of M-H divergence 
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(pseudogene insertion) were 2.36 - 2.95 million years before present. These estimates are 
based on a large number of assumptions and have errors of unknown magnitude 
associated with them. The major assumption is that mtDNA nucleotide substitution rates 
are constant within and between species over time. 
Wallace et al. (1997) estimated a time of insertion of 770 thousand years before 
present for the COIl pseudogene which is in the range of 0.74 - 0.92 million years 
estimated in this study. Wallace and coworkers estimate is based on more substitutions 
and so is likely to be more accurate. Both estimates place the insertion after the 
divergence of hominids from the present P. troglodytes lineage but before the major 
human radiation as estimated by Cann et al. (1987). Additionally, the estimates of both 
Wallace et al. (1997) and the present study are based on zero rates of change of the 
pseudogene since insertion. Within sample 94-107, in addition to the changes in the 
pseudogene found by Wallace et al. (1997), there is a G ~ A at nt 7757. This is a 
mosaic, however, as it is not found in clone 3-1-4. The presence of this change, even 
within one individual, suggests that the COIl pseudogene is not static. 
The ND4IND5 pseudogene has never been reported previously. A divergence 
time of 2.36 to 2.95 million years places the insertion point after the hominid - P. 
troglodytes divergence but prior to the major human radiations (Horai et al., 1992). It is 
expected, therefore, that all modern humans would harbour this insertion. Like the COIl 
pseudogene, the ND41ND5 pseudogene appears to be a mosaic and therefore a zero rate 
of change may have underestimated the divergence (insertion) time. 
The HV1 pseudogene, based on Table 4.4 and the phylogenetic tree analysis (Fig. 
4.8) is estimated to have a much older insertion time. It is therefore inappropriate to use 
the zero change method for calculating the time of insertion. Using the method of Li et 
al. (1981), however, requires the resolution of phylogenetic branches beyond the time of 
insertion. Within the present study these branches could not be resolved with greater 
than 50% confidence (Fig. 4.8). Because of this, the previous method was used to give a 
very conservative estimate of insertion time. Assuming a time of last common ancestor 
(T) of humans and P. troglodytes (H-C) of between four and five million years, the rate 
of nucleotide substitution per site per million years (knuc) (calculated for HV1) is 
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between 0.0295 and 0.0369. Then, assuming that the rate of change since insertion of the 
HV1 pseudogene is zero, the theoretical time of insertion of the HV1 pseudogene 
(calculated from M-H) is K for M-H divided by the constant rate of substitution per 
million years calculated above. This gives M-H divergence (pseudogene insertion) times 
of between 8.5 - 10.5 million years before present. This is considered to be a relatively 
inaccurate estimate of insertion time because of the assumption that the nuclear 
pseudogene mutation rate is zero. Collura and Stewart (1995) using mtDNA Cyt b genes 
and associated pseudogenes estimated that H. lar diverged from the great apes about 16 
million years ago. The HV1 pseudogene found within sample 94-107 mayor may not 
predate this H. lar divergence. 
The HV1 region of the mtDNA D-Ioop is made up of a number of different 
domains with differing amounts of sequence conservation between species (Saccone et 
al., 1991; Sbisa et al., 1997). Sbisa et al. (1997) recognise two ETAS domains in all 
mammals studied. These sequences are relatively conserved and may have roles in the 
regulation of transcription and replication. In primates the ETAS domains are separated 
by an insertion sequence (IS). In humans this IS is the most variable stretch of DNA in 
the entire D-Ioop (Wallace et al., 1995). Sbisa et al. (1997) noted that "in this domain 
human is more similar to gibbon, which possesses the IS element, than to evolutionally 
closer species such as gorilla and orangutan." Within the present study an alignment of 
ETAS domains shows that H. sapiens, P. troglodytes, P. paniscus, P. pygmaeus abelii 
and H. lar all share similarity in the IS region whereas G. gorilla and P. pygmaeus have 
divergent IS sequences (Fig. 4.9). The HVI pseudogene IS also shares similarity to the 
human IS. Given the proposed time of insertion of the HVI pseudogene in the nuclear 
DNA, and the fact that pseudogenes may act as molecular fossils, this finding supports 
the suggestion that the IS seen in H. lar, H. sapiens, P. troglodytes, P. palliscus and P. 
pygmaeus abelii is ancestral and that the IS elements of G. gorilla and P. pygmaeus have 
diverged from this. 
Given the calculated time of insertion of the 94-107 HVI pseudogene, it may 
seem surprising that this sequence has not been seen previously. Most studies analysing 
HVI variation use PCR primer binding sites directly flanking, and within two base pairs 
of, the HVI region; in tRNAPro on the 5' end of HVI and in the D-Ioop central domain 
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HVI sequence similarity 
HVI pseudogene 
H.lar 
Rpygmaeus 
R abelii 
G. gorilla 
R troglodytes 
H. sapiens 
Figure 4.9. Phylogenetic relationship of six primate species and their HV1 alignments with respect to H. 
sapiens. Shaded regions indicate IS sequences with no similarity to H. sapiens IS sequence. Sequence 
gaps are for alignment purposes only but may indicate sites of insertions and deletions. HV1 sequences 
are all from Figure 4 6. The phylogenetic relationship is as per Collura and Stewart, (1995). The 
position assignment of the 94-107 HV1 pseudo gene branch is tentative. 
109 
on the 3' end ofHVI (eg. Vigilant et al., 1991; Krings et al., 1997). The 94-107 HVI 
pseudogene, however, includes at least part of tRNAPro• Within tRNAPro the HVI 
pseudogene contains at least a T -+ C transition at nt 16017 (results not shown). This 
transition falls within the binding site of the upstream primer of all of the above studies, 
suggesting these primers would not bind, and the pseudogene would not be amplified. 
The upstream primer chosen in the present study binds 5' of the conventional upstream 
primer. 
Method analysis 
Given the number of pseudogenes characterised in sample 94-107 it may appear 
surprising that more were not seen in other amplicons. There are a number of possible 
reasons for this. Firstly, one or both of the PCR primers may fall on a substitution site. 
This would then mean that the primers will prime only off the normal mtDNA strands 
and only the mtDNA sequence would be amplified. SSCP will then show only a normal 
pattern and no RFLPs would be seen unless they also occur in the normal mtDNA 
sequence. A second possibility is that the nuclear DNA being amplified may be restricted 
to the pseudogenes found to date. Lastly, it is possible that the SSCP lacks some 
sensitivity given the lack of changes found in the other BstNI cleaved COil fragments 
that contain changes reported by Hirano et al. (1997) and Wallace et al. (1997). 
PCR-SSCP screening of the COlI amplicon and analysis of the clone sequences 
shows that approximately 34% of the DNA is pseudogenic (densitometry ofHVI shows 
approximately the same levels). Sperm have approximately 50 copies of mtDNA each 
but are haploid for nuclear DNA. White blood cells within semen are diploid but have 10 
fold more copies of mtDNA than sperm. Therefore, the effective ratio of nuclear DNA to 
mtDNA templates is 1 :50 or higher. Primers were designed specifically for mitochondrial 
DNA, and touchdown PCR was employed to increase priming specificity. Given the 
template ratio and specificity of priming it was expected that mitochondrial DNA would 
be preferentially amplified (at least 50 times higher than nuclear DNA) but this was not 
seen in the observed mutant ratio. Like the study of Davis et al. (1997), however, the 
PCR template in the present study was prepared by boiling cells. When extracting DNA 
from white blood cells Hirano et al. (1997) found that boiling preferentially extracts 
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nuclear DNA with only partial extraction of mitochondrial DNA (presumably due to the 
resistance of mitochondrial membranes to boiling). This would severely alter the number 
of mtDNA templates available for PCR whilst increasing in proportion the number of 
nuclear templates. This is sufficient to explain the seemingly incongruous normal to 
'mutant' ratio. 
These pseudogenes were found in only one out of 223 individuals in the present 
study. Given the calculated dates of pseudogene insertions this is highly unlikely to be 
the true frequency in any human population. Hiraro et al. (1997) found the COIl 
pseudogene in four Alzheimer disease patients and four unselected controls. 94-107 is 
one of four semen samples in the present study with a sperm count over 300 x 106 per 
mi. MtDNA PCR reactions were not template concentration specific but rather contained 
an equivalent of 0.5 ~l of semen, irrespective of sperm count. The 94-107 COIl PCR 
reaction therefore contained more total DNA than most others in the present study. It is 
anticipated, therefore that the limiting factor in amplifYing these pseudogenes was 
nuclear DNA concentration within the PCR. To this end, Hirano et al. (1997) effectively 
criticised Davis et al. (1997) for using a boiling method for DNA extraction. I still feel 
justified in using this technique for the reasons given in Chapter 2, and because in almost 
all instances mtDNA was amplified preferentially to a supposedly common nuclear 
pseudogene. None of the semen samples with counts over 300 x 106 sperm/mi, other 
than 94-107, had the COlI pseudogene amplified. 
HI 
Chapter 5 
GENERAL DISCUSSION 
Sensitivity of SSCP analysis to detect mutations in the ATPase and con 
amplicons 
The sensitivity of SSCP to detect mutations in the present study is unknown. 
Little base line data is available about the inter-individual variation in the ATPase and 
corr genes in humans. Hofmann et al. (1997) used a PCR-SSCP screening approach but 
found no polymorphisms in 67 German individuals in the ATPase or corr genes. Tanaka 
and Ozawa (1994) on the other hand using direct sequencing found 9 corr and 6 
ATPase gene polymorphisms in 43 Japanese individuals. Marzuki et al. (1991) 
sequenced mtDNA from 13. unrelated European individuals and found three corr and 10 
ATPase gene polymorphisms. The studies of Tanaka and Ozawa (1994) and Marzuki et 
al. (1991) sequenced individuals with known mtDNA diseases whilst that of Hofmann et 
al. (1997) used control individuals. 
In this study one heteroplasmic and four different homoplasmic point mutations 
were found in the ATPase amplicon of 210 semen samples (Table 2.1). Seven different 
homoplasmic point mutations, one homoplasmic deletion, and one heteroplasmic 
substitution/insertion were found in the screening of223 semen samples for variation in a 
corr amplicon (Table 3.1). Two base substitution heteroplasmies seen in SSCP analysis 
ofthe corr amplicon of semen samples AM433B and 94-107 were artefactual. 
The ATPase and corr amplicons overlap by 274 bp, the overlap being made up 
of 101 bp of COlI, the COWtRNALys intergenic spacer, tRNALys and 77 bp of ATPase 8. 
COIl screening identified three mutations in this ATPase/COrr amplicon overlap; a 9 bp 
deletion, a transition at nt 8251 and a heteroplasmic point mutation and insertion in 
semen sample TM. These three mutations were seen in eighteen semen samples in the 
corr amplicon screening. Seventeen of these 18 semen samples were also screened for 
changes in the ATPase amplicon (Appendix 1). None of the three mutations in the 
ATPase/COIl amplicon overlap seen in corr screening were seen during the ATPase 
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screening. This lack of SSCP sensitivity on the ATPase amplicon was thought to be 
caused by the excessive length of the fragments used in the SSCP analysis in the ATPase 
amplicon. Ways of overcoming this problem (discussed in Chapter 2) were impractical 
for the present study. 
The effect of size of the DNA fragment on SSCP sensitivity is much debated. The 
optimum fragment size is predicted to be between 100 and 300bp, with fragments of 400 ~ 
500bp having a sensitivity of between 70 and 80% (Beier, 1993). Different DNA fragments 
of similar sizes can yield mutations to SSCP analysis with very different frequencies 
suggesting that sequence context is as important as DNA fragment size (Sheffield et al., 
1993). 
It is considered that the sensitivity of SSCP analysis to detect mutations in the 
con amplicon was reasonable although no studies are published that give a good 
estimation ofthe expected numbef'ofpolymorphisms within the con gene. The work of 
Davis et al. (1997), although flawed in its claims of con heteroplasmy (see Chapter 4), 
could provide these data. No polymorphisms from the study of Davis and coworkers 
have been published. 
PCR-SSCP as a means of detecting heteroplasmy 
Differentiating between true and false heteroplasmy is very important. The 
polymerase chain reaction has an inherent error rate resulting in artefactual heteroplasmy. 
Artefactual heteroplasmy resulting from PCR errors was seen in three instances in this 
study (results not shown) but was discounted by repeat PCR amplification and screening. 
PCR primers were chosen so that they would not bind to sequences containing known 
mutations or polymorphisms. 
PCR primer binding is specific but not discriminatory. In semen sample 94-107, 
the apparent extensive heteroplasmy was created by PCR primers binding to 
complementary nuclear DNA and mtDNA The co-amplification of mtDNA and nuclear 
DNA leading to ambiguous results has been reported previously (Collura and Stewart, 
1995; Davis et al., 1997; Hirano et al., 1997; Wallace et al., 1997). To avoid co-
amplification of nuclear pseudogenes some studies suggest carrying out specific 
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enrichment or purification of mtDNA from nuclear DNA (Arctander, 1995; Collura and 
Stewart, 1995). With small sample volumes this is often not possible. An alternative 
approach used in this study, is to use small amounts of template DNA in the PCR 
reaction to eliminate pseudogene amplification by dilution effects. Thus, while the COlI 
pseudogene is likely to be common (Hirano et al., 1997; Wallace et al., 1997), it was 
only found in one semen sample in the present study. By reducing template concentration 
one runs the risk of underestimating the real level of heteroplasmy, as rare mtDNA 
mutants may be subjected to allele drop out. Traditional non-PCR based methods of 
mtDNA isolation and cloning also negate the problem of nuclear pseudogenes. 
An additional cause of false heteroplasmy is sample contamination. To rule out 
sample contamination, new samples must be analysed, preferably in a different 
laboratory. While it was not possible to do this with semen sample AM433B, the changes 
found in heteroplasmy were also found in homoplasmy in semen sample QD788L 
(Chapter 3) suggesting contamination of the latter with the former. 
MtDNA mutations and fertilising potential 
From the present study it seems unlikely that mtDNA mutations are a frequent 
primary cause of poor male fertilising potential although in order to show this 
definitively, both a larger sample size and more mtDNA genes have to be screened with 
higher resolution and sensitivity. More and more studies are highlighting the importance 
of secondary mutations in mtDNA diseases (reviewed in Torroni and Wallace, 1994). 
Recent evidence suggests that secondary mutations may be seemingly neutral mtDNA 
polymorphisms (Lertrit et al., 1994). In addition to acting as secondary mutations, 
polymorphisms (categorised in populations as haplotypes) can define a genetic 
susceptibility to mtDNA diseases. Hofmann et al. (1997) showed that LHON and other 
mtDNA diseases were more prevalent in certain German haplotypes, even though the 
disease causing mutations themselves arose spontaneously, Marchington et al. (1996) 
hypothesised that a T --t C transition at nt 16189 within the D-Ioop creates a 
predisposition for the formation or fixation of deleterious mutations in tRNALeu(UUR). This 
transition at nt 16189 creates a homopolymeric CIO tract followed by length 
heteroplasmy akin to the T --t C transition at nt 8827 in semen sample TM in the present 
study. 
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Relationship of ATPase mutations to fertilising potential 
Only one of the homoplasmic point mutations found in the ATPase amplicon was 
found in more than one semen sample. This change, causing a HaeII RFLP, was not fully 
characterised (Chapter 2; pattern 4). The proportion of samples that were 
oligozoospermic and had pattern 4 was not statistically significantly different from the 
proportion of samples in the sampled population that were oligozoospermic. The same 
was true for those samples that were asthenozoospermic and had pattern 4. Therefore 
oligo and asthenozoospermia were not associated with pattern 4. 
A T ~ C transition at nt 8821 was the only heteroplasmic change found in the 
ATPase amplicon. Though predicted to deleteriously affect ATPase 6 structure and function, 
it is unknown what effect this change has on the fertilising potential in semen sample 
QR568B. The repeat sample ofQR568B, QF205F, had 100% abnormal head morphology in 
mature sperm that do not have detectable levels of the mutation. The proportion of mutant 
DNA required for phenotypic effects in sperm is unknown. Folgere et al. (1993) did not 
quantifY the proportion of the A ~ G transition heteroplasmy at nt 3243 in the mitochondrial 
tRNA1eu(UUR) found to affect sperm motility in one individual. Nor, in fact, did Folgere et al. 
(1993) even show that this individual was heteroplasmic although the rest of the individual's 
maternal family was heteroplasmic for this change (Folgere et al., 1995). In the present study, 
the nt 8821 heteroplasmic transition within the ATPase 6 gene was not detected in 36 single 
mature sperm or mature sperm aggregates so it is not known if it causes a reduction in sperm 
motility akin to the mutation of Folgef0 and co-workers study. The proportion of mutant 
DNA required for phenotypic effects is probably dependent on the distribution of the mutant 
DNA in the semen sample and the pathogenicity of the mutation itself The five other 
pathogenic mutations seen in the ATPase 6 gene (Chapter 2) all require well above 90% 
mutant DNA for phenotypic effects in somatic tissues. As such, these ATPase 6 mutations are 
effectively homoplasmic. The proportion ofPCR products from semen samples QR568B and 
QD205F with the T ~ C transition at nt 8821 was 16 to 18%. The mutant DNA from semen 
samples QR568B and QD205F was detected, almost in homoplasmy, from two aggregates of 
immature sperm. Whether the T ~ C transition at nt 8821 had any bearing on the lack of 
maturation of these aggregates is not known. This transition has not been seen in 
heteroplasmy or homoplasmy previously and the amino acid residue that nt 8821 helps to 
encode is invariant within vertebrates (Fig. 2.9). Given that the heteroplasmic T ~ C at nt 
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8821 was not found in mature sperm it may have a secondary affect on the fertilising potential 
of QR568B and QD205F's donor by reducing the number of mature sperm within the 
ejaculate. 
Relationship of con mutations to fertilising potential 
No true coding region heteroplasmies were found in the COlI amplicon. Semen 
sample TM had heteroplasmic length variation within the COWtRNALys spacer. 
Homoplasmic changes have been seen in this spacer before as neutral length variants 
(Chapter 3). There is no reason to suspect the TM length variant is anything other than a 
neutral variant. 
The G -) A transition at nt 8251 (Chapter 3; pattern 3) was found in the COlI 
amplicon from 11 semen samples. Two out of the 10 samples with pattern 3, for which 
data were available, were. oligozQospermic and two were asthenozoospermic. These 
proportions were not significantly different to the proportions of oligozoospermic and 
asthenozoospermic semen samples in the sampled popUlation. Therefore the presence of 
oligo and/or asthenozoospermia was not associated with the COlI amplicon pattern 3. 
The other homoplasmic change in the COlI amplicon, found in more than one sample 
was a 9 bp deletion in the COWtRNALys intergenic spacer (Chapter 3; pattern 2). Up to 
94% of Polynesian individuals in New Zealand carry this deletion (Sykes et al., 1995). In 
the present study it is likely that the donors of all 7 semen samples with this deletion have 
a Polynesian maternal ancestry. Twenty eight percent of the sampled population were 
oligozoospermic, while 33% of the six semen samples with pattern 2 were 
oligozoospermic (excluding missing data). These proportions are not statistically 
significantly different. The five semen samples, for which sperm motility was available, 
that had the 9 bp deletion were all asthenozoospermic. This proportion of 
asthenozoospermia is statistically significantly different to the 46% of asthenozoospermic 
samples in the sampled population. This significance was nullified when other donor 
characteristics were considered. Two of the 7 semen samples with this deletion were 
from the same individual who had Kallmann's syndrome, likely to cause severe seminal 
defects. It is unlikely that the 9 bp deletion has a pathological linkage with 
asthenozoospermia, but that the relationship is based on cultural differences. Men in 
Polynesian ethnic groups may be less likely to seek help with mild male infertility 
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problems. Additionally, men in Polynesian ethnic groups may be less likely to give 
consent for the residue of their semen ejaculate to be used for research purposes unless 
their fertility problem was severe. As shown below, Polynesian men are under-
represented in the sampled population. 
Was the sampled population representative of tile Christchurch population? 
Eighty six percent of residents in the Christchurch urban area identifY with a 
European ethnicity, 9% with a Polynesian ethnicity and four percent with an Asian 
ethnicity (Statistics New Zealand, 1997). Ethnicity is self perceived and so individuals 
can belong to more than one ethnic group. The uncharacterised HaeIl RFLP creating 
ATPase amplicon pattern 4, is a marker for European haplotype K (Torroni et al., 1991) and 
is found in 7.4% of European individuals. This RFLP was seen in 13 semen samples (6.2%) in 
the present study which is not significantly different to the European population proportion at 
the 95% confidence limit. The G ~ A transition at nt 8251 within the COIl amplicon 
causes a HaeIlI RFLP. While this marker is not only found in Europeans it has been used 
to define European haplotype I. Between 7.4% (Torroni et al., 1994) and 7.5% 
(Shoffner et al., 1993) of Europeans have haplotype I. Within this study, 4.9% of the 
samples contained this change (11/223). This is not statistically significantly different to 
the population percentage of between 7.4 and 7.5%. Seven semen samples from six 
individuals (3.1 %) had a 9 bp deletion in the COIIItRN A Lys intergenic spacer. The 
proportion of semen samples with the 9 bp deletion in the sampled population was 
statistically significantly different to the proportion of the Christchurch population that 
identifies with a Polynesian ethnicity (Chi2 = 9.28, df = 1, P > 0.05). This implies that 
Polynesian men are under-represented in the sampled population which may support the 
idea that cultural differences are responsible for the linkage between the presence of the 
9 bp deletion and asthenozoospermia. 
Nine homoplasmic single base substitutions in the ATPase and COIl amplicons were 
seen from individual semen samples. None of these are predicted to have pathogenic 
consequences, hence all are assumed to be population polymorphisms. All single base 
substitutions found only once were present at a population frequency ofless than 0.5%. None 
of these changes have been defined previously as haplotype markers with a defined population 
proportion. 
117 
Two true heteroplasmies were observed in the present study. Although neither 
the substitution heteroplasmy in semen sample QR568B nor the length heteroplasmy in 
semen sample TM were shown to be confined to mtDNA, this was inferred. Single cell 
and aggregate PCR-SSCP analysis of the T ~ C transition at nt 8821 within semen 
sample QR568B showed that both almost-homoplasmic normal and mutant SSCP 
patterns could be obtained from cell aggregates. If the mutation were a nuclear insertion 
it is expected that all single cells and aggregates analysed would appear heteroplasmic. 
The homo polymeric tract length heteroplasmy in the COIIItRNALys intergenic spacer of 
semen sample TM is an example of a multiplasmy. For this to be the result of 
pseudogene amplification, multiple insertions of different length homopolymeric 
mutations would have to be present in semen sample TM. 
All mtDNA mutations have to go through a heteroplasmic phase. An analysis of 
the true mutation rate of mtDNA must incorporate both the rate of change fixation into 
the population and the rate of Unfixed heteroplasmy (parsons et aI., 1997). Direct 
sequencing of mtDNA may not resolve unfixed heteroplasmy because heteroplasmy may 
be indistinguishable from sequencing artefacts. Mutation detection systems such as SSCP 
analysis and the Heteroduplex method have the potential to detect all heteroplasmy with 
a proportion of mutant DNA above 5%, and are limited only by their mutation detection 
sensitivity. That an appreciable level of true heteroplasmy was not detected in this study 
could either be because the true level of heteroplasmy was low or that the SSCP analysis 
lacked sensitivity. Alternatively, the choice of tissue may have affected the level of 
heteroplasmy detected (Kiechle et al., 1996). 
Future directions 
Improvements in experimental approach 
If this study were to be repeated there are a number of possible improvements to 
the experimental approach taken. SSCP is a laborious, and potentially insensitive 
approach to mutation detection. Capillary electrophoresis based methods have the 
potential to increase speed and accuracy (Mitchelson et al., 1997) but detection of DNA 
molecules relies on laser induced flourescence making this a method with high setup 
costs. The recent advent of oligomer -chip technology (Hoheisel, 1997) and its 
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application to mtDNA mutation analysis (Chee et al., 1996) makes this an attractive 
future possibility. Oligomer-chip technology is presently limited by cost and an inability 
to detect heteroplasmy. 
To definatively show that a mutation causes disease one has to directly 
demonstrate a biochemical defect and an additional lack of other confounding mutations. 
Neither of these two things were done in this study. To demonstrate a biochemical defect 
one would have to measure the respiratory activity of semen samples or of stable 
lymphoblastoid cultures derived from donated blood. To demonstrate that no other 
mutations were present, one would have to sequence firstly, the whole mtDNA genome, 
and secondly, the genes of all nuclear derived polypeptides associated with OXPHOS 
energy production. 
Fertility analysis 
One of the problems in determining if mtDNA mutations are associated with 
fertilising potential is the lack of quantitative data. In order to get more quantitative data 
a very large multicentre population study could be undertaken. An alternative to this may 
be available. 
In 1992, Carlsen et al. gleaned from the literature 61 reports of seminal counts 
and volume from 1938 to 1990. Statistical analysis of data from these reports showed 
that over the past 50 years, human sperm counts in first world countries have dropped by 
an average of 42%, along with a decrease in seminal volume. Opponents of the decrease 
point out that literature selection bias and variability of collection methods make such a 
trend statistically insignificant (Olsen et al., 1995). Opponents have also pointed out that 
literature pertaining to the past 20 years show mean sperm counts increasing. 
Laboratories in Finland (Vierula et al., 1996) and the USA (Macleod and Wang, 1979, 
cited in Carlsen et al., 1992) both have records showing no change in seminal counts 
over the 50 year period, although the mean seminal counts are different. Similarly, the 
seminal counts from farm animals have shown no change over the same period (Setchell, 
1997). What these studies have highlighted, however, is that there are geographical 
differences in sperm count irrespective of whether there has been a temporal decline. The 
fact that Finnish men have higher sperm counts than English men, for example, has been 
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attributed to different lifestyles, with suggestions being put forward that men in urban 
centres have lower sperm counts than men in rural areas (eg. Bujan et al., 1996 cf. Auger 
et al., 1995) and that those on organic diets having higher sperm counts than those who 
are not (Abell et al., 1994). Whatever the reason, mtDNA polymorphisms (and hence 
haplotypes), given that they are population specific, may act as markers for this 
variability in sperm count and/or may act as susceptibility factors for the decrease in 
sperm count over the past 50 years. In this way the issue of variability ofmtDNA and its 
interaction with fertilising potential could be addressed. 
Pseudogene analysis 
The apparent heteroplasmy in the COIl amplicon of semen sample 94-107 was 
created by the co-amplification of a nuclear pseudogene. Further analysis using PCR 
primers specific for mtDNA identified two more pseudogenes co-amplified with mtDNA. 
The COIl and ND4IND5 pseudogenes have sequences intermediate between human and 
P. troglodytes suggesting that the times of pseudogene insertion were since the time of 
the last common ancestor of these two species. The HVI pseudogene, however, is very 
divergent from all human and primate sequences. The mtDNA D-Ioop has a very high 
substitution rate (Parsons et al., 1997) and therefore any potentially useful phylogenetic 
information is rapidly obscured by multiple substitutions at single nucleotide positions. 
No HVI regions with the same IS structure have been found that can be accurately be 
predated to the insertion of the HVI pseudogene from semen sample 94-107. The 
accurate assignment of insertion times using the model of Li et al. (1981), however, 
requires the resolution of phylogenetic branches beyond the time of insertion. Because of 
this it has not been possible to date the time of HVl pseudogene insertion with any 
degree of accuracy. The HVI pseudogene boundaries are presently defined by the site of 
primer binding. It is anticipated that the inserted sequence was larger than just HVl, 
however. The 5' flanking genes ofHVI are tRNAPro, tRNAThr and Cyt b. These genes 
are highly conserved between mammalian species. If paralogous pseudogenes of these 
genes were part of the HVI pseudogene, they could be sequenced as more informative 
markers of insertion time. 
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Appendix 1 Seminal data for samples used in tins study. Counts are given as million 
sperm per mt of semen. Motility is a percentage of all sperm. D. O.B is the donors date of 
birth. ATPase and COlI columns denote samples screened in those studies with astricts 
beside those with a confirmed change. For notes on 'Comments' see the end of this 
appendix. 
Sample Count Motility D.O.B ATPase COIl Conul1ents 
1 95-5 24.00 75 1956 y* Y 
2 95-9 25.00 27 1958 Y Y no coagulation 
3 95-13 37.00 70 1945 Y y* 
4 95-15 3.10 52 1956 Y Y 
5 95-17 5.30 26 y* Y 
6 95-19 15.00 57 1962 Y 
7 95-22 6.70 57 1954 y* Y 
8 95-23 12.00 80 1962 Y Y 
9 95-24 28.00 28 Y y* 
10 95-26 1.30 36 1960 Y Y 
11 95-27 79 66 1954 Y y* 
12 95-29 65.00 36 Y Y AAs 
13 95-30 0.10 0 Y Y 
14 95-34 7.20 47 1959 y* Y AAs 
15 95-35 23.00 47 Y Y 
16 95-37 2.20 32 1961 Y y* Kallmann's syndrome 
17 95-38 84.00 73 . Y Y 
18 95-40 34.00 62 1958 Y Y no coagulation 
19 95-54 26.00 35 1965 Y Y viscous 
20 95-56 245.00 69 Y Y viscous 
21 95-79 20.00 37 Y y* 
22 94-107 349.00 66 1955 Y y* 
23 94-108 345.00 78 1961 Y Y 
24 94-109 210.00 46 1961 Y 
25 94-110 446.00 42 1955 Y Y 
26 94-124 3.40 75 1961 Y Y from gradient 
27 94-149 34.00 40 1961 y* Y 
28 94-149P 1956 Y Y 
29 94-150 26.00 19 1951 Y Y 
30 94-160 11.00 36 1970 Y 
31 94-173 204.00 67 Y Y 
32 95-173 125.00 40 Y Y 
33 A (SF94-014) 131.00 68 1959 Y Y 
34 AM22lJ 21.00 36 1963 y Y 
35 AM229R 60.00 55 1964 Y Y 
36 AM232N 39.60 62 1949 Y Y 
37 AM235Q 9.90 32 1958 Y 
38 AM241P 112.00 42 1960 Y Y 
39 AM264B 0.90 58 1958 Y Y 
40 AM295L 16.30 60 1959 Y Y 
41 AM302J 17.90 61 1955 Y 
42 AM311L 74.00 57 1961 Y Y 
43 AM367J 31.30 15 1964 Y Y 
44 AM378N 64.00 23 1957 Y Y 
45 AM422U 114.00 55 1956 Y Y 
46 AM433B 49.00 36 1958 Y y* from gradient 
47 AM435D 2.60 47 1963 Y Y 
48 AM436E 70.00 53 1959 Y y* 
49 AM4471 73.00 79 1960 Y Y 
50 AM459N 3.10 61 1960 Y Y 
51 AM4670 290.00 51 1960 Y Y 
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52 AM468P 124.00 55 1958 Y Y 
53 AM470K 88.30 68 1962 Y y* 
54 AM472M 19.80 57 1949 Y Y 
55 AM477R 208 89 1965 Y Y 
56 AM498B 22.70 64 1971 Y Y 
57 AM539M 54.00 39 1958 Y Y 
58 AT440E 173.00 59 1966 Y Y 
59 AT449N 35.00 47 1961 Y Y 
60 AT470T 33.50 46 1964 Y y 
61 AT635U 148.00 80 1957 Y Y 
62 AT648W 21.50 71 1961 Y 
63 AT665C 51.00 29 1959 Y y* abnormal forms 
64 AT689M 41.00 81 1957 Y Y 
65 AT697N 25.00 73 1963 Y Y 
66 AT734U 13.10 29 1966 Y Y 
67 AT752B 0,00 0 1959 Y Y 
68 B(SF94-015) 48.50 37 1952 Y Y 
69 BG 23.00 47 1967 y y 
70 BT 3.70 31 1961 Y y* Kallmalm's syndrome 
71 C (SF94-O 19) 66,00 62 1963 Y Y 
72 CCR 152.00 1 Y y* viscous 
73 CD 0,65 8 1965 Y Y 
74 CM 5.20 22 Y y 
75 Collins 0.50 33 1966 y y 
76 CP 1.60 10 y Y 
77 D (SF94:..o20) 107,00 53 . 1955 Y Y 
78 DISR 0.00 0 1956 Y Y post vasectomy 
79 E(SF94-064) 107.00 53 1961 Y y 
80 EV 7.70 53 y* no acrosomes 
81 EZDW2 19.10 61 1954 y y yellowish 
82 F(SF94-070) 113.00 57 1964 y 
83 GBl 6.70 63 y* Y 
84 GB2 49.00 7 Y Y 
85 GI 61.00 67 Y Y precipitous 
86 JH 20.00 87 1959 Y y 
87 IN 15.00 61 1957 Y y* 
88 KT 36.30 3 1967 y y 
89 MC 5.20 22 y* Y IgAAAs 
90 MR 365.00 59 1961 Y Y 
91 NG 19.00 66 y Y 
92 OP992Cl 41.00 64 1964 Y 
93 OP992C2 y* 
94 PK 88.00 59 Y Y 
95 PRI 7.70 53 1959 Y Y 
96 PR2 109.00 71 Y Y 
97 QD20lB 67.00 60 1948 y y 
98 QD202C 129.00 68 1961 y y 
99 QD203D 74.00 61 1953 y 
100 QD205F 0.90 17 1968 y* repeat of QR568B 
101 QD216J 151.00 71 1961 Y 
102 QD2880 24,00 52 Y Y 
103 QD720I 54.00 31 y* y* 
104 QD741P 8.00 9 1962 Y Y 
105 QD742Q 35,00 56 1947 y y 
106 QD747V 200.00 57 1962 y* y* 
107 QD762W 196.00 67 Y 
108 QD765C 95.00 46 1957 Y Y 
109 QD788L 85.00 50 1957 Y y* 
110 QD8070 10.00 7 y* 
111 QD844A 76.00 37 1958 y Y 
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112 QD845B 101.00 58 1956 Y Y 
113 QD848E 146.00 70 1965 Y Y 
114 QD862E 125.00 66 1965 Y 
115 QD874 0.05 0 1963 Y Y 
116 QH447L clumpy 0 1927 Y "clmnping,yellow" 
117 QH448M 59.00 48 1952 Y Y 
118 QH474R 93.00 65 1956 Y 
119 QH507E 85.00 59 1967 Y 
120 QH514E 330.00 48 1961 Y Y 
121 QH516G 262.00 61 1966 Y Y 
122 QH529M 80.00 51 1962 Y Y 
123 QN148Q 13.30 61 1962 Y 
124 QN149E 0.00 0 1964 Y Y 
125 QN167V 50.00 28 1957 Y 
126 QN178C 0.80 34 1966 Y Y 
127 QN182W Y y* 
128 QN187E 6.20 21 1962 Y Y 
129 QN188F 207.00 72 1968 Y Y 
130 QN191B 220.00 60 1966 Y 
131 QN208J 411.00 54 1962 Y 
132 QN209K 81.00 67 1955 Y 
133 QN213H 7.40 56 1960 Y 
134 QN2141 0.15 100 1946 Y 
135 QN220H 72.00 43 1965 Y 
136 QN222J 44.00 72 1955 Y 
137 QN228P 99.00 68· 1956 Y Y 
138 QN2:30K 44.00 31 1957 Y Y 
139 QN237R 136.00 68 1965 Y Y 
140 QN242P 105.00 48 1947 Y Y 
141 QN417L 1.90 44 1958 Y Y 
142 QR497E 36.40 23 1955 Y Y 
143 QR498F 28.60 49 1965 Y Y 
144 QR509H 222.00 57 1966 Y y* 
145 QR510B 113.00 56 1963 Y Y 
146 QRSllC 74.40 55 1962 y* Y 
147 QRS22G 0.80 38 1966 Y Y 
148 QR568B 0.30 20 1968 y* Y 
149 QR569C 50.60 30 1970 Y Y 
150 QU337C 76.30 73 1965 Y Y 
151 QU3711 100.00 35 Y Y 
152 QU379Q 128.00 70 1953 Y 
153 QU380K 3.00 39 1958 Y y* precipitous 
154 QU447K 48.60 85 1967 Y Y 
155 QU498F 28.60 49 1965 Y Y 
156 QW217C 1.90 44 1958 Y Y 
157 RR 6.00 44 1958 Y Y Vas reversal; AAs 
158 RS 45.00 20 1965 Y Y 
159 SCI 4.60 48 1959 Y Y debris 
160 SC2 19.00 63 1959 Y Y 
161 SCnew sample 13.50 16 Y Y round cells 
162 SF-437 125.00 66 1964 Y 
163 SF-459/94-459 204.00 55 Y extra chromosome 
164 SF 104 65.00 70 1956 Y 
165 SF148 27.00 52 1958 Y 
166 SF331 38.00 53 1949 Y 
167 SF362 24.00 43 1965 y* Y 
168 SF461194-461 104.00 52 Y 
169 SF639 174.00 62 Y 
170 SF94-100 41.00 35 1970 Y Y 
171 SF94-101 23.30 39 1959 Y Y 
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172 SF94-102 53.00 40 y Y 
173 SF94-104 21.00 74 1962 Y round cells 
174 SF94-114 157.00 45 y Y 
175 SF94-299 7.40 50 1959 Y y* 
176 SF94-303 22.10 6 1959 y y 
177 SF94-315 47.20 49 1953 y y 
178 SF94-316 135.00 64 Y y 
179 SF94-344 85.70 27 1961 Y Y 
180 SF94-347 82.70 48 1960 Y Y 
181 SF94-350 32.00 68 1963 Y Y 
182 SF94-356 51.30 72 1961 y Y 
183 SF94-357 201.00 72 1959 y Y 
184 SF94-380 15.80 66 1959 y y oily-lubricant? 
185 SF94-399 81.00 60 1947 Y y 
186 SF94-408 174.00 78 1964 Y y 
187 SF94-409 118.00 72 1962 Y y* 
188 SF94-69 18.70 38 Y y 
189 SF94-78 51.00 21 1955(?) y y 
190 SF94-83 51.60 37 Y Y 
191 SF94-86 85.70 35 1959 y* y 
192 SF94-87 14.60 47 y y 
193 SF94-90 112.00 74 Y Y 
194 SF94-91 21.90 50 Y y 
195 SF94-92 44.00 67 Y Y 
196 SF94-97 86.00 72 y Y 
197 SF94-99 4.00 50 . 1959 Y Y 
198 SF95/612 y* 
199 SF95/657 45.00 64 1951 Y 
200 SF95-049 105.00 59 1963 y y 
201 SF95-079#2 107.00 53 1959 y y 
202 SF95-114 157.00 45 y y 
203 SF95-120 115.00 62 1958 Y y 
204 SF95-122 26.00 50 1964 Y y* 
205 SF95-138 140.00 74 1964 Y y 
206 SF95-144 y y 
207 SF95-160 167.00 Y y* 
208 SF95-171 30.00 33 1963 y* y 
209 SF95-196 16.40 56 Y y 
210 SF95-265 27.00 56 1962 Y y 
211 SF95-555 1955 Y y 
212 SF95-590 80.00 35 1967 Y y 
213 SF95-611 43.00 35 1960 y y 
214 SF95-628 208.00 37 1961 y y 
215 SF95-633 48.00 0 1976 Y y* 
216 SF96-150 33.00 55 1965 Y 
217 SF96-166 186.00 38 1950 Y 
218 SF96-17 154.00 64 1966 y 
219 SF96-173 13.00 36 1960 Y 
220 SF96-197 131.00 52 1955 y 
221 SF96-201 87.00 66 1962 Y 
222 SF96-202 78.70 64 1958 Y 
223 SF96-220 67.00 47 1958 Y 
224 SF96-229 75.00 50 1961 Y 
225 SF%-238 0.00 1962 Y 
226 SF96-255 12.00 65 1961 y 
227 SF96-279 65.00 30 1960 y* 
228 SF96-280 2.30 46 1965 y cryptorchidism 
229 SF96-281 135.00 36 1965 Y 
230 SF96-283 8.40 17 1958 y 
231 SF96-289 106.00 60 1962 Y 
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232 SF96-305 140.00 67 1955 y 
233 SF96-309 1.10 16 1962 y 
234 SF96-310 152.00 56 1955 y 
235 SF96-333 0.50 33 1966 Y 
236 SF96-341 126.00 50 1970 y chemical worker 
237 SF96-342 94.00 63 1957 y 
238 SF96-389 0.25 10 1955 y 
239 SF96-393 39.00 57 1964 y 
240 SF96-398 69.00 71 1958 Y 
241 SF96-400 62.00 53 1958 Y 
242 SF96·434 17.00 26 1964 Y 
243 SM 6.40 53 Y 
244 STEVENS 81.00 36 y y 
245 TC 76.00 60 1943 y Y 
246 TI 1.35 22 1951 y* y 
247 TM 3.40 23 1961 y y* cryptorchidism 
248 TR y Y 
249 WT 110.00 26 y 
250 ZC .05-1 6 1957 Y 
251 ZKl 3.30 40 1961 Y 
252 ZK2 1.20 43 Y 
Notes: 
AA's refer to antibodies in the semen that may be present as an immune response to an infection. These 
can frequently cause clumping in semen. Where known, causes for reduced sperm count and motility are 
indicated, including vasectomy, cryptorchidism, Kallman's syndrome and the presence of extra 
chromosomes. Semen from gradients is enriched in motile sperm and so is a biased representative of 
these samples. 
Appendix 2 
5% SSCP gel. 
3.5 ml Acrylamide mix (49:1) 
3.5 ml5 x TBE 
27.5 ml ddHzO 
degas 5 min 
0.3 mll0% Ammonium per sulphate (APS) 
11 -14 ~tl TEMED 
Silver stain protocol 
Fix for 20 min in 10% Acetic acid and 0.02% Formaldehyde 
Wash for 2 min with ddHzO, repeat twice more 
Rinse with 0.02% Sodium thiosulphate for 1 min 
Repeat 2 min washes with ddHzO 
Impregnate for 30 min with 0.2% Silver nitrate and 0.03% Formaldehyde 
Wash for 20 sec with ddHzO 
Develop with 15 giL Sodium carbonate, 0.02% Formaldehyde and 0.0005% Sodium 
thiosulphate 
Stop development with 10% Acetic acid 
6% Urea PAGE sequencing gel 
35 g Urea 
10.5 ml Acrylamide (sequencing grade mix; 19:1) 
7 mllOxTBE 
made up to 70 ml with ddHzO 
degas 5 min 
0.7 mllO% APS 
11111 TEMED 
prehybridisation solution 
6xSSC 
5 x Denharts reagent 
0.5% (v/v) SDS 
0.5% (w/v) blocking reagent 
SOC plates 
10 gil Bactotryptone 
10 gil NaCI 
5 gil Bactoagar 
15 gil Agar 
10 mVIIM MgS04 
10 ml/l 1M MgCh 
glucose to 20mM 
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Selection media 
Xgal to 20 J.lglml 
IPTGto 0.5 ruM 
Amp to 50 J.lglml 
142 
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Appendix 3 Single cell data. Only cells or clusters that gave positive PCR results are 
included. Classes are defined in Table 2.2. Result classes are normal (n) and mutant (m) 
SSCP patterns. 
Date Cell Class Result 
1.11.94 1-16 IV 11 
1.11.94 17-27 III 11 
1.11.94 28-33 II n 
29.11.94 1-3 II 11 
29.11.94 5,7,9,11 VI 11 
29.11.94 12,15 III n 
29.11.94 13,14 VI 11 
29.11.94 16 III 11 
29.11.94 17,25 VI 11 
29.11.94 18 IV 11 
29.11.94 20 V(SRC cluster) m+n 
29.11.94 21-24,26 V(SRC cluster) n 
29.11.94 27 VlI(round headed sperm) 11 
29.11.94 28 VII(round headed sperm) m(tiny n) 
29.11.94 29 V(110 tails) n 
29.11.94 30 V(SRC cluster) n 
29.11.94 31 VI(huge cells) m+n 
29.11.94 34 V(small cells) m+11 
6.12.94 2 V(LRC cluster) 11 
6.12.94 4 IV(rou11d head) 11(tiny m) 
6.12.94 5 III 11 
6.12.94 6,7,9 VII(rou11d headed sperm) 11 
6.12.94 11 V(SRC) 11 
6.12.94 21 VII( spermatids) m(ti11y 11) 
14.12.94 2,3,6,9 IV 11 
14.12.94 1,10,11 IV(large head) n 
14.12.94 4,5,7 IV(split tail) 11 
19.12.94 3,6 IV(large head) 11 
6.7.95 1 VII(5-6 immature sperm) 11 
6.7.95 2 Vll(9-1O immature sperm) 11 
6.7.95 3 IV 11 
6.7.95 4 Vll(mature and immature sperm) n 
6.7.95 5 VII(mature and immature sperm) m+n 
6.7.95 6 VII(mature and immature sperm) n 
6.7.95 7 VII(immature sperm) 11 
6.7.95 8 VII(mature sperm, 6 cells) n 
6.7.95 9 VII(immature sperm, 10 cells) 11 
6.7.95 10 VII(mature and immature sperm) n 
25.10.95 1,2,6,8 II 11 
25.10.95 3 II m(with high band) 
26.10.95 4,6,9 II 11 
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Appendix 4 Individual COIl clone sequences for mutant and normal patterns of semen 
sample 94-107. Dots(.) indicate synonymous nucleotides to the Cambridge sequence 
(Anderson et al., 1981). Numbering is based on the Cambridge sequence. Clone 3-1-4 does 
not have a change at 7757. This clone was only sequenced from 7610 to 7811. Five 
changes were seen only once and were assumed to be PCR artefact. 
Cambridge 
1-1-43 
1-1-53 
2-1-9 
2-1-20 
2-1-23 
3-1-4 
1-1-42 
2-1-7 
Cambridge 
1-1-43 
1-1-53 
2-1-9 
2-1-20 
2-1-23 
3-1-4 
1-1-42 
2-1-7 
Cambridge 
1-1-43 
1-1-53 
2-1-9 
2-1-20 
2-1-23 
3-1-4 
1-1-42 
2-1-7 
Cambridge 
1-1-43 
1-1-53 
2-1-9 
2-1-20 
2-1-23 
3-1-4 
1-1-42 
2-1-7 
Cambridge 
1-1-43 
1-1-53 
2-1-9 
2-1-20 
2-1-23 
3-1-4 
1-1-42 
2-1-7 
7 
6 
1 
o 
7 
6 
2 
o 
7 
6 
3 
o 
7 
6 
4 
o 
7 
6 
5 
o 
7 
6 
6 
o 
7 
6 
7 
o 
7 
6 
8 
o 
ctacaagacgctacttcccctatcatagaagagcttatcacctttcatgatcacgccctcataatcattttccttat 
........................................ t ................................... . 
..........•........................•..•. t .••.....•.......••....••....•.....•• 
.....................••....•..•......... t .......••...................••...... 
........................................ t ................................... . 
........................................ t ................................... . 
......•.....................•••......••. t ...•.......................••.•....• 
7 7 7 7 7 7 7 7 
6 7 7 7 7 7 7 7 
9 0 1 2 3 4 5 6 
0 0 0 0 0 0 0 0 
ctgcttcctagtcctgtatgcccttttcctaacactcacaacaaaactaactaatactaacatctcagacgctcagg 
..••...•..•..•••.. c .•.•••.•.•••••..•.•...•..•.••••••••••••. g ...••....• a .•••.• 
.•.••....•.....•.. c .....•.•• t •...........••.......•.................•. a .••.•• 
...•••••...•.••... c ••....••••......•.•.....••••••....••••.••• 0 0 0 •••••• a .•...• 
...... ,. ........................ c." ......................................................... " ................................ a ......... .. 
................... "" ........... c o .............................................................................................. a ....... .. 
..... ;, .. " ...... ~ .............. c ....... '0 .... " .... " ...................... ,. .................................... * ................ ~ ........... ,. 
7 
7 
7 
o 
7 
7 
8 
o 
7 
7 
9 
o 
7 
8 
o 
o 
7 
8 
1 
o 
7 
8 
2 
o 
7 
8 
3 
o 
7 
8 
4 
o 
aaatagaaaccgtctgaactatcctgcccgccatcatcctagtcctcatcgccetceeatccctacgcatcctttac 
•••••••• 0 0 ••• o. 0 ••• 0 •••••• 0 ••••• 0" o' 0" 0 0 0" .to •••• 00 ••• o. o. o. 0 ••••••••••••• 
•••••••••••••••••••• 0 ••• 0 0" 0 •••• 0 0 0 •••••••••• t .•......•.••. t ..... 0 ••••• c. 0" 
•• 0 ••••••••••••••••••••••••••••••••••••••••••• t ............................. . 
••••••••••••••• 0 ••••••••••••• 0 0 0 0 •••• 0.0 •••••• t ..... 00. 0 o. 0.0 •••••••••••••••• 
•••••••••••••••• 0 •••••••••• 0.00 •• 0 •••••••• 0" .to 0 •• 0 0 •••••••• 0 ••••••• 0 ••• 0 0 0 0 
00.0000.00 •• 00000. 0 o' 0 0.000 •• 0.00000 ••• 0000 ••• t. 
••••••••••••••••••••••••• 0 0 ••• 0 •• e ...........•..•.........••••........•...... 
7 
8 
5 
o 
7 
8 
6 
o 
7 
8 
7 
o 
7 
8 
8 
o 
7 
8 
9 
o 
7 
9 
o 
o 
7 
9 
1 
o 
ataacagacgaggtcaacgatccctcccttaccateaaatcaattggccaccaatggtactgaacetacgagtacac 
•••••• 0 0 ••• 0. 0 0 ••• 0 o. 0 ••••• t ... 0 0 •••••• 0 0 •••••• 0 0 .t .... 0 0 •• 00000 •••• o •• a ••••• 
•••••••••••••••••••• 00 ••••• t .... 0 •••••••••• 0 0 ••••• t ..... 0 ••• 0 •••••••••• a ••••• 
••••••••••••••••• 0 0 ••• o' o •• t .. 0 ••• 0 0 o' 0" 0 ••• 0 0 o •• to 0 0 0 ••••• 0 •••••••••• a. 0 0" 
•••••••••••••••••••••••••• 0 t ........... 0" 0" 0 •••• t ........... o •••••••• a ..••• 
........................... t ...................... t ............... 0 •••• a ••••• 
7 7 7 7 7 7 
9 9 9 9 9 9 
2 3 4 5 6 7 
0 0 0 0 0 0 
egactacggeggaetaatcttcaactcctacatacttcccccattattcctagaace a 
Appendix 5 PCR conditions for primers used in Chaper 4 amplicon analysis 
(complimentary to Table 4.1). 
HMTL321-HMTH455, 
94°C/30 sec, 60°C/30 sec, 72°c/l min 30 sec x5, 
94°C/30 sec, 56°C/30 sec, 72°C/l min 30 sec x5, 
94°C/30 sec, 54°C/30 sec, 72°c/l min 30 sec x25, 
2mMMgCh. 
HMTL604-HMTH735, 
94°C/30 sec, 60°C/30 sec, 72°C/I min 30 sec x5, 
94°C/30 sec, 56°C/30 sec, 72°c/l min 30 sec x5, 
94°C/30 sec, 54°C/30 sec, 72°c/l min 30 sec x25, 
2.4mMMgCh. 
HlVITL 712-HMTH844, 
94°C/30 sec, 60°C/30 sec, 72°C/l min 20 sec x5, 
94°C/30 sec, 56°C/30 sec, 72°C/l min 20 sec x5, 
94°C/30 sec, 54°C/30 sec, 72°C/l min 20 sec x25, 
l.4mMMgCh, 
HMTL817-HMTH934, 
94°C/30 sec, 60°C/30 sec, 72°C/l min 20 sec xS, 
94°C/30 sec, 56°C/30 sec, 72°c/l min 20 sec xS, 
94°C/30 sec, 54°C/30 sec, 72°C/I min 20 sec x25, 
2mMMgCb. 
HMTL 1 012-HMTH1246, 
94°C/30 sec, 54°C/30 sec, 72°CI2 min 30 sec x30, 
1.6mMMgCb. 
HMTL1161-HMTH1357, 
94°C/30 sec, 60°C/30 sec, 72°CI2 min 30 sec x5, 
94°C/30 sec, 56°C/30 sec, 72°C/2 min 30 sec x5, 
94°C/30 sec, 54°C/30 sec, 72°C/2 min 30 sec x25, 
72°C/5 min xl, 
2mMMgCb. 
HMTL1445-HMTH1585, 
94°C/30 sec, 45°C/30 sec, 72°CIl min 30 sec x30, 
2.6 mM MgCh. 
HMTL 1598-HMTH1642, 
94°C/30 sec, 55°C/30 sec, 72°C/45 sec x30, 
noc 4 min xl, 
2mMMgCb. 
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Appendix 6 Individual ND41ND5 clone sequences for mutant and normal patterns of 
semen sample 94-107. Dots(.) indicate synonymous nucleotides to the Cambridge 
sequence. Italicised and bolded bases have recognised polymorphisms (Wallace et al., 
1995) in which this study also find change. Question mark (?) indicates an un-resolved 
nucleotide. Numbering refers to the numbering assigned by Anderson et al. (1981) to the 
Cambridge sequence. 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-2-890-6 
178-4-531-7 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-2-890-6 
178-4-531-7 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-2-890-6 
178-4-531-7 
178-4-388-10 
178-4-388-11 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-2-890-6 
178-4-388-10 
178-4-388-11 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-4-388-10 
178-4-388-11 
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1 
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1 
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o 
1 
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1 
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cttcaccggcgcagtcattctcataatcgcccacgggcttacatcctcattactattctgcctagcaaact 
.....•.••.•.•••••..•••.•• g .•..•••... a .•••.•.••..•......•.••..••••••.... 
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1 
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1 
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o 
1 
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o 
1 
1 
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2 
o 
caaactacgaacgcactcacagtcgcatcataatcctctctcaaggacttcaaactctactcccactaata 
............. t .. c ...•............. t .................... c .....••..•..... 
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8 
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8 
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o 
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8 
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o 
1 
1 
8 
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o 
1 
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o 
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1 
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9 
o 
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· .c .•.............•........ a .... t ..........•......•.......•.•. a .....••. 
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ctctgtgctagtaaccacgttctcctgatcaaatatcactctcctacttacaggactcaacatactagtca 
.................. a ................................••.••........... a., • 
••..••••••••••.•• • a .••••••••.••.••••.••••..•.••••••••••••••••••• t .. a ••• 
•••••••••••••••••• a •• 
1 
1 
9 
7 
o 
1 
1 
9 
8 
o 
1 
1 
9 
9 
o 
1 
2 
o 
o 
o 
1 
2 
o 
1 
o 
1 
2 
o 
2 
o 
1 
2 
o 
3 
o 
cagccctatactccctctacatatttaccacaacacaatggggctcactcacccaccacattaacaacata 
•••••••••••••••••••••••••••••••••••••••• a ••••• g •.•• g ••••••••.•••••••••• 
....•..•.•••••...............•••.•••.••• a ••..• g •..• g •••••••..••.••..••• 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-4-531-7 
178-4-388-10 
178-4-388-11 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-4-531-7 
178-4-388-10 
178-4-388-11 
Cambridge 
178-1-601-3 
178-1-531-4 
178-1-531-10 
178-2-890-13 
178-4-531-7 
178-4-359-9 
178-4-359-3 
178-4-388-10 
178-4-388-11 
Cambridge 
178-1-601-3 
178-2-890-6 
178-4-359-9 
178-4-359-3 
Cambridge 
178-2-890-6 
178-4-359-9 
178-4-359-3 
Cambridge 
178-2-890-6 
178-4-359-9 
178-4-359-3 
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1 1 1 1 1 1 1 
2 2 2 2 2 2 2 
0 0 0 0 0 0 1 
4 5 6 7 8 9 0 
0 0 0 0 0 0 0 
aaaccctcattcacacgagaaaacaccctcatgttcatacacctatcccccattctcctcctatccctcaa 
................ ~ ......................................................... 5 ................................................... ~ .. 
.......•.................. t ..........•........••.. t .. C ••••••••••••••••• 
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............................. " .................... " .................................. ~ .... " ....................................... .. 
.......................................................................... ~ ................ " .................................. " ........ .. 
1 1 1 1 1 1 1 
2 2 2 2 2 2 2 
1 1 1 1 1 1 1 
1 2 3 4 5 6 7 
0 0 0 0 0 0 0 
ccccgacatcattaccgggttttcctcttgtaaatatagtttaaccaaaacatcagattgtgaatctgaca 
...... t .........•..•...•... C ••••••••••••••••••••••••• t •.......••....•.. 
...... t .................... C ••••••••••••••••••••••••••••••••••••••••••• 
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...... t .•....•.••••.....•.. C •••••••••••••••••••••••••••••••• 0 0.0 ••• 0.0. 
1 1 1 1 1 1 1 1 
2 2 2 2 2 2 2 2 
1 1 2 2 2 2 2 2 
8 9 0 1 2 3 4 5 
0 0 0 0 0 0 0 0 
acagaggcttacgaccccttatttaccgagaaagctcacaagaactgctaactcatgcccccatgtctaac 
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•... . t ..•.............. at ..... C ••••••• 
..•.. t •........••.•••.• at ............ . 
........................ .. ........ . ........ " .................... 
...................................... " . .. . ........................ 
1 1 1 1 1 1 1 
2 2 2 2 2 2 2 
2 2 2 2 3 3 3 
6 7 8 9 0 1 2 
0 0 0 0 0 0 0 
aacatggctttctcaacttttaaaggataacagctatccattggtcttaggccccaaaaattttggtgcaa 
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o 
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Cambridge 
178-2-890-6 
178-4-359-9 
178-4-359-3 
Cambridge 
178-2-890-6 
178-4-359-9 
178-4-359-3 
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1 1 1 1 1 1 1 
2 2 2 2 2 2 2 
4 4 4 5 5 5 5 
7 8 9 0 1 2 3 
0 0 0 0 0 0 0 
cctttattatcagtctcttccccacaacaatattcatgtgcctagaccaagaagttattatctcgaactga 
• .c .. g .... t ..................•....... a.a .........•..... c .....•.. a ..... . 
· .c .. g •••. t .......................... a.a ..........•.•.. c ...•.... a ....•. 
1 
2 
5 
4 
o 
1 
2 
5 
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o 
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2 
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o 
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5 
7 
o 
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••••• g .• a ••••.•••••......• a •..... 1 .... 
· ..•....•.•..••...........•...... 1 ..•. 
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Appendix 7 Individual HV1 clone sequences for mutant and normal patterns of semen 
sample 94-107. DotsO indicate synonymous nucleotides to the Cambridge sequence. 
Numbering refers to the numbering assigned by Anderson et al. (1981) and is the 
numbering of the Cambridge sequence only. Dashes (-) are present for alignment 
purposes only, but may indicate possible sites of inserts and deletions. Maximum 
homology alignment was performed using the EMBL Homology Alignment Program in 
DNASIS. 
Cambridge 
180-9-13 
180-9-16 
180-9-17 
180-8-14 
180-8-20 
180-9-25 
180-8-30 
180-8-26 
180-9-27 
Cambridge 
180-9-13 
180-9-16 
180-9-17 
180-8-14 
180-8-20 
180-9-25 
180-8-30 
180-8-26 
180-9-27 
Cambridge 
180-9-13 
180-9-16 
180-9-17 
180-8-14 
180-8-20 
180-9-25 
180-8-30 
180-8-26 
180-9-27 
Cambridge 
180-9-13 
180-9-16 
180-9-17 
180-8-14 
180-8-20 
180-9-25 
180-8-30 
180-8-26 
180-9-27 
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o 
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o 
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o 
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o 
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o 
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· . at. c .•.•. a .• g ... cat .•••••••• a ...•••.••• c ..• c ..•.• ca. c. t .• -ttt •.. ag .. a 
1 
6 
1 
o 
o 
1 
6 
1 
1 
o 
1 
6 
1 
2 
o 
1 
6 
1 
3 
o 
1 
6 
1 
4 
o 
1 
6 
1 
5 
o 
1 
6 
1 
6 
o 
tcgtacattactgccag~caccatgaatattgtacggtaccataaatacttgaccacctgtagtacata-a 
· ... ga ..• t ••.. t •..•••..••.•.... a •• tao ... t •... t.g ... a •. tgtaca •••••.••• tc 
· ••. ga •.• t •..• t .••••....•...••. a .• ta •••. t .••• t. g .•• a .. tgtaca •••.••••. tc 
· ..• ga ..• t ...• t .•.•••.••••.•••• a •. tao .•. t .•.• t.g ••• a •• tgtaca •.•..•... tc 
· •.. ga •.. t ••.• t •••.•....••...•. a .• ta .••• t ..•. t. g ••• a •. tgtaca ••..••••• tc 
· ••• ga •.• t •... t .•...••..••.•••. a •• tao ..• t .•.• t.g .•• a •. tgtaca ..•...•.. tc 
• ••. ga ..• t .... t •......•.••••... a .• ta .••• t .••• t. g ••• a •• tgtaca •...•.•.. tc 
.... ~ .. ,. ............ ~ ..................................... '" .... " ...................................................... ~ .... - .. 
1 
6 
1 
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o 
1 
6 
1 
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o 
1 
6 
1 
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1 
6 
2 
o 
o 
1 
6 
2 
1 
o 
1 
6 
2 
2 
o 
1 
6 
2 
3 
o 
aaacceaa-tccacatcaaaaccccctccccatgcttacaagcaagtac-agcaatcaaccctcaactatc 
..•. ga •• c .. a •.. a .•• ct •• t •. c.a.g.c •........•••• g •. t •. a.ta.cttaact .•. gg.a 
.... ga •. c .• a .•• a .•• ct .• t •• c.a.g.c ..••...•.•.•. g .. t .. a.ta.cttaact ••• gg.a 
•••• ga •• c •• a ••. a ..• ct •. t •. c.a.g.c •.••.•••..•.. g •• t .. a.ta.cttaact ... gg.a 
.••. ga .• c •. a ... a ..• ct .• t •• c.a.g.c .••..••.•••.• g .. t •• a.ta.cttaact ••• gg.a 
• .•• ga •• C •• a ••• a ... ct .• t •• c. a. 9 .c ••..••.•••••• g •• t •• a. ta .cttaact .•. gg. a 
•.•• ga •. c .. a ..• a ... ct .. t •• c.a.g.c .••....•..••. g .• t •• a.ta.cttaact ..• gg.a 
· ............. -................ , ......... ~ ............ " .......................... " ...... -., ...................................... .. 
.............. - .................................... 5 ................................ ,.. - .................... " .................. .. 
.............. -............................................... ~ ........................ .. - . ..................................... .. 
1 
6 
2 
4 
o 
1 
6 
2 
5 
o 
1 
6 
2 
6 
o 
1 
6 
2 
7 
o 
1 
6 
2 
8 
o 
1 
6 
2 
9 
o 
1 
6 
3 
o 
o 
aeacatcaactgea-actcc-aaagccacccctcacccactaggataccaaeaaac-ctaeecaceettaa 
.•.•.• t •. acc .. ce •••. a ...• aa •• tt .•.• a •.•• a •• cg ..•... a •••• a .•• tat. t •••. 
· .••.• t •• acc •• ec •... a .... aa .. tt •.•• a .••• a •• cg ••...• a .... a ..• tat. t ..•• --
...••• t •. acc •. ce •..• a •..• aa •• tt .•.. a ••.• a •. cg ...•.. a •.•• a .•• tat.t •••• --
· .••.. t •. acc •• ee .... a ...• aa •• tt ...• a .••• a .• cg •••... a •... a .•• tat. t •••• --
....•• t •• acc •. cc •..• a ••.. aa •• tt .••. a ••.. a •• cg •.•... a .••. a ... tat.t •••• --
· .••.• t •. ace .• cc .... a .•.• aa •• tt •••• a ...• a •. cg ••••.. a •... a .•• tat. t •••• --
................ " .......... - ......... -....... '" .... "' .................................................... - .................. " .. ~ .. .. 
.............. -....... - ................... - .. ~- ................. ~ ... ~ ......... . 
....... " ................ - ... " ... -* ................. " .............. " ..... " .. " '" .. ". - ........ ,," *" ........ . 
Cambridge 
180-9-13 
180-9-16 
180-9-17 
180-8-14 
180-8-20 
180-9-25 
180-8-30 
180-8-26 
180-9-27 
Cambridge 
180-9-13 
180-9-16 
180-9-17 
180-8-14 
180-8-20 
180-9-25 
180-8-30 
180-8-26 
180-9-27 
150 
1 1 1 1 1 1 1 
6 6 6 6 6 6 6 
3 3 3 3 3 3 3 
1 2 3 4 5 6 7 
0 0 0 0 0 0 0 
cagtacatagtacataaagccatttaccgtacatagcacattacagtcaaatcccttctcgtccccatgga 
g •...••....•••• ct.at.gc.c.tg .•. g •.•.••.... c ••.. t ••• caag.c ...••. aat.c .. . 
g .•.••..•..•..• ct.at.gc.c.tg ... g .•.••..... c ..•• t ..• caag.c ..•... aat.c .. . 
g ••.•••••.•.... ct.at.gc.c.tg ••. g .•..•.•••. c •... t ..• caag.c •••••. aat.c .•. 
g •...••.••..... ct.at.gc.c.tg ..• g .•..••.•.• c ••.. t ••. caag.c ••••.. aat.c •.. 
g ••.•.......... ct.at.gc.c.tg ... g •.•••.•.•• c .••. t ..• caag.c .•.•.. aat.c ..• 
g •..•••..••..•. ct. at .gc. c. t ••.. g •.••• " ..• c ..•• t •.. caag. c •••.•• aat. c .. . 
....................................•................ t ................ . 
..................................................... t ................ . 
...................•....••...•...................... . t ................ . 
1 
6 
3 
8 
o 
1 
6 
3 
9 
o 
tgacccccctcagataggggtcccttga 
.. t ............. t ..... g ... t 
.-.t .•..•••.••... t ..... g ..• t 
.-.t ............. t ..... g .•• t 
.-.t ... .••...•.. . t •.... g •.. t 
.-.t ••...•....••• t ..... g .•• t 
.. t ............. t ..... g ... t 
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Appendix 8 ND41ND5 primate homology alignment. P. troglodytes, G. gorilla, Pongo 
pygmaeus and Hylobytes lar sequences and alignment follows that of Brown et al. 
(1982). P. panisclis sequence is from Genebank (accession no. D38116). Dots(.) indicate 
synonymous nucleotides to the Cambridge sequence. Italicised and bolded bases have 
recognised polymorphisms (Wallace et aI., 1995) in which this study also find change. 
Question mark (7) indicates an un-resolved nucleotide. Numbering refers to the 
numbering assigned by Anderson et al. (1981) to the Cambridge sequence. 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
If. lar 
Cambridge 
94-107 mutant 
P. troglodytes· 
P. paniscus 
G. gorilla 
P. pygmaeus 
If. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscuB 
G. gorilla 
P. pygmaeuB 
If. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
1 
1 
6 
9 
o 
1 
1 
7 
o 
o 
1 
1 
7 
1 
o 
1 
1 
7 
2 
o 
1 
1 
7 
3 
o 
1 
1 
7 
4 
o 
1 
1 
7 
5 
o 
etteaeeggegeagteatteteataategeeeaegggettaeateeteattaetattetgeetageaaaet 
••••.•••••••••••••..•..•• g •••••••••• a •••••••••••••••••.•••••••••••••••• 
............. a.t •• e ••••••••••••••••• a ••••••••••••••• t ................. . 
..................... t .............. a •.•••...••.••.••.••••..•••.••..•.• 
............... tg .... t ...•. t ...•.... a •....... a ...... t .........•........ 
· .... , ....... ae .. ee ..... g .. t ..... t .. a .. e ......•. ec .•.. g .......•........ 
... t .. a .. t ... ae.g. e ...•...•....•.... a .. a .. c .. t .. ee.g ...•....... t .....•. 
1 
1 
7 
6 
o 
1 
1 
7 
7 
o 
1 
1 
7 
8 
o 
1 
1 
7 
9 
o 
1 
1 
8 
o 
o 
1 
1 
8 
1 
o 
1 
1 
8 
2 
o 
eaaaetaegaacgeaeteacagtcgcatcataatcctetctcaaggacttcaaaetctactcecactaata 
............. t .. e ...•............. t .................... c .............. . 
.... t .. t ........ e ••...•.....•....• t ..... e .••....•••....•.••••.••••..... 
.... t ... ;; ....... e •.....••.••..••.. t ..... c .••• , •..••.•.......•.......... 
•........•... a .. e ••... e •.......... t ........•..... c ..... e ........•.....• 
.. ~ ................ ~a .... c ....... ,.c ... ~ ....................... " .... " ........ c ......... ~ ...... " .............. c ..... ~ .. .. 
• •••••••••••. a •••••••• e •••••••••••••• a •••• g •.. g .. e ••• 9 . ct .......... g .. . 
1 
1 
8 
3 
o 
1 
1 
8 
4 
o 
1 
1 
8 
5 
o 
1 
1 
8 
6 
o 
1 
1 
8 
7 
o 
1 
1 
8 
8 
o 
1 
1 
8 
9 
o 
getttttgatgaettetagcaageetcgctaacetcgccttaccccccaetattaaeetaetgggagaact 
· .c ..•••...•••.....•.••...• a .••• t ............................. a ...•... e 
· .e ........... e ..........••. , ......•... c .•..••. t .. e •.... t .. c .. a .. g .... . 
.. ~c ... " ............. c ........................ c ...... ~ ....... c ................. c ........ t .. c .... a ............. ~ 
· . cc ............. g ........•.. c ••.................. e ........... a ... " g .. 
· . ec . c .......•.........•... a ....... t ... e .... a ..... c .. c ....• t •. a ....... . 
· . c .. e .....•.. cge .................•.... c ................... e .. a .. t .... . 
1 
1 
9 
o 
o 
1 
1 
9 
1 
o 
1 
1 
9 
2 
o 
1 
1 
9 
3 
o 
1 
1 
9 
4 
o 
1 
1 
9 
5 
o 
1 
1 
9 
6 
o 
etetgtgctagtaaeeacgttetectgatcaaatateaeteteetacttacaggacteaacataetagtea 
..••..•....•••.... a •.••.•..........•.•.•••........•.•.••••••••••..• a ••• 
... e ........•... t.a .......•........ e ......•...•. e ...... t ...•....•.. a .. . 
· .. e ......•..... t . a ...•..•...•..... ct .. e ........ c ...•.. t ...•.••..•. a • t . 
... c .. a ...•....... a ..•.........•. c.e ... c .. tt ........... tet ..••....• a. t. 
· .. e .. a ..• a .. g ... t a ....• t .•... t .. e ..•.. ca ....... a .•.........•.•.... a .. . 
.. tc .. a •.. a.gg .. t.e ...•.... gg ..•. c.ct ... a.tac •.. c •• e .. g ....•• g ..••• a .. . 
1 
1 
9 
7 
o 
1 
1 
9 
8 
o 
1 
1 
9 
9 
o 
1 
2 
o 
o 
o 
1 
2 
o 
1 
o 
1 
2 
o 
2 
o 
1 
2 
o 
3 
o 
eagecetataetceetctacatatttaccaeaacacaatggggeteaetcaeccaceaeattaaeaaeata 
....••.••.••.••.....•..•.••....•••.••.•. a ..... g •••• g ••••.•••••••••.•••• 
..•.... g ....•...•..... g •••..••..•.••••.. a •••.•••.••••••••••••••• t ..... . 
•••.••• g •••••••••••••• g .••••..•••••••••• a ..•....•...•.....•••••. t ..... . 
• .••••• g •••••••• t .. t .................... a ••• e ••••••• a •••••••• c.c ••.•... 
· . a ...•...... t ..... t ..... c .••..••....• e. a •. ta ... c .•. a ......•• e •..•••... 
.g ......•..•.... t .......... t .. t ....... C.a .•• a •••. t .. a ......•.••• a ..... . 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. paniscus 
G. gorilla 
P. pygmaeus 
H. lar 
1 
2 
o 
4 
o 
1 
2 
o 
5 
o 
1 
2 
o 
6 
o 
1 
2 
o 
7 
o 
1 
2 
o 
8 
o 
1 
2 
o 
9 
o 
1 
2 
1 
o 
o 
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aaaccctcattcacacgagaaaacaccctcatgttcatacacctatcccccattctcctcctatccctcaa 
.......................... t ....................... t .. c •................ 
• .g ...••........•••••.. t •. t •.•.. a .. tt ...•..•••...••.. c ..... t ••.••••.•.. 
.......................... t ..... a •• t ................. c ••....••....•..•• 
...•....... t .•...•..•...• t ...... a ••.•• g •..••..••.••.• c •••..•.....•..... 
•••. . t •. t •......• c •.••• t .•..••••• c •••.••••••.•....•.. c •...•• t ..•.•••... 
· ..•••..• c .•.....••••••.• tat. a •• ac. t •• g ..•. c •. t ...• c.c ..•..••.• a ..•.... 
1 
2 
1 
1 
o 
1 
2 
1 
2 
o 
1 
2 
1 
3 
o 
1 
2 
1 
4 
o 
1 
2 
1 
5 
o 
1 
2 
1 
6 
o 
1 
2 
1 
7 
o 
ccccgacatcattaccgggttttcctcttgtaaatatagtttaaccaaaacatcagattgtgaatctgaca 
· ..... t .................... c .•.••.••.••..•..........••••.••..... ; .....• 
t .. t .. t •.... c •• t •. a •• ca •••• c ..••.••••.•••.•.••••......•••...•••.••.•••• 
t .• t .. t •. t •. c •. t •• a .• ca ..•. c .•....•..•.••..•...••••.••••...•.....••.••. 
.••.•• t •• t •. c .••..... ca •••• c ...•..••••.•••••••••...•••.•••...•••...•• t. 
· •.• ag ••..•• cg. t .•... cg •.. ac .••.•••••..••.........•.. t ••••.•••••..• a . t. 
· .• ta .•....•... t .. c .•• a • tc. c ••••.• c .•...••.• t ••..••.• t •••..•.•••••• a ••. 
1 
2 
1 
8 
o 
1 
2 
1 
9 
o 
1 
2 
2 
o 
o 
1 
2 
2 
1 
o 
1 
2 
2 
2 
o 
1 
2 
2 
3 
o 
1 
2 
2 
4 
o 
1 
2 
2 
5 
o 
acagaggcttacgaccccttatttaccgagaaagctcacaagaactgctaactcatgcccccatgtctaac 
••••..••. c •..•..•••...•...•.••..••.••• t ••.••••••••..•..• at .•..•••....•• 
••••••••• C •••••••••••••••••••••••••• t.t ..•.•...•••. t •... at ••..•.. C ••••• 
....•.... c ..••..•••••••.••.•.••..•.. t.t ...••....••• t .•.• at •••..• ,c •. , •• 
• •••••••• C •• a .••••..•••......•..••..• gt •..• g .....•..••.. a .•••• g •. ct ..•• 
· t •• g. c.cc .. a ..•.•••••.••..••••.••••.••..•••••.•••.•.. tca. t- ..•..• g .•.. 
• t ..•...• cgaa .•• t ••• gc .•...•..••.•. c .•...•.••...•••.••. ctat •••.••• a ..•• 
1 
2 
2 
6 
o 
1 
2 
2 
7 
o 
1 
2 
2 
8 
o 
1 
2 
2 
9 
o 
1 
2 
3 
o 
o 
1 
2 
3 
1 
o 
1 
2 
3 
2 
o 
aacatggctttctcaacttttaaaggataacagctatccattggtcttaggccccaaaaattttggtgcaa 
.......•.•....................•..• c ...• g .•••••••••••••••.•••••••••••.•• 
......•........••..••.....•......• c .... g ..••••••••••••.•.••••••.••.•••• 
........•..•..•••..•.............. c ...• g •.••••..••••••••••••••••••••..• 
••.•.•••.•••...••••.•.•••.•....•••.•••.....••...... a ......•.•••.••.•••• 
•.••••••••••••• g ••••••••••••.•••••••••• c •.•.....•.. at ...•...••••..••... 
...............•.••..••.•.•.••••....•.••..•.••.••.. a ..•...•..•...•..... 
1 
2 
3 
3 
o 
1 
2 
3 
4 
o 
1 
2 
3 
5 
o 
1 
2 
3 
6 
o 
1 
2 
3 
7 
o 
1 
2 
3 
8 
o 
1 
2 
3 
9 
o 
ctccaaataaaagtaataaccatgcacactactataaccaccctaaccctgacttccctaattccccccat 
.••.••..••.•••••..•••••. t .. g .••...•• c •••..•.• g •.•• a •..•.. t •..••..•.. t .. 
•••..••.•.•••.•••••.•••. t. t •..•• c .•..•.... t .•••.•• a •.• c .. t •••... t ••.... 
· ..•.•...•....••.•.•••.• t. t .•.•. c ..•...•.• t ......• a ••• c .• t •..•.. t •..... 
.•.....•.......•.••. t .•• t .. g .... c •.•..••.. t •• g ...• a ••.••. t •••...•••. t .. 
· ........•....•• c.g •••.. ttt •. c •• c ••••• tg ••.. c .•• t. a ..•...••••. c ••.•...• 
• •....••........•• g. a .•. t .••• c .. c •.• g .•• tt •••.. g •• a •• c •.•.•••••••••.••. 
1 
2 
4 
o 
o 
1 
2 
4 
1 
o 
1 
2 
4 
2 
o 
1 
2 
4 
3 
o 
1 
2 
4 
4 
o 
1 
2 
4 
5 
o 
1 
2 
4 
6 
o 
ccttaccaccctcgttaaccctaacaaaaaaaactcatacccccattatgtaaaatccattgtcgcatcca 
•..•.••.•••.. a ••••.••.•. t .............. t ........ a •..••.•••.•• a ••..••••• 
.•. c •.......• a .•..•.•••..•.•.•......... t ........... g ..•••••.• a •.•• g ..•. 
•.. c ••.••.••. a •••••.••...•..•.......... t ........... g ••....•.• a •••. g .••• 
• .•••....• t .• a. c •• t .....•..••.•. g ••..•..•....•.. c ••.••••• t .• c •••..•..•. 
taccg. t ..•.•. a .••.... c •.....•..... c .•.••..••. c .•••....• a.ggcca ..•..•.. g 
tacag ..•••.. ta ••.•... c .• t ...•. g ..•• t ..•••. g .. c .• c ..•... ttg. cca. t .. c •. t. 
Cambridge 
94-107 mutant 
P. troglodytes 
P. panisGus 
G. gorilla 
P. pygmaeus 
H. lar 
Cambridge 
94-107 mutant 
P. troglodytes 
P. panisGus 
G. gorilla 
P. pygmaeus 
H. lar 
1 
2 
4 
7 
o 
1 
2 
4 
8 
o 
1 
2 
4 
9 
o 
1 
2 
5 
o 
o 
1 
2 
5 
1 
o 
1 
2 
5 
2 
o 
1 
2 
5 
3 
o 
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cctttattatcagtctcttccccacaacaatattcatgtgcctagaccaagaagttattatctcgaactga 
· .c .• g ••.• t .......................... a.a .........•....• c ...••.•. a ...•.. 
...•.. . c .. t .. c .• t •.•....•..........•. a .•.......•••••.. c ..•...... a ..••. g 
••••... c .. t .. c •• t .................... a .••••..•.•.•...• c ...•..••. a ..... g 
· ...... c •.... c •••••.....•....•.... tc. a •.•••.....•••••. c ..••..... a.g •... 
• ••... c ...... c •. ta .... a ......••..• t .. c ....... ga ...... acc .. cg •• a. a ..... . 
· •...•• a ..... c •• a •. t ..•••.. t ...•..•..••.. ac ...•••.... acc .•••. t .. a •.•... 
1 
2 
5 
4 
o 
1 
2 
5 
5 
o 
1 
2 
5 
6 
o 
1 
2 
5 
7 
o 
cactgagccacaacccaaacaacccagctctccctaag 
...•. g •. a ...•.....•••••.•• a .•••.• ? ••• 
.....•.• a .•...•.••••••••••.•.••.•••••• 
•••••••• a ••••••••••••••••••••••••••••• 
•••••.. . a .••..•••••••. tt .. a ...•••...•. 
tg ...• a. a .. c •.... g .•. cta •. a ..... a •..•. 
...... a.tg ...•••.••. gctag.a ......•.... 
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Appendix 9. An evaluation of the derivation ofknuc from Kimura, (1981) as it applies to 
mitochondrial pseudogenes. 
Kimura (1981), states that the base substitution rate per unit time{knuc) is equal to 
the overall corrected base substitution rate (K) divided by twice the divergence time (T) 
i.e. : 
knuc = Kl2T (1) 
This is based on dendrogram relationships of terminal taxa where the nucleotide changes 
in time T are subdivided into two internode branches from an internal node to the 
terminal taxa. i.e. : 
mt 1 mt2 
However, for mtDNA pseudogenes, the rate of change along the nuclear branch since 
the time of insertion approximates zero. The terminal pseudogene node therefore 
approximates the internal node (assuming branches represent nucleotide changes) and 
therefore the tree can be re-drawn. i. e. : 
mt 1 
Thus to better approximate the base substitution rate per unit time when applied to 
mtDNA pseudogenes equation (1) should be modified to : 
knuc = KIT (2) 
as changes are only occuring along one internode branch in time T. 
